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Abstract 
 
Introduction: Obstructive sleep apnoea syndrome (OSAS) is common but remains 
underdiagnosed and is linked with several disease states and increased risk of 
mortality. The key symptom, excessive daytime sleepiness, is commonly measured with 
the Epworth Sleepiness Scale which is not always easily completed by patients. The aim 
of this thesis is to develop pictorial material for assessing sleepiness and risk of OSAS. 
 
Methods: Health literacy was measured in a sample sleep population and the Epworth 
Sleepiness Scale was investigated for ease of use. Images were developed to translate 
the Epworth into pictures and the response to pictures of ‘driving while sleepy’ was 
investigated in detail. A new tool, the pictorial Sleepiness and Sleep Apnoea Scale, was 
devised by adding four sleepiness images from the pictorial Epworth to four new images 
representing ‘risk of OSAS’. Evaluations were made in two populations of the tool’s 
potential in predicting those at risk of OSAS. 
 
Results: Poor or impaired health literacy was found in 16% of patients attending the 
sleep clinic. Evaluation of the Epworth Sleepiness Scale found that a third of new 
patients made quantifiable errors. A preference for the pictorial Epworth Sleepiness 
Scale was reported by 55% of users and a kappa statistic indicated good agreement 
between the pictorial and traditional Epworth Sleepiness Scale. Drivers were more 
inclined to record feeling sleepy if the image in Q8 depicted the sleepy person in the car 
as a passenger. In a sleep clinic population the pictorial Sleepiness and Sleep Apnoea 
Scale was slightly better at predicting disease than the Epworth. In a cardiac 
rehabilitation clinic use of the witnessed apnoea image from the pictorial Sleepiness and 
Sleep Apnoea Scale, along with the Epworth Sleepiness Scale, helped to identify 
symptoms suggestive of sleep apnoea in a third of those screened. When investigated 
with a sleep study, the prevalence of sleep–disordered breathing in this patient group 
was 14.8%.  
 
Conclusion: Pictorial tools for patients with potential obstructive sleep apnoea syndrome 
have clinical value and can help bridge the gap between poor or impaired health literacy 
and the material we use to assess sleepiness and likelihood of obstructive sleep apnoea 
syndrome.  
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Glossary of Terms 
 
Case finding 
 
 
An epidemiological term given to a system of identifying a specified 
medical condition within a population of hospital inpatients or 
primary or secondary care outpatients. Case finding may be 
contrasted with screening which seeks to identify those at risk of a 
medical condition amongst a general population. 
 
 
Functional 
literacy 
 
 
The level of literacy skills needed not only to read and write but 
also to understand and use printed information in daily life, at 
home, in work or in the community. 
 
 
Guessability 
testing 
 
 
A technique for testing the understandability of pictorial images. 
The respondent writes a few words or a short sentence to describe 
an image. 
 
 
Obstructive 
Sleep Apnoea 
Syndrome 
 
 
The diagnosis of obstructive sleep apnoeas coupled with symptoms, 
usually of excessive sleepiness in the daytime. 
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REALM 
 
 
The Rapid Estimate of Adult Literacy in Medicine is a short test 
evaluating adult reading age.  
 
 
Screening 
 
 
An epidemiological method of identifying people in a general 
population who may have an increased risk of a particular medical 
condition. 
 
Translucency 
testing 
 
 
A technique for testing comprehensibility of pictorial images. The 
respondent numerically rates the relationship between an image 
and the corresponding written definition. 
 
Witnessed 
apnoea 
 
 
A bed partner reporting that the subject stops breathing during 
sleep. 
 
 
 
Glossary of Abbreviations 
 
AHI Apnoea Hypopnoea Index 
CPAP Continuous Positive Airway Pressure 
CPRP Cardiac Prevention and Rehabilitation Programme 
EDS Excessive Daytime Sleepiness 
ESS Epworth Sleepiness Scale 
ICNSH Idiopathic Central Nervous System Hypersomnia 
MAP Multivariable Apnea Prediction 
MAS Mandibular Advancement Splint 
MSLT Multiple Sleep Latency Test 
MWT Maintenance of Wakefulness Test 
ODI Oxygen Desaturation Index 
OSA Obstructive Sleep Apnoea 
OSAS Obstructive Sleep Apnoea Syndrome 
OSLER Oxford Sleep Resistance Test 
pESS  Pictorial Epworth Sleepiness Scale 
pSSAS Pictorial Sleepiness and Sleep Apnoea Scale 
REALM Rapid Estimate of Adult Literacy in Medicine 
RTC Road Traffic Crash 
RPSGT Registered Polysomnographic Technologist 
SSS Stanford Sleepiness Scale 
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Overview 
 
This thesis describes the development of a pictorial measure of daytime sleepiness and a 
tool to assess the likelihood of an individual having obstructive sleep apnoea syndrome. 
The main body of work concerns the following two disciplines of medical science: 1. the 
assessment of breathing during sleep and 2. the use of pictures in medicine. 
 
Obstructive sleep apnoea syndrome is common but underdiagnosed. Chapter 1 reviews 
the burden of disease associated with the condition, discusses the importance of 
assessing the symptom of excessive daytime sleepiness, and appraises how the 
syndrome is diagnosed and managed. 
 
The first experimental study in Chapter 2 asks how well patients self–complete a 
currently commonly used sleepiness scale, the Epworth Sleepiness Scale? Chapter 3 
provides an introduction to the subject of health literacy and an assessment of literacy 
levels in patients with obstructive sleep apnoea syndrome and chronic lung disease. 
Chapter 4 describes the pictorial translation of the Epworth Sleepiness Scale and 
assesses the new scale in the clinical environment. Here, the depiction of “sleepiness 
whilst driving” is also explored, which leads to a refinement of images in Chapter 5. 
Four new pictorial questions relating to the assessment of obstructive sleep apnoea 
syndrome are created and a new tool, the pictorial Sleepiness and Sleep Apnoea Scale is 
devised. Specific methods to assess the understanding of pictograms are tested in 
patients in the UK, Pakistan and Hong Kong. The tool is assessed against patients’ 
descriptors of sleepiness and against an objective measure of sleepiness in the 
laboratory in Chapter 6. The reproducibility and internal consistency of the scale are 
described. 
 
Patient trials of the pictorial Sleepiness and Sleep Apnoea Scale are reported in Chapter 
7. Sleepiness and case finding components of the scale are measured against diagnosis 
of obstructive sleep apnoea syndrome and the clinical decision to treat with continuous 
positive airway pressure therapy in a sleep clinic population. To conclude, the use of the 
pictorial Sleepiness and Sleep Apnoea Scale, in conjunction with the Epworth Sleepiness 
Scale, is trialled amongst patients in a cardiology prevention and rehabilitation 
programme.  
 
20 
 
Chapter 8 discusses the overall direction of the work and considers the usefulness of the 
new scale in the clinical setting. This discussion includes a summary of the limitations 
of the work and outlines future directions in which it may be taken. The use of the 
pictorial Epworth Sleepiness Scale by the British Lung Foundation is described. 
 
Statistical analysis was made using SPSS Statistics version 17.0.1 and IBM SPSS 
Statistics version 21.0.1 with some descriptive statistics made using Microsoft excel 
2010.  
 
Ethical approval for the studies undertaken in this thesis came from Charing Cross 
Ethics committee and the National Research Ethics Service West London REC 2. 
Further information is available in Appendix 10. 
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Chapter 1  
 
Obstructive Sleep Apnoea Syndrome 
 
Introduction  
 
Much has been discovered about sleep in the last century. The first recordings of 
electrical activity in the human brain noted differences in EEG rhythms between wake 
and sleep and in the 1950s continuous all–night recordings revealed 90–minute sleep 
cycles interspersed with periods of lightening or rapid eye movements which increased 
in frequency as sleep progressed into the early hours. 1 2 The introduction of 
instruments that measure and record blood oxygen saturation, respiratory airflow, the 
electrical activity of various muscles, to name a few, are technological advances that 
have enabled clinical sleep studies. The recognition of sleep as an independent 
scientific and medical modality has grown together with the technological advances in 
the field over the last seventy years.  
 
Sleep is important for well–being; poor quality or inadequate sleep at night has 
consequences on how we function in the subsequent waking hours. Studies have 
demonstrated that sleep duration is associated with morbidity and life expectancy and 
sleep disorders are common from the young infant through to those in their senior 
years.3 Children that snore in their sleep have been reported to be poorer performers at 
school and, in adults, snoring can be a major social problem with impacts on quality of 
life and on partners’ sleep. 4 For some, the problem with breathing at night extends to 
intermittent collapse of the upper airway resulting in obstructive sleep apnoeas.  
Obstructive sleep apnoea syndrome (the presence of apnoeas coupled with symptoms) 
was first described by French and German groups in 1965.5 6 In the 48 years since, 
research into this disorder has grown and it is probably the most common disorder of 
sleep seen by specialists today. Insomnia, is believed to be the biggest sleep complaint 
presenting in primary care.  
 
How easy is it for those with a suspected disorder of sleep to access professional help? 
In the UK, sleep medicine is still in relative infancy. Clinical sleep practices are 
principally the interest of a mixed group of health professionals who operate from a 
secondary care setting, comprising mainly respiratory specialists, ENT physicians and 
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surgeons, anaesthetists and neurologists. 2008 was a landmark year for Sleep (and 
aspiring Sleep practitioners), when the UK National Institute of Clinical Health and 
Excellence issued a positive technology review on continuous positive airway pressure 
therapy for obstructive sleep apnoea syndrome. The implications of the review were 
that continuous positive airway pressure therapy should now be available to all 
patients diagnosed with moderate to severe obstructive sleep apnoea syndrome, and to 
those with mild symptomatic disease.  
 
The measurement of sleepiness with the Epworth Sleepiness Scale was a key feature of 
the technology review. Evidence was presented from 23 randomised control trials 
which compared continuous positive airway pressure therapy for obstructive sleep 
apnoea syndrome with placebo or usual care; the assessment of sleepiness was 
evaluated with the Epworth Sleepiness Scale. Meta–analysis of these studies identified 
a significant reduction in daytime sleepiness in those on continuous positive airway 
pressure therapy (weighted mean difference in Epworth Sleepiness Scale score −2.7; 
95% confidence interval [CI] −3.5 to −2.0). 7 These recommendations have affected the 
provision of sleep services across the UK.8 While this is a positive move toward 
recognition of obstructive sleep apnoea syndrome, the challenges of meeting the 
increased demand on existing sleep services and commissioning new services are 
problematic in today’s economic conditions and cuts to public services. Screening or 
case finding, and targeting care to those most in need is one partial way of addressing 
the problem. Ensuring that high risk groups, such as professional drivers, those having 
bariatric surgery, or those with uncontrolled hypertension have easy access to a service 
and to swift treatment is one way of addressing the burden of undiagnosed obstructive 
sleep apnoea syndrome.  
 
 
 
Obstructive sleep apnoea syndrome diagnosis and treatments 
 
Obstructive sleep apnoea syndrome is associated with significant morbidity and 
mortality. It is the most common form of sleep disordered breathing worldwide and 
encompasses a spectrum of disease that ranges from snoring and possible pre–morbid 
disease, with increases in upper airway resistance and reduced airflow (hypopnoeas), 
through to the frank apnoeas that can be alarming for the bed partner to witness 
(figure 1.1). 3  
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Figure 1.1. Example of a 5 minute recording of breathing in sleep. Repetitive 
obstructive sleep apnoeas, represented by a) recurrent pauses in nasal airflow 
(measured via a nasal cannula and pressure transducer), b) chest and abdominal wall 
movements, c) dips in oxygen saturation and d) pulse rate arousal. Snore trace 
extracted from the flow measure.  
 
 
 
 
During the apnoeic events, affected people suffer repetitive narrowing or collapse of the 
pharyngeal airway, resulting in intermittent nocturnal hypoxia (figure 1.1). These 
events are frequently terminated by an arousal which causes disruption of quality of 
sleep and fragmentation of sleep structure. For many this leads to a feeling of excessive 
sleepiness during the day. The number of apnoeas or hypopnoeas per hour can be used 
as an index of the disturbance of normal respiration during sleep. Obstructive sleep 
apnoea syndrome is the association between these respiratory disturbances and the 
presence of symptoms, such as excessive sleepiness in the daytime. 9   
 
Prevalence studies suggest that obstructive sleep apnoea syndrome affects between 1% 
and 5% of adults (35–65 years); 9 certain types of body habitus, including obesity, 
predispose to the condition, with a higher incidence of obstructive sleep apnoea 
syndrome in males and an increase in prevalence with age.10 These age related 
increases have been reported to  plateau at about 65 years of age although the true 
extent of obstructive sleep apnoea in the elderly is complicated by an increase in 
a. obstructive 
apnoea event 
b. chest and abdominal 
wall  movements 
c. dips in oxygen 
saturation 
d. pulse rate 
arousal 
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central sleep apnoeas and differing levels of daytime sleepiness compared to younger 
counterparts.9 11  
 
The collapse of the upper airway and resulting cascade of events is a multi–factorial 
process. Neurological control of airway muscle tone during sleep, facial morphometry, 
gravitational effects, and fat deposition in the structures surrounding the upper airway 
are main contributors.12 13 Weight loss may be effective in controlling the number of 
events and eliminating the syndrome for some, but not for all. Obstructive sleep 
apnoea syndrome may occur in those who are not obese. In a large Edinburgh sleep 
practice, 50% of newly diagnosed patients with obstructive sleep apnoea syndrome had 
a BMI < 30 kg.m2. 14 13 Structural abnormalities or compromise of the oro–pharyngeal 
airway by causes such as retrognathia or macroglossia predispose to the condition. 
Other causes include some chromosomal disorders for example Down’s Syndrome and 
muccopolysaccaridosis.  
 
Breathing instability and impaired control of breathing during sleep also contribute to 
an increase in apnoeas during sleep.15 The increase in central sleep apnoeas mentioned 
may be partly attributed to disease; a higher incidence of central apnoeas is observed 
in heart failure and stroke patients.16 17 It has been demonstrated that during central 
loss of respiratory drive and apnoea, there is also partial airway occlusion. This 
evidence, derived from imaging the upper airway, showed the airway wall’s 
susceptibility to collapse in the latter half of the apnoea.18-20  Mixed or central apnoeas 
can be observed during a sleep study when chest and abdominal wall movements are 
measured. The absence of movement in these measurements guides the scorer to the 
respiratory event being centrally mediated.  
 
Sleep phase can contribute to changes in the pattern of breathing and airway patency.  
During rapid eye movement (REM) sleep, it is not uncommon to observe waxing and 
waning of airflow in normal individuals. Thus, for those with a predisposition to 
obstructive apnoeas, these apnoeas may worsen or become apparent during REM sleep 
(figure 1.2). Conwell and colleagues report that REM related obstructive sleep apnoea 
is responsible for 15–35% of cases of sleep disordered breathing in sleep clinics. The 
neurochemical basis of the moderation of genioglossus muscle activity during REM 
sleep has recently been discovered, offering hope of a pharmacotherapeutic solution in 
the future.21 22;23  
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Figure 1.2. Overview of a night’s sleep recording; traces of interest 1. EEG 
(Electroencephalogram) 2. SpO2 (oxygen saturation) and 3. obstructive apnoea events: 
showing frequent intermittent changes in oxygen saturation with periodic worsening 
during REM sleep episodes, highlighted by the arrows, and an increase in the duration 
of apnoeas consistent with REM intervals. 
 
 
 
Care should be taken in avoiding substances that worsen apnoea, especially in those 
who are vulnerable to sleep disordered breathing. Opioid based drugs and sedatives 
   1.      
EEG 
 
2.  
REM REM REM 
3.  
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such as benzodiazepines depress respiratory drive and affect airway muscle patency 
thus contributing to a worsening of apnoeas and sleep related breathing problems.15 24  
 
In the UK, those suspected of having obstructive sleep apnoea syndrome by their 
general practitioner are referred to a centre (where there is one available) for specialist 
testing. Diagnostic methods vary from basic home oximetry, which counts the number 
of times there is an oxygen desaturation (normally a 4% deviation from baseline), and 
generates a second pulse wave that indicates the likelihood of an associated arousal 
and sleep disturbance (figure 1.3), to home or inpatient respiratory case finding with 
added measures of respiratory flow, normally via cannulae at the nares measuring 
pressure, sleep position, and chest and abdominal effort (figures 1.1 and 1.4). 
Respiratory effort is best measured using an oesophageal pressure sensor but is less 
common in the clinical setting as it is relatively invasive; a good surrogate is 
respiratory inductance plethysmography which is superior to older technologies such 
as piezoelectric sensors. In the UK, full attended polysomnography with EEG is rarely 
carried out to diagnose obstructive sleep apnoea syndrome; in North America and parts 
of Europe such as France or Belgium, however, full polysomnography with EEG is 
common practice.  
 
The severity of obstructive sleep apnoea is measured by the number of apnoeic or 
desaturation events occurring per hour of sleep (figure 1.1). This allows stratification 
into mild (0–15 events per hour), moderate (15–29 events per hour) and severe disease 
(>30 events per hour). 25 The change in amplitude of the flow signal and the duration of 
the apnoea are both important in determining and classifying the apnoea or a 
hypopnoea, with a general rule of thumb that an apnoea lasts 10 seconds or more and 
is less than 15% of the flow signal and a hypopnoea is less than 50% of the flow signal 
and is accompanied by a desaturation.26  
 
Different models of diagnostic equipment use different oximeters and flow measures, 
which have differing levels of sensitivity. If an oximeter alone is used to collect data on 
the number of oxygen desaturations and pulse rate changes overnight (without flow or 
other measurements), apnoeic episodes may be missed, and further study may be 
needed. In other words, desaturations with an associated history of daytime 
somnolence or (other symptom such as) witnessed apnoea, can offer a positive 
diagnosis but a ‘negative’ test does not exclude apnoeas during sleep.  
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Figure 1.3. Example of oxygen saturation and pulse rate measurements from a patient 
with frequent obstructive sleep apnoeas during sleep, represented by recurrent dips in 
oxygen saturation (SpO2). Each row displays one hour’s data, with the upper trace 
showing SpO2 and the lower trace the associated pulse (heart) rate.  
 
 
 
Trace reproduced by courtesy of Professor Partridge. 
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Figure 1.4. Example of a 5 minute recording of breathing during sleep showing (a, row 
2) episodic snoring (b, row 3) frequent obstructive sleep apnoeas represented by 
recurrent pauses in nasal flow measured with a thermistor (c, row 4) heart rate 
arousals and (d, row 5) associated dips in oxygen saturation. Sleep position was supine. 
 
 
Treatment for obstructive sleep apnoea is in the main confined to those that benefit the 
most; those that are symptomatic and sleepy. Until recently there was little evidence 
that asymptomatic patients with sleep apnoea derive benefit from continuous positive 
airway pressure therapy. However, MOSAIC, a multi–centre randomised controlled 
trial of continuous positive airway pressure therapy in the less symptomatic 
individuals (inclusion criteria was an oxygen desaturation index >7.5 events per hour 
but an ESS <10) showed that less symptomatic patients have improvements in 
subjective and objective daytime sleepiness and self–assessed health status. Despite 
these positive findings, the evidence for improvements in vascular risk was not proven 
and the long term benefit that continuous positive airway pressure therapy confers on 
survival in less symptomatic patients, remains unclear and needs further 
investigation.27 28 29 
 
Treatment with nasal continuous positive airway pressure therapy can successfully 
reduce daytime sleepiness, increase alertness, reduce the rate of road traffic crashes 
and, in those with more severe obstructive sleep apnoea syndrome, is associated with a 
reduction in blood pressure.30 31  One observational study  in the Lancet concluded that 
obstructive sleep apnoea syndrome leads to fatal and non–fatal cardiac events, and 
b 
d 
c 
a 
  
 29 
reported that the risk of events in those with moderate disease is reduced with 
continuous positive airway pressure therapy (figure 1.5).32  
 
Figure 1.5.  Cumulative risk of fatal and non-fatal cardiovascular and cerebrovascular 
event is reduced with continuous positive airway pressure therapy. Study groups were 
followed annually for 10 years after diagnosis.  (Long-term cardiovascular outcomes in 
men with obstructive sleep apnoea-hypopnoea with or without treatment with 
continuous positive airway pressure: an observational study, Lancet, 2005). Figure 
reproduced with the kind permission of the author Jose M Marin. 
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It has been estimated that in reducing road traffic crashes alone, treating 500 patients 
with continuous positive airway pressure therapy over five years at a cost of 0.4 million 
pounds, would save 5.3 million pounds compared with the cost of therapy;  a 12.3 fold 
return on each pound spent. 33  
 
Continuous positive airway pressure therapy is a relatively novel treatment. It was 
first described by Colin Sullivan in 1981, the same year that data was published on 
surgical interventions on the upper airway with uvulopalatopharyngoplasty for 
obstructive sleep apnoea syndrome.34 35 Delivered from a pump, via a nasal or oro–
nasal mask, positive pressure in the range of 4–20 cmH2O splints the airway thus 
preventing luminal collapse. Titration studies are useful in setting the treatment 
pressure required; individuals with the same severity of disease may need very 
different treatment settings. For example in an elderly group of patients matched for 
disease severity, body mass index and neck circumference, continuous positive airway 
pressures required were lower in the elderly than in the younger controls [mean (sd): 
6.9 (1.9) cmH2O and 9.4 (3.5) cmH2O, respectively; P<0.0001]. This study postulated 
that greater lung inflation and reduced tracheal tug in the older group was responsible 
for the effect. 36 Modern advancements in continuous positive airway pressure therapy 
include auto–titrating machines which vary delivered pressures over the night. While 
auto–titration appears cost effective in reducing the need for titration studies and some 
patients report additional comfort and preference compared to standard fixed pressure 
CPAP, there is currently little evidence to suggest one modality is superior to the 
other.37 38 Cognitive behavioural therapy for new CPAP recruits has shown to be useful 
in improving adherence to therapy.39 
 
Prior to continuous positive airway pressure therapy, tracheostomy had been the only 
viable treatment available. Guilleminault was one of the first to recommend this in the 
treatment of a 10 year old child with sleep apnoea in 1972. 1 Today tracheostomy is 
rarely used, but it still is a treatment option where other options are limited or have 
failed.   Continuous positive airway pressure therapy is not always easy to adhere to 
and there are few viable alternatives. Uvulopalatopharyngoplasty and more modern 
surgical variations of this operation lack the sound scientific evidence that compare 
efficacy to alternatives such as continuous positive airway pressure therapy or no 
treatment. These surgical interventions are currently not recommended for moderate 
to severe, symptomatic obstructive sleep apnoea although sadly it is not uncommon to 
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find that some patients with likely obstructive sleep apnoea syndrome may still be 
offered the procedure without prior investigation and, in rare cases, be offered the 
surgical procedure post diagnosis. 25 
 
Other potential treatments for obstructive sleep apnoea syndrome such as conventional 
weight–loss methods, avoiding the supine sleep position and lifestyle modification are 
difficult to achieve or have limited effects.40 Mandibular advancement splints probably 
have a role in mild to moderate disease but there is limited long–term clinical evidence 
that they are well tolerated and cause no long–term side effects such as 
temporomandibular disorders or need for dental treatment.41 A Cochrane review of oral 
appliances for the treatment of sleep disordered breathing concludes that oral 
appliances improve the symptom of excessive sleepiness but that CPAP was superior in 
controlling the number of apnoea / hypopnoea and oxygen desaturation events in 
sleep.42    
 
There is a growing interest in bariatric surgery and maxillary and mandibular 
repositioning as alternatives to continuous positive airway pressure therapy in selected 
patients, but the evidence that these should be routinely offered is not yet established. 
A Nordic review suggests that there is currently no data to support bariatric surgery’s 
role in the control of obstructive sleep apnoea syndrome in the obese. 43 However, as a 
therapy option it is a growing area of interest and many studies report improved 
outcomes such as a reduction in daytime sleepiness. Whether these changes are 
sustainable is questionable and rather than a cure, modest improvements in the 
condition are more likely to be reported. The coupling of improved weight loss with a 
reduction in symptoms might mean some bariatric patients no longer need or meet the 
diagnostic criteria for therapy for continuous positive airway pressure therapy. 44;45 46 47 
Following weight loss with bariatric surgery patients may require lower continuous 
positive airway pressure therapy settings, such as the reduction reported by Kuzniar of 
halving the pressure required from 16 cmH2O to 8 cmH2O seven months after 
surgery.48 There is the risk of recurrence of obstructive sleep apnoea syndrome in this 
patient group, demonstrated by Patrick Lavie’s group in France, where a cohort of 
obese patients who had maintained weight loss and initially experienced 
improvements, found the condition had returned seven and a half years after surgery.49  
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Drug therapies are a move towards personalised medicine in the treatment of 
obstructive sleep apnoea syndrome, directing treatments to the different causes and 
areas of obstruction, for example targeting genioglossus muscle activity in REM–
related obstructive sleep apnoea, which was mentioned earlier.21 22;23 Currently, there 
is little evidence that drug therapies are effective in controlling symptoms and have at 
best modest reductions in apnoea–hypopnoea index.50 It is a developing area of interest 
for future treatment of the condition. 
 
 
Delays in diagnosis and the burden of disease 
 
The burden of disease associated with obstructive sleep apnoea syndrome has 
implications for society and the health of nations. 51, ,52,53 In a statement on health 
outcomes research in sleep apnoea, the annual cost of reduced productivity due to all 
sleep disorders in the US was estimated to be $18 billion.54 Another North American 
study estimated the costs of untreated obstructive sleep apnoea syndrome to be $3.4 
billion in additional medical costs. 55 Canadian evaluations have shown use of 
healthcare services by patients in the ten years prior to the diagnosis of obstructive 
sleep apnoea syndrome is higher compared with matched controls. In the year prior to 
diagnosis patients were heavier users of medication, particularly medicines used to 
treat cardiovascular disease, and health care costs of people with undiagnosed 
obstructive sleep apnoea syndrome are twice those of a control population. 53,56, 57 58, 52, 
 
It is estimated that 82% and 93% (respectively) of middle–aged men and women, with 
moderate to severe obstructive sleep apnoea remain undiagnosed. 59  
 
Studies indicate that obstructive sleep apnoea syndrome has a greater prevalence 
amongst black–American men in comparison to other communities, and as the 
literature grows, other social groups appear to have higher than average rates.60 One 
community–based study in Delhi, conducted across four different socio–economic zones, 
found a prevalence of obstructive sleep apnoea of 9.3%, which is double the 2–4% 
prevalence considered normal in western countries. 61 59 9 Two publications studying 
professional drivers report an incidence of 15.8% and 28.1% respectively, which is far 
greater than previously reported in general population studies.  62 63  
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In my opinion there are three main challenges to making population studies of 
obstructive sleep apnoea syndrome and to comparing such studies. First, are the 
variety of methods used for carrying out studies. Second, are the different diagnostic 
parameters utilised by different laboratories. Third, the night to night variability of 
individuals’ presentation of obstructive sleep apnoea syndrome can render different 
results. Le Bon and colleagues found a 15–25% difference in positive diagnosis rate 
dependent on which of two nights’ sleep recordings were used.64 The range of 
technologies available for making a diagnosis is great. As mentioned earlier, depending 
on where you live, diagnosis might involve full attended EEG studies or single home 
oximetry tests. Equipment and analysis parameters vary from laboratory to laboratory 
and country to country. Mirrakhimov and colleagues recently published the first 
systematic review on the prevalence of obstructive sleep apnoea in Asian adults and 
commented 65: 
 
‘…it is difficult to estimate the potential prevalence of OSA/OSAS in the general 
population in these countries, because of the heterogeneity of the subjects and methods 
used to assess patients at risk and different types of sleep monitoring devices used…’  
 
Flow at the anterior nares can be measured using cannulae and a pressure transducer 
or by naso–oral devices such as thermistors or thermocouples, or by a surrogate 
marker such as the summed channels of respiratory effort. Respiratory effort in turn, 
can be measured in several ways: using bands and a strain gauge or respiratory 
inductance plethysmography for example.  
 
The inter– and intra–scorer reliability of marking apnoeas and hypopnoeas during 
manual scoring varies and automated computer analysis is still not sufficiently 
reliable.66  The degree of susceptibility to obstructive sleep apnoea syndrome in one 
person can fluctuate over time.66  Night to night variability is driven by alcohol, 
sedative medication, sleeping position, smoking and health status (i.e. nasal congestion 
and colds, or seasonal changes to the mucosal linings of the upper airway); all can 
influence airway collapsibility. Weight gain (in the vulnerable) may tip one into the 
morbid category.10 
 
There are few studies that make longitudinal or serial evaluations of breathing during 
sleep over lifespan.10;67;68 Much of the burden of disease in obstructive sleep apnoea 
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syndrome occurs before the diagnosis is made. Historically those suspected of having 
obstructive sleep apnoea syndrome in the UK have incurred long waiting times before 
access to a diagnostic service became available. Due to delays in diagnosis, the 
condition carries significant financial and personal cost to individuals and health care 
systems. 53,56, 57 58, 52 Delays in diagnosis impact on quality of life and relationships. In 
earlier published work, I measured the duration of the symptoms of sleepiness, of 
snoring and of witnessed apnoea prior to diagnosis.51 I found patients experienced 
sleepiness and witnessed apnoea for a median of eight years (range 0.5–62 years and 
1–49 years respectively) and duration of snoring complaint was 12 years (range 2–52 
years) before visiting the sleep centre. Delays suggest a general lack of awareness 
amongst the public and health professionals about the condition. 
 
Cognitive impairments and sleepiness in those with obstructive sleep apnoea syndrome 
are well documented and can lead to an impaired quality of life and a reduction in 
vitality. Risk of road traffic crashes is seven times that of the general population. 69 70 
Even in mild disease, sleepiness can be an issue; in the Wisconsin Sleep Study cohort, 
sleepiness was reported in 23% of women and 16% of men who had an AHI ≥5 events 
per hour compared to 10% of non–snoring women and 3% of non–snoring men with 
apnoea hypopnoea indices of less than 5 events per hour.9 Changes in brain 
morphology of patients diagnosed but not yet treated for obstructive sleep apnoea 
syndrome have been found when compared to healthy age–matched controls. 71, 72 In 
particular, deficits in grey matter in the cerebellum may result in motor dysfunction 
and working memory deficits, with negative consequences for tasks such as driving. 72 
 
Obstructive sleep apnoea syndrome is an important risk factor for hypertension 
independent of excess weight or other potential cofounders and studies support an 
association between the disorder and myocardial infarction.  73,74 ,75  In those with 
coronary artery disease, elevated respiratory disturbance indices were connected with 
increased mortality, myocardial infarction and cerebrovascular events. 76 77  Animal 
models support the relationship between severe obstructive sleep apnoea and 
hypertension and the up–regulation of intracellular molecules such as HIF–1α via 
chronic cyclical intermittent hypoxia is well documented.78 Sleep fragmentation and 
arousal also trigger biological pathways that increase sympathetic activation and 
inflammatory markers. Together these two mechanisms are proposed to lead to insulin 
  
 35 
resistance, hypertension and cardiovascular disease; obesity and visceral fat 
independently activate these pathways.79 
 
Once obstructive sleep apnoea syndrome is diagnosed, there may be further delay 
before continuous positive airway pressure therapy treatment can begin. During the 
period of the last UK government (1997–2010), directives were put in place to help 
patient pathways; services were required to see and treat patients within 18 weeks of 
the initial referral.80 These rules improved waiting times in the sleep service I worked 
in. However, with limited resources and staff this was a difficult challenge to meet. In 
addition, sleep services around the UK are not uniformly distributed or geographically 
matched to populations. Referral is largely dependent on the fortune of having facilities 
close to home, or a general practitioner or health professional with the knowledge to 
make the referral. Figure 1.6 shows the rate of sleep studies undertaken per 
population by PCT (2011) from the NHS Atlas of Variation in Healthcare for 
Respiratory Disease. 81 Access to diagnostic assessment for sleep disorders is described 
as ‘patchy’ with ‘a failure to diagnose being common’ and ‘intervention rates are low 
compared to the prevalence of sleep disorders’.  The Atlas describes respiratory sleep 
disorders as having the highest level of service inequality of all respiratory related 
disorders, with a 57 fold difference in sleep studies between the lowest and highest 
providers of tests.  
 
One of the recommendations made by the publication (of the NHS Atlas of Variation in 
Healthcare for Respiratory Disease), to reducing inequality in sleep service provision is 
a review of models for initial diagnostic testing and triage approaches to referral 
management.  Prioritising those that most need access to tests and treatment is 
difficult and there are no guidelines on how to do it. Screening for obstructive sleep 
apnoea syndrome in the UK has been tried but with limited success. In the hospital 
setting, neck circumference adjusted for height was found to be a useful predictor of 
obstructive sleep apnoea, however it did not substitute the need for sleep studies to 
diagnose the condition.82 In another study in a district general hospital all referrals for 
snoring were passed to the respiratory department where a nurse and consultant led 
team evaluated patients using  a sleep questionnaire and home oximetry; 38% were 
identified as being likely obstructive sleep apnoea syndrome and 30% were started on 
CPAP therapy. Those with negative tests still required a sleep study.83  Both these 
examples are cases of case finding at a secondary care level. 
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Figure 1.6. The rate of sleep studies undertaken per population by Primary Care Trust 
2011: NHS Atlas of variation in Healthcare for people with Respiratory Disease. A 57 
fold difference in number of sleep studies exists between the highest and lowest 
providers of studies. 
 
Reproduced with the permission of Right Care, NHS Atlas of Variation in Healthcare 
for People with Respiratory Disease: Reducing unwarranted variation to increase value 
and improve quality. September 2012. http://www.rightcare.nhs.uk/atlas/ 
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Where there is expertise in the UK, some services have developed links with local 
communities and strategies to enhance diagnostic capabilities. For example, a model of 
care developed at Papworth Respiratory Support and Sleep Centre, the largest UK 
sleep centre (Papworth Hospital, Cambridge) where in addition to the central provision 
of sleep services, staff travel to satellite sleep clinics in local communities and home 
diagnostic sleep studies are available. Hence broadening the accessibility of sleep 
studies and providing additional expertise to communities where there might not be 
local support or specialist care.84 Another established UK sleep centre, the Oxford 
Sleep Unit (Churchill Hospital, Oxford) provides county wide referral advice to general 
practitioners using a locally developed symptom questionnaire and a well–known 
sleepiness questionnaire, with a recommendation of referring those who are 
symptomatic and have excessive sleepiness scores above a given threshold. Practical 
advice is also given on how to locally managing patients that are less symptomatic and 
advice to pre–screen bariatric patients before surgery.85 
 
Using the estimation of 2% of women and 4% of middle aged men suggested by Young 
to have likely obstructive sleep apnoea syndrome,86 the number of adults aged 35 years 
old and over with likely symptomatic disease in the UK in the year 2011, would be       
1 045 920 people (677 520 men and 368 400 women); calculations based upon 
population figures from the Office for National Statistics, population census 2011 
(appendix 2).87 This sum does not account for children or people younger than 35 years 
of age or any ethnic or other population bias for the condition; for example those with 
obesity, heart disease or metabolic syndrome.68 88 89 Diagnosing this number of people 
constitutes a considerable effort and level of resources.  
 
It is impossible to tell how many of those 1 million people have had access to a sleep 
service or test and been offered treatment. Until 2008 there was no mandate to treat 
the condition. In 2008 the National Institute for Health and Care Excellence (NICE) 
published a technology appraisal that supported the provision of CPAP in those with 
moderate to severe obstructive sleep apnoea syndrome.  Over the last four years there 
has been an increase in testing and provision of CPAP therapy in the UK. A recent 
review of UK sleep study data by Graeme Hill and John Stradling estimates a 41–60% 
increase in sleep studies over the three years from 2007/8 to 2009/10 and an 80–126% 
increase in CPAP provision since the NICE 2008 technology appraisal (table 1.1).  
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Table 1.1. The change in sleep study and CPAP provision in the UK 2007–2010, data 
presented by G Hill & J Stradling at the Winter British Thoracic Society meeting 2012: 
Change in sleep study and CPAP provision following the NICE CPAP TA. Thorax 2012 
poster 258 8 
 Number of Sleep 
Studies  
Percentage rise 
in sleep study  
CPAP provision  Percentage rise in 
CPAP provision  
Source of data Year 
2007/8** 
Year 
2009/10** 
 Year 
2007/8* 
Year 
2009/10** 
 
Primary Care Trust 
 
30,000 48,000 60% ≤17,000 ≥37,000 126% 
Department of 
Health∞ 
61,000 ≥86,000 41% Not 
provided 
Not 
provided 
Not 
provided 
CPAP Industry 
data
+
 
n/a n/a n/a Not 
provided 
Not 
provided 
80% 
 
*    Primary Care Trusts or associated hospitals data, approximately 66% complete 
**  Primary Care Trusts or associated hospitals data, approximately 75% complete  
∞    Department of Health data from their website 
+     Limited sales data provided by CPAP companies for comparison 
NICE CPAP TA: National Institute Health and Care Excellence Technology Appraisal 
 
If the figures in the table are accurate and approximately 37,000 CPAP machines were 
prescribed in the year 2009/2010, we are making progress towards treating people 
living with the condition in the UK.  While testing for obstructive sleep apnoea 
syndrome has improved in recent years, the Stradling review highlighted that 
diagnostic sleep services do not geographically match their populations, and access to 
treatment is still a post–code lottery (a statement supported by the NHS Atlas of 
Variation in Healthcare for people with Respiratory Disease which was discussed 
earlier.) 
 
The lack of sleep services in some areas is not only a problem of general population and 
service mis–match; facilities should ideally be co–ordinated with areas where 
co-morbid conditions such as heart disease or obesity are high. The problem of 
undiagnosed obstructive sleep apnoea is compounded by a modern epidemic of obesity 
in both adults and children.90 The number of people needing access to sleep services 
and treatment is likely to keep rising.  
 
Young argues that meeting the need of the 2–4% with suspected disease (who are 
symptomatic) ought to be a minimum requirement of healthcare systems, as the 
number of people with apnoea or hypopnoea at night, without associated daytime 
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sleepiness is even greater. The full implication of a raised apnoea–hypopnoea index, 
without sleepiness or other symptoms, is not yet fully understood.9  Enabling people 
with milder disease or less symptomatic disease access to testing and advice might 
prevent pre–morbid disease becoming a more serious problem in later life. 91 
 
There have been several attempts to try and address the burden of undiagnosed 
obstructive sleep apnoea syndrome. Questionnaires which ask about snoring and 
sleepiness, such as the BERLIN questionnaire, the ‘Multivariable Apnea Prediction’ or 
more recently the STOP and STOP BANG questionnaires, designed in Toronto for 
preoperative use on surgical patients have had varying degrees of success but have not 
been widely taken up by sleep or community health services. 92 93 94 63 One of the 
difficulties of screening and case finding using such questionnaires are the significant 
numbers of false positives and negatives that render them unhelpful for routine 
clinical use.82 94 95 In addition some of these questionnaires (Multivariable Apnea 
Prediction and BERLIN) have been criticised for taking too long to complete and for 
having complicated scoring systems. 96  
 
Perhaps an additional problem with such tools, which are designed to be self–
completed, are the large numbers of people with impaired health literacy and 
numeracy? Effective screening or case finding remains problematic.97  
 
Oximetry has had some usefulness in identifying those with barn–door sleep apnoea 
(i.e. those with large swings in nocturnal oxygen saturation and classic symptoms) 
when used by experienced observers, but some studies indicate it lacks sufficient 
sensitivity and specificity and can produce a high number of false negatives.25 93 98 
Assessing the value of polysomnography in an Edinburgh study, false negatives 
occurred in a third of cases when oximetry alone was evaluated. 99 Combining 
questionnaires with home oximetry in a two–step model has had some success in one 
Australian study based in primary care. 96 
 
As service providers and health professionals, how do we cope with the growing 
demand placed on services with limited resources? How do we prioritise those that 
most need access to tests and what clinical tools do we have to aid this process?   
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An easy–to–use screening or case finding tool would be useful in order to:  
 
1) assess the likelihood of disease in specific communities, e.g. to reduce perioperative 
risk to those undergoing bariatric surgery or the risk to the public from drivers with 
undiagnosed obstructive sleep apnoea syndrome; 
 
2) provide a method of triage for obstructive sleep apnoea syndrome at secondary care 
to determine urgency of need for both investigation and treatment; and  
 
3) provide a tool that could be used in primary care or for population screening 
programmes. 
 
 
 
Sleepiness as a feature of obstructive sleep apnoea syndrome 
 
 
Summarised by Bliwise in his 2001 paper, ‘Is the measurement of sleepiness the holy 
grail of sleep medicine?’  excessive daytime sleepiness assessments are a vital part of 
evaluating those with a possible sleep disorder.  100;101 There is a need for a collective 
agreement on the definition of sleepiness as well as an acknowledgement of the 
limitations and methods used to assess it.102 Establishing the difference between 
sleepiness and fatigue or tiredness is important. While fatigue or tiredness may be 
present in complainants of problems with sleep, they are a less useful discriminator 
than sleepiness of those with a diagnosable sleep disorder.  
 
Sleepiness is a normal physiological experience that peaks and troughs over a 24 hour 
period. Population studies on the prevalence of sleepiness show marked variations in 
sleepiness according to study and how sleepiness is assessed.  Excessive daytime 
sleepiness (or sleepiness during wake time) is estimated to affect 10 – 20% of the 
general population.103 The American Sleep Disorders Association (now the American 
Academy of Sleep Medicine) and the International Classification of Sleep Disorders 
both stratify the severity of excessive daytime sleepiness into mild, moderate and 
severe categories.104 These estimations of sleepiness are based on the frequency and 
the context in which sleepiness occurs (appendix 1).  
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Excessive sleepiness has been implicated in some of the world’s biggest preventable 
disasters. In the UK, the Selby train derailment (2001) which killed ten people and 
injured more than seventy people was attributed to a driver falling asleep at the wheel 
of his Landrover.105 Later that same year, a head–on collision between two trains in 
Michigan, which spilled three thousand gallons of oil and killed two crew members, 
was reported to have been caused by sleepiness in two employees with a diagnosis of 
severe obstructive sleep apnoea.106 Sleepiness is the largest preventable and 
identifiable cause of crashes in all modes of transport worldwide.105 
 
Assessing sleepiness is not easy. It may be a transient phenomenon or a more long–
term condition. Establishing the severity at either point is important and scales that 
are easy to use and understandable by the patient are essential in evaluations. 
Sleepiness may be objectively measured in the laboratory by several methods: the 
multiple sleep latency test (MSLT), the maintenance of wakefulness test (MWT) and 
the OSLER (Oxford sleep resistance test) which is a modified behavioural maintenance 
of wakefulness test. However all have their limitations and they do not always 
correlate well with different sleep pathologies, or with each other. 107 108 109 Practice 
parameters published in 2005 have helped to standardise these tests but sleep 
latencies can be manipulated and are affected by numerous internal and external 
influences. 110 111;112   Physiological or objective measures of sleepiness are labour 
intensive and require significant input from trained staff and from the patient 
undergoing the study. Facilities to run these tests in the UK are limited and for this 
reason are not routinely available or practical for the assessment of sleepiness in 
patients with suspected obstructive sleep apnoea syndrome.  
 
In the clinical setting paper–based questionnaires and scales are more often used. 
Several, subjective, written scales to measure sleepiness have been developed over the 
years. 113 114 115 Of these, the Epworth Sleepiness Scale (Figure 1.7) is probably the 
most widely used clinical measure worldwide.116 Developed by Murray Johns in 
Australia in 1991, it is a behavioural measure of an individual’s subjective sleepiness 
during the daytime, in eight predefined situations. The advantage of the Epworth 
Sleepiness Scale is that it is a short questionnaire and considered to be relatively easy 
to administer to those who speak English and who have adequate literacy skills. 
Despite the ubiquity of the scale – it appears to have become synonymous with 
sleepiness and is often the only quoted measure in clinical research and medicine – the 
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scale is not always easily understood by all. 114 116 For those who are non–English 
speakers, the form requires translation; it has been translated and validated into 
German, Chinese, Spanish and Greek, as just a few examples, with acceptable results. 
117 118 119 120 In my own experience it is not uncommon to find answers in the Epworth 
Sleepiness Scale ticked or annotated rather than given a numerical value and some 
questions may simply be left blank. It is difficult to easily assess those with reduced 
literacy or recognise who may need help in filling in forms and it has been shown that 
physicians overestimate patient literacy. 121 To my knowledge, the ease of use of the 
scale has never been formally assessed and an evaluation of how patients fill in the 
scale would be useful. 
 
Due to the importance of excessive sleepiness as a clinical indicator of sleep pathology 
and for lack of a better screening tool, the Epworth Sleepiness Scale is often employed 
as a screening or case finding tool for obstructive sleep apnoea syndrome, something 
for which it was never designed. It has also found use beyond the realm of the 
consultation room or hospital. For example, the Epworth Sleepiness Scale is often used 
in assessment for the Driver and Vehicle Licensing Agency evaluation of fitness to 
drive and there have been reported cases of the Epworth Sleepiness Scale in forensic 
cases, to give evidence regarding a driver’s sleepiness at the wheel. 
 
 
Examples of other paper based questionnaires are the Stanford Sleepiness Scale and 
the Karolinska Sleepiness Scale. 115 113;122 These two scales ask about sleepiness in the 
here and now, e.g. ‘how sleepy are you at this moment in time?’, in contrast to the 
Epworth Sleepiness Scale which asks about the propensity to sleepiness over a longer 
time scale. An advantage of the ‘here and now’ method is that it enables the sequential 
recording of sleepiness over a short time frame or in response to an acute event, such 
as before and after the effects of a new medication or over the course of the day in 
conjunction with objective laboratory tests for sleepiness. All these scales carry the 
same language limitations of the Epworth Sleepiness Scale, and as far as I am aware 
have never been tested for their ease of use among varying or diverse patient groups. 
Other methods of quantifying sleepiness and the effects of sleepiness are visual 
analogue scales, psychometric testing and performance of vigilance tasks and 
pupillometry. These methods tend to be the choice of researchers rather than clinicians 
and are not commonly employed in clinical practice. Overall, objective and subjective 
measures of sleepiness do not consistently correlate well with one another. 102 This poor 
  
 43 
correlation probably reflects the complexities of defining the meaning of sleepiness. 
Each method carries its own validity and usefulness, picking up on one aspect or 
construct that sleepiness represents. 
 
Figure 1.7. The Epworth Sleepiness Scale, devised by Murray Johns in 1991. An 
internationally used scale designed to measure the degree of subjective, daytime 
sleepiness a person has. A score ≥11 / 24 is considered pathologically sleepy.  
 
 
  Epworth Sleepiness Scale 
 
In contrast to just feeling tired, how likely are you to doze off or fall asleep in the 
following situations? Even if you have not done some of these things recently, try 
to work out how they would affect you. Use the following scale to choose the most 
appropriate number for each situation. 
 
                          0 = no chance of dozing 
  1 = slight chance of dozing  
  2 = moderate chance of dozing 
  3 = high chance of dozing 
 
  Situation 
Chance 
of dozing 
Sitting and reading  
Watching T.V.  
Sitting inactive in a public place (e.g. Theatre or meeting)  
As a passenger in a car for an hour without a break  
Lying down to rest in the afternoon when circumstances permit  
Sitting and talking to someone  
Sitting quietly after lunch without alcohol  
In a car while stopped for a few minutes in the traffic  
Level of sleepiness                                                                                   =          /  24 
 
 
Understanding patient sleepiness and quantifying sleepiness over time is essential to 
monitoring the response of sleep therapies. 
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Figure 1.8. There are many causes of excessive sleepiness in the daytime. The 
schematic shows the spectrum of medical disorders associated with hypersomnolence. 
AD: seasonal affective disorder, ICNSH: idiopathic central nervous system 
hypersomnia, PLMs: periodic limb movement disorder, DSPS: delayed sleep phase 
syndrome, ADSP: advance sleep phase syndrome, OSA: obstructive sleep apnoea. 
Figure reproduced with the kind permission of Dr John Shneerson, Handbook of Sleep 
Medicine (1st Ed) p119. 
 
In the case of obstructive sleep apnoea syndrome, sleepiness is often the defining 
variable, determining who with a positive diagnosis receives treatment.7;118 25  Several 
studies report improvements in daytime sleepiness in response to continuous positive 
airway pressure therapy. The Epworth Sleepiness Scale predicts relatively well who 
with sleep disordered breathing will respond to continuous positive airway pressure 
therapy in comparison to other measures of disease severity, such as the apnoea–
hypopnoea index. 123-125 A thorough sleep history and account of co–morbidities should 
always be taken alongside subjective sleepiness scale ratings. Being sleepy in the 
daytime or during wake hours and having a positive diagnosis of sleep apnoea, does not 
guarantee the two are related.  There are many causes of excessive sleepiness and 
figure 1.8 summarises these.126 
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Chapter 2 
 
Problems with the Epworth Sleepiness Scale 
 
Introduction 
 
My experience suggests that patients have difficulty understanding and accurately 
self–completing the Epworth Sleepiness Scale. 
 
Difficulty with completing forms can occur for many reasons. The written word and 
numerals are not universally understood and problems with functional literacy in 
medicine are both common and underestimated 127-130.  
 
This study describes an evaluation of the ability of patients to self–complete the 
Epworth Sleepiness Scale. 
 
Methods  
For each of the eight questions in the Epworth Sleepiness Scale, the scorer (the 
patient) is required to rate their likelihood of sleepiness from 0 – 3: [0=no, 1=slight, 
2=moderate and 3=high chance of dozing]. 114  The total score is marked out of a 
maximum of 24 and a score ≥11 is considered abnormal.  
 
I evaluated the ease of completing the Epworth Sleepiness Scale in two groups of 
patients attending Charing Cross Hospital (a West London Teaching Hospital):  
1) Epworth naïve patients (new patients attending a sleep clinic, n = 80) and  
2) Serial users of the scale (patients on treatment for obstructive sleep apnoea 
syndrome attending a follow–up clinic, n=121).  
 
The numbers chosen in each group were pragmatic and represented those attending 
the hospital during this portion of the study. Consecutive patients were given the 
Epworth Sleepiness Scale at the start of their clinic attendance and observed 
completing the form. A check list was used (figure 2.1) to record whether the Epworth 
Sleepiness Scale was correctly completed, whether help was provided, and what 
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problems, if any, were experienced. A Chi–squared test was used to assess differences 
between naïve and repeat users of the Epworth Sleepiness Scale. 
 
Figure 2.1. Checklist used to assess the ease of use of the Epworth Sleepiness Scale in 
201 patients attending the Sleep Centre (80 new patients and 121 patients on 
treatment for obstructive sleep apnoea syndrome attending a follow–up clinic.)  
 
Epworth Naive?   Yes   /   No                                                   (please circle)   
 
  
 yes no 
Was the ESS filled in correctly by the patient?   
If no which of the following applies. Tick as many as required 
Did you have to help with filling in the form? 
 
  
Did the person ask a family member to fill in the form for them? 
 
  
Did you have to explain what the different chances of dozing meant? 
 
  
Were you asked what time of day the questions related to? 
 
  
Were some questions left blank? (please circle which questions were left 
blank) 
Q1.         Q 2 .         Q 3 .       Q 4 .        Q 5.         Q6 .       Q 7 .           Q 8 
 
  
Instead of giving a score of 0, 1, 2, or 3 were the answers ticked ‘√’ or 
marked with a cross ‘x’ ? 
  
Instead of giving a score of 0, 1, 2, or 3 was a ‘yes’ or ‘no’ written? 
 
  
Instead of giving a score of 0, 1, 2, or 3 were other words used or the 
answer annotated? 
  
Instead of giving a score of 0, 1, 2, or 3 was a half score given i.e. 1.5 or 1–
2 score recorded?  
  
As far as you are aware where any of the following problems encountered? 
Were there language* difficulties in filling in the ESS? 
(*eg English as a second language) 
  
Did the person volunteer that they could not read or write? 
 
  
Did the person report that they had left their glasses at home? 
 
  
Please make any additional comments on any help given which is not included in 
the table above: 
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Results 
201 patients were evaluated completing the Epworth Sleepiness Scale (80 naïve and 
121 serial users of the questionnaire).  
 
Analysis of how well the Epworth Sleepiness Scale questionnaires were completed 
confirms that patients can have problems completing the scale. In total, one third of 
naive users (33.8%, 27/80) and 15.7% (19/121) of routine users made errors p=0.0029 
(figure 2.2).  
 
Figures 2.3a – 2.3c are examples of poorly completed Epworth Sleepiness Scale forms: 
in 2.3a, answers are left blank, annotated and scores are given as fractions; in 2.3b, 
answers are ticked and left blank; in 2.3c, answers are given no numerical value and 
instead ‘O.K.’ is written.   
 
Figure 2.2. The percentage (%) of correct and incorrect Epworth Sleepiness Scale (ESS) 
forms in 201 patients attending the Sleep Centre (80 new patients and 121 patients on 
treatment for obstructive sleep apnoea syndrome.) 
 
 
 
  
66.3 
33.8 
84.3 
15.7 
correct forms incorrect forms
**p 0,0029 
ESS naive users group 
                 
ESS routine users group 
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Figure 2.3a. Example of difficulties filling in the Epworth Sleepiness Scale form. One 
item is left blank, one item is given an answer between scores (1–2), four items are 
annotated; one giving no numerical score and one given two scores, for different times 
of day, and an additional 9th scenario  ‘on a train’ has been added.  
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Figure 2.3b. Example of problems filling in the Epworth Sleepiness scale form. Six out 
of eight answers were ticked, and the remaining two were left blank. A tick appears to 
have been made against ‘3=high chance of dozing’. The form was then completed with 
the help of the physician who wrote the respondent’s answers in the right hand 
margin. 
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Figure 2.3c. Example of problems filling in the Epworth Sleepiness scale form. The 
form was annotated with ‘O.K.’ as a response to each of the eight scenarios and no 
numerical value was given by the patient. The physician later helped and wrote the 
patient’s responses on the form. 
 
 
 
  
   with help from 
 the doctor 
patient’s 
responses 
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Of those that had difficulty with completing the form, the most frequent problem was 
writing an answer between scores, i.e. 1–2 or as a fraction 1 ½ (13.8% naive, 5.8% 
previous users, p = 0.053). This might not be considered a problem by some but it can 
make determining the final score variable especially when coupled with other problems 
with the questionnaire, as demonstrated in figure 2.3a. Other problems included 
annotating answers or writing ‘yes’ or ‘no’ (7.5% naive, 10.8% previous users) or leaving 
questions blank (10.0% naive, 3.3% previous users, p=0.0499), or putting a tick or a 
cross to the questions rather than scoring them (3.8% naive, 1.7% previous users). A 
further group volunteered that they could not read or write (3.8% naive, 0.8% previous 
users), or stated that they had left their spectacles at home (2.5% naive,1.7% previous 
users). In total 28/201 (13.9%) needed additional help from either a family member, 
friend or health professional, to enable them to complete the scale (23.8% naïve and 
8.3% routine users group, p=0.0022). Full results are shown in figure 2.4. 
 
Figure 2.4. Percentage (%) problems with completing the written Epworth Sleepiness 
Scale form in 201 patients attending the Sleep Centre (80 new patients and 121 
patients on treatment for obstructive sleep apnoea syndrome.)  
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Chapter 2 comments  
 
Whilst the traditional written Epworth Sleepiness Scale has received international 
acceptance, it has limitations. In our practice I observed patient difficulties in 
completing the form and quantified this finding. I have demonstrated how one third 
(33.8%) of new users and one sixth (15.7%) of routine users of the Epworth Sleepiness 
Scale make errors or need assistance with completing of the scale. For international 
use it requires translation and it is likely to be less useful in those with reduced 
literacy skills. 119 117 118 120 My study suggests this is a highly prevalent problem and it 
would be useful to try and improve how the Epworth Sleepiness Scale is understood 
and completed. People have problems filling in forms for many reasons. The addition of 
pictures is one method of broadening accessibility to medical questionnaires which 
could be applied to the Epworth Sleepiness Scale. Developing a pictorial sleepiness 
scale will be explored in subsequent chapters. 
 
 
Chapter 2 key findings: 
 
 80 naïve and 121 serial ESS (201 total group) users were observed completing 
the ESS. 
 33.8% of naïve ESS users made errors completing the form. 
 15.7% of routine users of the ESS made errors completing the form. 
 13.9% of the 201 patients needed additional help from family or a friend or a 
health professional to complete the ESS. 
 For the 201 patients observed completing forms, problems ranged from giving 
the answer as a fraction (9.0%), annotating answers or writing ‘yes’ and ‘no’ 
instead of giving a numerical value (9.0%), leaving questions blank (6.0%), 
putting a tick or a cross (2.5%), and volunteering they could not read or write 
(2.0%). 
 5.0% of the 201 patients needed help to explain the ‘chance of dozing’ and 3.5% 
queried the ‘time of day’ the ESS referred to.  
 3.0% of the 201 patients had suspected language difficulties. 
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Chapter 3 
 
Health Literacy and Sleep Apnoea 
 
 
What is Health Literacy? 
The term Health Literacy was first used some 30 years ago in relation to health 
education and social policy. At the time, it was considered to be the ability to read and 
comprehend written medical information and instructions. Since then, the 
understanding and definition of health literacy has broadened to include a range of 
competencies: basic health knowledge; reading, comprehension and evaluation of 
health information; the application of health preventing, promoting and self–care 
behaviours; verbal communication with health professionals and health decision 
making. 131 
 
Measuring health literacy is not easy. 121 132 Patient appearance, speaking ability and 
other physical characteristics are often misleading and inaccurate predictors of 
literacy. 133 Physicians have been shown to overestimate patient literacy during a 
routine consultation. One North American study in Texas demonstrated physician 
overestimation of literacy levels in 54% of African American patients, 11% of white 
(non–Hispanics) patients and 36% of other–ethnicity patients  when compared with a 
formal measure of health literacy (Rapid Estimate of Adult Literacy in Medicine 
scores).121 Similarly in Kentucky, US, doctors were unsuccessful in identifying 36% of 
patients who had low literacy scores on the Rapid Estimate of Adult Literacy in 
Medicine test.132 The stigma associated with low literacy is likely to lead to 
compensatory behaviours in patients, which make it genuinely difficult to identify 
those that may need additional help. It has been shown that 40% of patients with 
literacy difficulties express feelings of shame, with two thirds not telling spouses of 
their literacy problems and over half never telling their children. 134 135 There are no 
comparable studies in the UK examining the relationship between clinician estimation 
and the patients’ actual literacy level.  
 
If we assume clinicians in the UK are as poor at identifying impaired literacy in their 
patients as those in the North America, routine recognition of those with a problem is 
difficult to achieve. In the last 10 years few groups have attempted to quantify patient 
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literacy in the secondary care setting. A Rheumatology clinic in Glasgow  estimated 
one in six patients (15%) attending their service were functionally illiterate to the 
degree that they would struggle to cope with patient education materials and 
prescription labels. 136 In a COPD service in London, 15% of those tested were unable 
to use written information and 13% of patients with asthma in an American study had 
a reading age below 3rd grade, which is comparable to an 8 year old child in the UK. 137 
138  
 
The Skills for Life Survey by the Department for Business, Innovation and Skills found 
significant impairments in literacy and numeracy which might explain why word–only 
questionnaires are not useful in population screening programmes. Table 3.1 shows 
literacy and numeracy levels, with examples of health information for 7000 people who 
were interviewed and completed the Skills for Life Survey. The 7000 people were a 
representative sample of a working population aged between 16–65 years of age.139 140 
From this survey, figures have been extrapolated to represent the number of working 
people aged 16–65 years old in England who due to impaired literacy and numeracy 
skills are likely to have problems with health information or screening material. 
 
Table 3.1. Example of health materials sampled and ratings from the Skills for Life 
survey. 7000 people taken as a representative sample of a working population aged 16–
65 years were questioned. 
Material Level of difficulty of 
health material 
% unable to 
effectively 
understand the 
information 
Number of English 
adults 16–65 years 
unable to effectively 
understand the 
information 
Instructions to 
calculate a child’s dose of 
paracetamol 
Readability: 14–16 
years (GCSE C or above) 
Maths: 5–7 years 
43% 15 million 
Instructions for 
fitting a child’s car seat 
Readability: 14–16 
years 
Maths: 7–9 years 
43% 15 million 
Instructions for using 
a bowel cancer screening kit 
Readability: 11–14 
years 
Maths: 11–14 years 
49% 17 million 
Calculating the Body 
Mass Index Chart 
Readability: 14–16 
years 
Maths: 14–16 years 
78% 27 million 
 
Table adapted and reproduced by kind permission of Rowlands, G, Protheroe, J – 
unpublished work in the process of completion for publication.   
 
http://www.keele.ac.uk/research/researchnews/2012/title,83993,en.php 
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Forty–nine percent of people questioned, which represents 17 million people in 
England, had literacy and numeracy levels equivalent to 11–14 year olds and would 
struggle with the instructions for using a bowel cancer screening kit. In an attempt to 
make medical information accurate, it is often made too complicated for many in the 
general population to understand. Using pictures to enhance the spoken word and 
understanding of medical instructions has proven benefits even amongst those with 
satisfactory literacy levels. 141 142 Studies have demonstrated how recall of medication 
and understanding of instructions are improved, when pictures are used in conjunction 
with (or instead of) the written word, even in those with normal literacy skills.143-145 
Such interventions are important and improve the understanding and compliance of 
medical therapies. 141;146 147  
 
Low or inadequate health literacy can have profound financial and health 
consequences. 148 Patients with poor health literacy have poorer health status, are at 
greater risk of hospitalisation, and have longer hospital visits. They experience delays 
in diagnosis and are less likely to attend screening programmes or to adhere to 
treatments and self–care plans; they incur substantially higher health costs and are 
less able to make appropriate health decisions. 148 149 150 Studies in patient numeracy 
are few and understanding problems with numeracy in the context of patient health 
care and health literacy would be useful. One study of health literacy and numeracy in 
an American emergency department found adequate health literacy scores but lower 
scores for numeracy amongst those tested. 151 The Epworth Sleepiness Scale is an 
example of a medical questionnaire that asks the patient first to understand the 
written instruction and the construct of sleepiness and then translate this information 
in to a numerical value. It may be that numeracy is a greater problem than literacy. In 
chapter 2, I demonstrated some of the problems common to assessing sleepiness with 
the Epworth Sleepiness Scale; patients sometimes tick the scenarios rather than giving 
a score of 0–3, may leave questions blank or simply struggle to interpret the task.  
 
The next section explores the contribution of impaired literacy to the problem of 
inaccurate completion of the Epworth and why patients might make mistakes.  
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Assessing Literacy levels in Sleep Patients 
  
Introduction 
 
In chapter 2, I demonstrated that patients have difficulty completing the Epworth 
Sleepiness Scale.152 To explore reasons for these difficulties, literacy skills were 
assessed in a new group of patients attending the Sleep Centre and Lung Function 
Laboratory. 
 
Methods 
 
122 patients (92 Sleep patients and 30 Lung Function patients as a comparator) were 
approached and asked to complete an assessment for level of functional literacy in 
medicine using the Rapid Assessment of Adult Literacy in Medicine Questionnaire 
(REALM).  
 
REALM is a screening instrument designed to test patient literacy level, comprising 66 
medical words and lay terms for body parts and illnesses (listed in 3 columns of 22 
words) figure 3.2. Designed in the US, it has been validated and correlates well with 
other educational assessments.153 154 Participants are asked to read aloud the list to a 
scorer. If the patient takes more than 5 seconds on a word, the instructor says ‘blank’ 
and points to the next word to move the patient along. The test takes between 2 and 3 
minutes to administer and score. Plus 1 (+1) is given to a correct word. No score is 
given to an error if the word is mispronounced or not attempted. If the patient self–
corrected a word this is counted as correct. Words pronounced with either a dialect or 
an accent are scored correctly as long as there are no additions or deletions to the word. 
For example if the patient says ‘alcohol’ instead of ‘alcoholism’ this would be counted as 
an error. Total scores are compared with the standard reading age of school age 
children: a total REALM score between 19 – 44 / 66 is equivalent to 4th / 6th grade 
reading level, 40 – 60 / 66 is equivalent to 7th / 8th grade reading level and a score 61–66 
is equivalent to a high school reading level (US education system). A score less than or 
equal to 60 suggests the person has a level of literacy that is inadequate to cope with 
standard patient education materials and prescription labels.  
 
In addition to REALM, information on educational attainment, English language data 
and ethnicity was collected. 
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Figure 3.2. The REALM questionnaire, used to assess patients’ level of literacy in 
medicine. Reproduced with permission of the author, Terry Davis. 153 
 
 
 
 
Results 
Of the patients approached, 86 / 92 (93.3%) Sleep group and 30 / 30 (100%) Lung 
function group completed the REALM questionnaire. Five (5.6%) in the Sleep group 
declined when shown the test. One did not complete owing to time restrictions. Mean 
age was 51.2 ± 11.8 years in the Sleep group and 56.1 ± 17 years in the Lung function 
group. Mean age leaving formal education was 18.7 ± 2.9 years in the Sleep group and 
17.7 ± 2.9 years in the Lung function group. In the Sleep cohort 38.4% (33 / 86) had a 
university education; 24% (21/86) graduate and 15% (13/86) postgraduate degrees vs. 
30% (9 / 30) Lung function; 27% (8/30) graduate and 3% (1/30) postgraduate degrees. 
REALM scores are shown in table 3.3 grouped into the traditional four ranges. Overall 
Sleep patients had lower literacy levels compared with Lung Function patients; 16.3% 
of the Sleep group had a REALM score ≤ 60, compared with 10% of the Lung Function 
group: Sleep 15.1% had a literacy level equivalent to 12–14 year olds and 1.2% 
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equivalent to 9–12 year olds; Lung Function 6.7% had a literacy level compared to 12–
14 year olds and 3.3% a literacy level of 9–12 year olds.  Seventy eight per cent of the 
Sleep group and 83% of the Lung function group spoke English as their mother tongue; 
all patients used English as their everyday spoken language (figures 3.3 and 3.4). 
 
Table 3.3. REALM reading ages, US education system and UK age equivalents. 
REALM score 
ranges 
Equivalent reading age 
  
         % Sleep group 
         (n=86) 
 
 % LF group 
(n=30) US school grade UK age equivalent 
0–18 Third grade or below 8 years or less        0.0 0.0 
19–44* Fourth/sixth grade 9–12 years        1.2 3.3 
45–60* Seventh/eighth grade 12–14 years        15.1 6.7 
61–66 High School 14–15 +        83.7 90.0 
*A score ≤ 60 suggests a literacy level that would struggle to cope with patient education materials and prescription labels. LF 
group, patients attending the lung function laboratory; Sleep group, patients attending the Sleep Centre; REALM, Rapid 
Estimate of Adult Education in Medicine. 
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Figure 3.3. Educational attainment in Sleep (n= 86) and Lung function (LF, n=30) 
groups.  
 
Figure 3.4. English as a first language data in Sleep (n=86) and Lung function (LF, 
n=30), groups. 
 
 
35 
28 
0
10
20
30
40
50
60
70
80
           Mean  age
± SD
Age leaving School
± SD
% graduate or
postgraduate
education
Sleep LF
78 
100 
83 
100 
0
20
40
60
80
100
% English Mother Tongue % English as their everyday
spoken language
Sleep LF
60 
 
Chapter 3 comments 
 
Determining which of our patients struggle with numeracy or literacy is difficult. I 
have previously shown that some patients have difficulty completing the Epworth 
Sleepiness Scale.  
 
In this study of 122 patients, I found evidence of impaired health literacy in 16.3% of 
the Sleep group and 10% of the Lung function group. Previous studies of Health 
literacy in the UK report levels between 11.4% and 15%. 155 128 Study design precluded 
statistical analysis of these results but leave little doubt that impaired literacy is 
common in those attending sleep centres and could be higher than in other hospital 
attendees. That some Sleep patients declined to be tested once shown the 
questionnaire may or may not imply that they would struggle with the test, but it does 
raise doubts over patient confidence in their literacy abilities and might suggest that 
even the 16.3% score recorded in the Sleep group is an underestimate.  
 
Why Sleep patients should fare worse than Lung function patients, if real, is unclear 
especially when educational attainments were higher and age was younger in the sleep 
cohort. All used English as their everyday language; however, fewer Sleep patients had 
English as their mother tongue. Cognitive deficits associated with undiagnosed 
obstructive sleep apnoea syndrome and increased sleepiness could conceivably be a 
contributory factor. 156  
 
This study suggests clinicians need to provide clinical material and information in a 
format that is comprehensible to a wide range of patients. Patients with obstructive 
sleep apnoea syndrome may have particular needs for such material.  
 
Chapter 3 key findings: 
 
 92 sleep patients and 30 lung function patients completed a REALM 
questionnaire. 38.4% of the sleep group had a graduate or postgraduate 
education; 30.0% of the lung function group had a graduate or postgraduate 
education; all patients used English as their everyday spoken language. 
 16.3% of the sleep group had deficits in functional health literacy: a REALM 
score equivalent to a 12-14 year old school child.  
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 10.0% of the lung function group had deficits in functional health literacy: a 
REALM score equivalent to a 12-14 year old school child. 
 1.2% of sleep patients had a deficit in functional health literacy equivalent to a 
9-12 year old school child. 
 3.0% of lung function patients had a deficit in functional health literacy 
equivalent to a 9-12 year old school child. 
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Chapter 4  
 
Translation and acceptability of a pictorial Epworth 
Sleepiness Scale 
 
Hypothesis 
In the same way that an English Language version of the Epworth Sleepiness Scale 
can be translated into other languages it should be possible for it to be translated into 
a pictorial scale with equivalent results to the traditional scale. 
 
Introduction 
In Chapter 2, I documented that patients have difficulty understanding and accurately 
self–completing the Epworth Sleepiness Scale and in Chapter 3 I demonstrated that 
impaired literacy skills may be a significant problem in patients attending sleep 
centres. Pictures and pictorial aids are a useful adjunct to medical information which 
help the transfer and comprehension of written and spoken information. A South 
African group have produced a cartoon faces sleepiness scale for children, which 
measures ‘point’ or ‘here and now’ sleepiness (as opposed to propensity to sleepiness 
associated with behaviours over time) 157. This study describes the translation of the 
standard Epworth Sleepiness Scale into a pictorial Epworth Sleepiness Scale. 
 
Methods 
Working with a medical artist and a team of health professionals with experience in 
sleep medicine, I explored different pictorial representations of the eight Epworth 
Sleepiness Scale scenarios. A series of silhouette images were developed depicting the 
possibly sleepy person with an altered body position, with increased likelihood of 
sleepiness (i.e. slumping forward in a chair) as in figure 4.1. The eight images thought 
to best portray the intent of the Epworth sleepiness questions were used to create a 
pictorial Epworth Sleepiness Scale. Question eight (Q8) required a decision as to 
whether the driver or the passenger was the sleepy character and two versions of the 
pictorial Epworth Sleepiness Scale representing this difference were produced and 
tested (studies 1 and 2). Wording from the traditional Epworth Sleepiness Scale was 
shown next to the pictures so that the scale would be applicable to both literate and 
literacy impaired populations. The sleep patients were then asked in study 3 to report 
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a preference for the pictorial Epworth Sleepiness Scale or the traditional Epworth 
Sleepiness Scale.  
 
Study 1 – translating the Epworth into pictures 
Patients attending the sleep centre or the lung function laboratory were asked to 
complete a traditional and a pictorial Epworth Sleepiness Scale, with the order of 
completion reversed on alternate days. Patients were asked to complete both 
questionnaires independently with minimal intervention. Those attending the lung 
function laboratory were having routine lung function tests for either: 1. diagnosis or 
follow up of a lung condition or 2. prior to an operation, and were not thought to have 
obstructive sleep apnoea syndrome. Total Epworth Sleepiness Scale and pictorial 
Epworth Sleepiness Scale scores for each patient were compared for variability using 
the Wilcoxon Signed rank test and a Cohen kappa statistic to measure agreement 
between item responses to pictorial and traditional Epworth Sleepiness Scale 
questions. A Cohen kappa statistic gives a quantitative measure of interrater 
reliability and is believed superior to a percentage comparison as the kappa statistic 
accounts for an answer arrived at by chance. Kappa ranges from ‘0’ being the worst to 
‘1’ the best level of agreement. Banding kappa scores into ranges allows the answer to 
be interpreted from poor agreement to very good agreement as proposed by Landis and 
Koch.159 Total sleepiness scores and item responses were compared for interest with 
those reported by Murray Johns in one of his original studies.158   
 
Study 2 – depictions of driving and the pictorial Epworth 
To test whether depiction of the sleepy person in question 8 as a passenger or as a 
driver altered the pictorial Epworth Sleepiness Scale score, a further set of patients 
(sleep n=82 and lung function n=54), repeated the methods above but their pictorial 
Epworth Sleepiness Scale carried a ninth question: Q8 showing a sleepy passenger in 
the vehicle and Q9 a sleepy driver in the vehicle figure 4.2). Total pictorial Epworth 
Sleepiness Scale scores were calculated using a) ∑ pictorial Epworth Sleepiness Scale 
Qs 1–8 (sleepy passenger) and b) ∑ pictorial Epworth Sleepiness Scale Qs 1–7 + Q9 
(sleepy driver) and compared to the respondents traditional Epworth Sleepiness Scale 
scores. Driving status (driver = respondent holding a provisional, full UK or 
international driving licence) was recorded and differences in response to the pictorial 
Epworth Sleepiness Scale and Epworth Sleepiness Scale amongst those holding a 
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driving licence and those who reported they could not drive, was evaluated using a 
Wilcoxon Signed rank test. 
 
Study 3 – what do patients prefer: a pictorial or traditional Epworth? 
To evaluate patient acceptability of the pictorial Epworth Sleepiness Scale and 
traditional Epworth Sleepiness Scale, 82 additional patients attending the Sleep 
Centre (who had not taken part in earlier studies) were issued the two scales 
(described in methods above). Patients were asked to choose one of four statements 
reflecting ease of completion for each scale: very easy, fairly easy, fairly difficult or very 
difficult and to express a preference for the traditional or pictorial Epworth Sleepiness 
Scale. This was recorded independently by the patient on a paper questionnaire (in the 
absence of laboratory staff) after they had completed both scales. A chi-squared test 
statistic was used to test a difference in 1) a preference for and 2) a difference in the 
ease of completion between the pictorial Epworth Sleepiness Scale and the traditional 
Epworth Sleepiness Scale. 
 
Results    A total of 363 patients contributed to the development of a pictorial Epworth 
Sleepiness Scale in this chapter. 
 
Translation of the Epworth Sleepiness Scale into a Pictorial Epworth Sleepiness Scale     
(n= 145) One hundred and forty five patients (93 Sleep Centre and 52 Lung function 
laboratory patients) completed the traditional written Epworth and the pictorial 
Epworth Sleepiness Scale (figure 4.1). Resulting Epworth Sleepiness Scale scores 
ranged from 0–24 with a group (n=145) mean total pictorial Epworth Sleepiness Scale 
score of 8.80 (± 4.72) and group mean total Epworth Sleepiness Scale score of 8.46 
(±4.43); full tabulated total pictorial Epworth and traditional Epworth Sleepiness Scale 
results are shown in table 4.1. A Cohen kappa statistic showed good agreement 
(median kappa score Qs 1–8 = 0.63, IQR 0.04) between item responses on the two 
scales. Kappa scores are summarised in figure 4.3 and figure 4.4. In figure 4.3, item 
responses to the eight questions are displayed. On the same chart are displayed the 
data from Professor Johns’ original study population in 1992. Wilcoxon Signed rank 
Test showed no significant difference between the overall score obtained from the 
traditional Epworth Sleepiness Scale compared with the scores on the pictorial 
Epworth  Sleepiness Scale (p=0.086). Ranking item scores from low to high (table 4.2 
and table 4.3) show similarities in response across the three groups with some items 
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Figure 4.1. Translation of the Epworth Sleepiness Scale into a pictorial Epworth 
Sleepiness Scale. Each scenario has a series of pictograms depicting increased 
likelihood of sleepiness; participants are asked to tick the image that best represents 
their level of daytime sleepiness.  
 
 
  
Pictorial Epworth Sleepiness Scale 
level of sleepiness           / 24 
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Figure 4.2. The amended pictorial Epworth Sleepiness Scale which includes a 9th 
question. Question 8 depicts the passenger as the sleepy character in the vehicle, 
question 9 represents the sleepy character as the driver of the vehicle.  
 
 
 
  
Pictorial Epworth Sleepiness Scale 
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(such as Q5) scoring consistently high while others (such as Q8 and Q6) producing 
consistently low results.  
 
Table 4.1.  Comparing the pictorial Epworth Sleepiness Scale to the Epworth 
Sleepiness Scale; mean pictorial Epworth Sleepiness Scale and Epworth Sleepiness 
Scale scores for: total (n=145), Sleep (n=93) and Lung function (n=52) groups. 
 
 
 Total pictorial Epworth Sleepiness Scale Total Epworth Sleepiness Scale 
 Total Group 
  
Sleep Lung Function Total  group Sleep Lung Function 
Mean score 
SD 
SE 
Median 
IQR 
8.80 
4.72 
0.39 
8.00 
7.00 
9.85 
4.83 
0.50 
9.00 
7.00 
6.92 
3.92 
0.54 
7.00 
6.00 
8.46 
4.43 
0.37 
8.00 
6.00 
9.45 
4.52 
0.47 
9.00 
6.00 
6.67 
3.69 
0.51 
6.00 
5.25 
 
Figure 4.3. Pictorial and traditional Epworth Sleepiness Scale responses for each of the 
eight questions for 145 patients (93 Sleep Centre and 52 Lung function laboratory). 
Shown in grey are the original Epworth Sleepiness Scale scores reported by Johns in 
1992 (n=144, 104 third year medical students and 40 sleepy patients). Values are mean 
responses with one standard error bars. Above each error bar is the corresponding 
kappa statistic comparing pictorial Epworth Sleepiness Scale and Epworth Sleepiness 
Scale item scores. 
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Figure 4.4. Cohen Kappa scores between pictorial Epworth Sleepiness Scale and 
Epworth Sleepiness Scale item scores. Median kappa statistic = 0.63 (IQR 0.04).  
 
 
 
Suggested Kappa statistic interpretation (reference: Landis J R and Koch G G (1977) pp159–174) 159:  
Scores between  0 – 0.2  =  poor agreement 
Scores between  0.21 – 0.4 =  fair agreement 
Scores between  0.41 – 0.6 =  moderate agreement 
Scores between  0.61 – 0.8 =  good agreement 
Scores between  0.81 – 1  =  very good agreement 
 
Table 4.2. Item scores ranked in order of lowest to highest mean scores, plus means 
(and SD in parenthesis) for the pictorial Epworth Sleepiness Scale, Epworth Sleepiness 
Scale current study 1 and John’s results158. Items that are shaded grey have different 
rankings. 
 
Rank 
(low to high score) 
Pictorial Epworth 
Sleepiness Scale 
Epworth Sleepiness 
Scale 
Johns 
158
  
1 Q8 0.28 (0.65) Q8 0.24 (0.53) Q6 
2 Q6 0.30 (0.62) Q6 0.27 (0.49) Q8 
3 Q3 1.02 (1.13) Q3 0.89 (0.80) Q3 
4 Q4 1.08 (1.02) Q4 1.03 (1.01) Q2 
5 Q7 1.22 (1.00) Q1 1.18 (0.88) Q7 
6 Q1 1.24 (0.93) Q7 1.28 (0.97) Q1 
7 Q2 1.50 (0.92) Q2 1.50 (0.89) Q4 
8 Q5 2.14 (0.95) Q5 2.12 (0.95) Q5 
0.61 
0.68 
0.58 
0.63 
0.59 
0.67 
0.62 
0.64 
0
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Table 4.3. Item scores grouped into 6 ranges (0–3 at 0.5 increments) for the pictorial 
Epworth Sleepiness Scale and Epworth Sleepiness Scale (study 1) and Johns’ original 
results 158. 
 
Item score Pictorial Epworth 
Sleepiness Scale 
Epworth Sleepiness 
Scale 
Johns 
158
  
0       –   0.50 Q8, Q6 Q8, Q6 Q6, Q8 
0.51  –   1.00 Q3 Q3 – 
1.01  –   1.50 Q4, Q7, Q1, Q2, Q4, Q1, Q7, Q2, Q3, Q2, Q7, Q1 
1.51  –   2.00 – – Q4 
2.01  –   2.50 Q5 Q5 Q5 
2.51  –   3.00 – – – 
 
 
 
Evaluation of the depiction of driving in the Pictorial Epworth (n = 136) 
  
One hundred and thirty six patients (82 Sleep Centre and 54 Lung function laboratory 
patients) completed the questionnaires.  
 
The mean sleepiness scores recorded were: 8.68 (± 5.2) pictorial Epworth Sleepiness 
Scale ∑Q1–8 (Q.8 representing the person in the vehicle as the sleepy passenger), 8.54 
(± 5.04) pictorial Epworth Sleepiness Scale ∑Q1–7 + Q.9 (Q.9 representing person in 
the image as the sleepy driver) and 8.63 (± 5.3) the standard Epworth Sleepiness Scale; 
full tabulated results for total pictorial Epworth Sleepiness Scale and Epworth 
Sleepiness Scale scores are shown in table 4.4 and figure 4.5.  
 
Item scores for the three different versions of question 8 were analysed separately. No 
differences in item scores across the three versions of question 8 were observed in those 
who reported they could not drive (n=49). However, respondents who held a driving 
licence (n=87) were significantly more likely to report sleepiness when the pictorial 
Epworth Sleepiness Scale depicted a sleepy passenger in the vehicle than when the 
pictorial Epworth Sleepiness Scale depicted a sleepy driver in the vehicle (p=0.003). A 
similar difference was seen in comparison to question 8 of the traditional Epworth 
Sleepiness Scale (p=0.02) and this was so whether the respondent came from the Sleep 
or Lung Function group of patients (table 4.5). 
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Table 4.4. Total pictorial Epworth Sleepiness Scale (versions Q8 and Q9), and 
traditional Epworth Sleepiness Scale scores for: total group (n=136), Sleep (n=82) and 
Lung function (n=54) patients; and for respondents categorised as a driver or non–
driver. A Wilcoxon signed rank test showed no statistically significant difference 
(p>0.05) in total pictorial and traditional Epworth scores between drivers and non-
drivers, whether the patients came from the sleep or lung function group. 
 
   
 Pictorial Epworth Sleepiness Scale Epworth Sleepiness 
Scale 
  Q1–8 
 
 Q1–7+9 
 
  Q1–8 
‘In a car, while stopped for a 
few minutes in traffic’ 
 
 Total 
group 
Sleep Lung 
Function 
 Total 
group 
Sleep Lung 
Function 
 Total 
group 
Sleep Lung 
Function 
Drivers and non–drivers           
Mean score  
 
SD  
SE 
Median score 
IQR  
 
8.68 
 
5.20 
0.45 
8.00 
6.25 
10.15 
 
5.09 
0.56 
10.00 
7.00 
6.46 
 
4.56 
0.62 
6.00 
4.75 
 8.54 
 
5.05 
0.43 
7.50 
6.25 
9.99 
 
4.90 
0.54 
10.00 
7.00 
6.35 
 
4.47 
0.61 
6.00 
4.50 
 8.63 
 
5.30 
0.45 
8.00 
6.00 
10.07 
 
5.29 
0.58 
10.00 
6.75 
6.43 
 
4.53 
0.62 
5.00 
4.74 
Drivers (n=87)            
Mean score  
 
SD  
SE 
Median 
IQR 
 
9.37 
 
4.95 
0.53 
8.00 
6.50 
10.14 
 
5.00 
0.59 
10.00 
7.00 
5.94 
 
2.95 
0.74 
5.00 
4.00 
 9.17 
 
4.77 
0.51 
8.00 
6.00 
9.96 
 
4.76 
0.57 
10.00 
6.50 
5.69 
 
2.96 
0.74 
4.00 
3.25 
 9.18 
 
5.13 
0.55 
8.00 
6.00 
10.00 
 
5.17 
0.61 
10.00 
6.00 
5.56 
 
2.99 
0.75 
5.00 
3.50 
Non–drivers (n=49)            
Mean score  
 
SD  
SE 
Median score 
IQR 
7.47 
 
5.45 
0.78 
6.00 
7.00 
10.18 
 
5.95 
1.79 
11.00 
8.50 
6.68 
 
5.11 
0.83 
6.00 
4.74 
 7.43 
 
5.36 
0.77 
6.00 
7.00 
10.18 
 
5.95 
1.79 
11.00 
8.50 
6.63 
 
4.98 
0.81 
6.00 
4.75 
 7.63 
 
5.50 
0.79 
7.00 
7.00 
10.55 
 
6.28 
1.89 
11.00 
11.00 
6.69 
 
5.03 
0.82 
5.50 
5.50 
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Figure 4.5.  Responses to each pictorial Epworth Sleepiness question which includes a 
ninth question where the sleepy character is depicted as a driver amongst Sleep 
Laboratory (n=82) and Lung Function Laboratory (n=54) patients, where patients are 
categorised as a driver or non–driver; error bars are SE. 
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Table 4.5. Comparing item scores for two pictorial derivations of question 8 pictorial 
Epworth Sleepiness Scale; one showing a sleepy passenger (Q8) and the other showing 
a sleepy driver (Q9) in the vehicle, and question 8 traditional Epworth Sleepiness 
Scale, amongst total group (n=136), Sleep Centre (n=82) and Lung Function laboratory 
(n=54) patients. 
 
   
 Q8 
 
Q9 
 
Q8 
‘In a car, while stopped for a 
few minutes in traffic’ 
 
 Total 
group 
Sleep Lung 
Function 
 Total 
group 
Sleep Lung 
Function 
 Total 
group 
Sleep Lung 
Function 
Drivers and non–drivers            
Mean score  
 
SD  
SE 
 
0.31 
 
0.74 
0.06 
0.40 
 
0.84 
0.09 
0.17 
 
0.50 
0.07 
 0.17 
 
0.54 
0.05 
0.24 
 
0.64 
0.07 
0.06 
 
0.30 
0.04 
 0.21 
 
0.59 
0.05 
0.27 
 
0.69 
0.08 
0.11 
 
0.37 
0.05 
Drivers (n=87)            
Mean score  
 
SD  
SE 
 
0.40 
 
0.83 
0.09 
0.44 
 
0.87 
0.10 
0.25 
 
0.58 
0.14 
 0.21* 
 
0.59 
0.06 
0.25 
 
0.65 
0.08 
0.00 
 
0.00 
0.00 
 0.24
† 
 
0.66 
0.07 
0.28 
 
0.72 
0.09 
0.06 
 
0.25 
0.06 
Non–drivers (n=49)            
Mean score  
 
SD  
SE 
0.14 
 
0.50 
0.07 
0.18 
 
0.60 
0.18 
0.13 
 
0.47 
0.08 
 0.10 
 
0.42 
0.06 
0.18 
 
0.60 
0.18 
0.08 
 
0.36 
0.06 
 0.14 
 
0.41 
0.06 
0.18 
 
0.40 
0.12 
0.13 
 
0.41 
0.07 
 
 
* p=0.003 between drivers’ responses: pictorial Epworth Sleepiness Scale Q8 versus 
pictorial Epworth Sleepiness Scale Q9. 
 
 † p=0.02 pictorial Epworth Sleepiness Scale Q8 versus Epworth Sleepiness Scale Q8. 
 
 
Patient preferences for the traditional or pictorial Epworth Sleepiness Scale (sleep 
n=82) 
82 further patients attending the Sleep Centre, who had not taken part in the previous 
studies, completed evaluations of the pictorial Epworth Sleepiness Scale and Epworth 
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Sleepiness Scale questionnaires with the following mean sleepiness scores: pictorial 
Epworth Sleepiness Scale 9.24 (±4.48) and traditional Epworth Sleepiness Scale 9.56 (± 
4.99); full results, table 4.6. Although not a statistically significant difference 54.9% 
(45/82) reported a preference for the pictorial Epworth Sleepiness Scale compared with 
45.1% (37/82) a preference for the traditional word–only Epworth Sleepiness Scale 
(figure 4.6a) p>0.05. The majority of patients, 96.8%, reported both scales to be easy to 
complete. More people, 75.6%, recorded the pictorial Epworth Sleepiness Scale as very 
easy to complete in contrast to the word only Epworth Sleepiness Scale questionnaire, 
64.6% (figure 4.6b), again this was not statistically significant with a chi-squared test 
statistic p>0.05. 
 
Table 4.6. Total pictorial Epworth Sleepiness Scale and Epworth Sleepiness Scale 
scores for 82 new patients from the Sleep Centre who scored a preference for the 
pictorial or traditional Epworth Sleepiness Scale. 
     
 Total pictorial Epworth 
Sleepiness Scale 
Total Epworth Sleepiness Scale 
Mean score 
SD 
SE 
Median Score 
IQR 
9.24 
4.82 
0.53 
9.00 
6.75 
9.56 
4.99 
0.55 
9.00 
6.50 
 
Figure 4.6. a) Preferences for completing either the pictorial Epworth or the tradional 
Epworth Sleepiness Scale: chi-squared test result p>0.05 and b) the % of patients recording 
the scales as ‘very easy’ to complete (n=82) chi-squared test result p>0.05. 
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Chapter 4 comments 
The addition of pictures to words in the Epworth Sleepiness Scale has been shown to 
be possible and is one method of broadening the accessibility of medical questionnaires 
or information. When tested with the traditional Epworth Sleepiness Scale the 
pictorial scale achieved an acceptable level of equivalence and comparable total 
Epworth Sleepiness Scale scores. Two of the item scores (Q3 and Q5) were in the 
moderate kappa range however overall median kappa results showed good agreement 
between the scales with an IQR of 0.04. Johns’ original study obviously used a different 
population from this study, but the distribution of scores between questions shows a 
similar pattern, with patients being more likely to report excessive daytime sleepiness, 
for example, when watching television or when resting in the afternoon, than when 
sitting and talking to someone or when in a car stopped for a few moments in traffic.  
 
Depicting the character of the sleepy person as the driver or the passenger in the 
vehicle, resulted in different responses according to whether the respondent held a 
driving licence or not. Measuring driver sleepiness is a sensitive and complicated issue 
and the interpretation of this finding is difficult. There may be reluctance to admitting 
to sleepiness whilst behind the wheel for legal reasons or for fear of losing one’s driving 
licence, particularly amongst people who rely on driving for their occupation. 
Alternatively this difference may be the result of driving producing a sufficient 
stimulus to reduce sleepiness. For the purpose of eliciting a valid response to 
sleepiness in a vehicle, depicting the passenger as the sleepy character may be the 
preferred option and has been chosen for the final pictorial Epworth Sleepiness Scale.  
 
Amongst patients who rated the two scales, both were reported to be easy to complete. 
However, more people rated the pictorial scale as very easy and a preference for the 
pictorial Epworth Sleepiness Scale was found in 55% of users.  
 
In summary, the addition of pictures to the Epworth Sleepiness Scale to produce a 
translated pictorial Epworth Sleepiness Scale did not detract from the original intent 
of the scale: I have shown that it is possible to devise a pictorial Epworth Sleepiness 
Scale which has good agreement with the traditional written Epworth Sleepiness 
Scale. The use of pictures in medicine should not exclude words. To elicit the best 
possible understanding, combining both pictures and words to maximally convey the 
intended meaning is important and necessary.141;146 147  
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My work supports studies by Johns and others that suggest propensity for sleepiness 
varies with situation. Ordinal ranking of the Epworth Sleepiness Scale and pictorial 
Epworth Sleepiness Scale item scores from lowest to highest rank demonstrates 
situation specific somnoficity. 160 In this study, question eight highlights one of the 
scenarios in which either somnoficity is low or there is a reluctance to admit to 
sleepiness while in a vehicle. The value of these low ranking scores to the contribution 
of the overall Epworth Sleepiness Scale score is questionable. Indeed, in this study, 
even though drivers reported a statistically significant chance of sleepiness when 
depicted as a passenger in the pictorial Epworth Sleepiness Scale this made no change 
to the total sleepiness (pictorial Epworth Sleepiness Scale) score.  
 
Utilising all of the results presented in this chapter the next phase of this programme 
involves developing a reduced number of situation–specific sleepiness scenarios from 
the pictorial Epworth Sleepiness Scale for a new tool.  
 
Chapter 4 key findings 
 
 A total of 363 patients contributed to the development of the pictorial Epworth 
Sleepiness Scale in this chapter. 
 A Cohen Kappa statistic showed good agreement between the pictorial and the 
traditional Epworth Sleepiness Scale item scores – median kappa score 0.63 
(IQR 0.04). 
 Ordinal ranking of mean item scores for the pESS and ESS from low to high 
shows situation-specific somnoficity.  
 Two versions of the pESS were trialled with variations on question 8: patients 
who were ‘drivers’ were less likely to report sleepiness when the image for 
question 8 showed a sleepy driver in the car, rather than a sleepy passenger 
(p=0.003).  
 54.9% of respondents reported a preference for the pictorial Epworth compared 
with 45.1% for the traditional word only Epworth (p=0.21). 
 75.6% of patients reported the pictorial Epworth to be ‘very easy’ to complete 
compared with 64.6% the traditional word-only Epworth (p=0.12). 
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Chapter 5 
 
Developing a new sleep apnoea scale 
 
 
Introduction 
 
Screening and case finding for obstructive sleep apnoea syndrome is not easy. Most 
studies in western countries show that obstructive sleep apnoea syndrome is common 
and underdiagnosed. Those adults most in need of testing and access to treatment 
often remain untreated for years or never receive appropriate referral for the 
condition.51  59 
 
At the time of conducting these studies, I worked in a busy sleep centre, located within 
the respiratory department of a large teaching hospital in the south of England. We 
had in–patient facilities in which we could test four patients, 5 nights a week (Sunday 
night to Friday morning), primarily reserved for respiratory sleep studies. 
Additionally, we had two specialist beds, running 4 nights a week (Monday night to 
Friday) which were reserved for full polysomnography and the investigation of other 
sleep disorders or complex sleep apnoea, but were available for respiratory sleep 
studies if free. Accounting for staff and public holidays, we typically tested for 
approximately 48 weeks a year, offering at full capacity the opportunity to study 
between 980–1384 patients per year for obstructive sleep apnoea syndrome (the 
maximum assumes no testing of ‘other’ sleep disorders). At the time of the introduction 
of the NHS 18 week pathway and 6 week diagnostic wait, we temporarily moved the 
service to 6 nights testing a week (Sunday night to Saturday morning) to bring waiting 
times in line with the diagnostic targets. 80 The diagnostic service and handling of 
continuous positive airway pressure therapy prescriptions and compliance monitoring 
was a multi–disciplinary effort involving physicians, clinical scientists, physiologists 
and nursing staff.  
 
Located in West London (Charing Cross Hospital), we were close to another large 
teaching hospital (The Royal Brompton) with facilities for testing sleep disordered 
breathing.  People living in our localities generally had access to a rapid service and 
appropriate treatment if their primary care provider suspected obstructed sleep 
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apnoea. We liaised with local GPs and promoted understanding of the condition yet it 
was not uncommon for our patients to have lived with symptoms for many years. 51  
Sleepiness is key to the diagnosis and management of so many sleep disorders that 
some look to the Epworth Sleepiness Scale to try and tease out who might benefit from 
treatment.  The Epworth has several merits that have promoted it’s use 
internationally, and it has filled a niche in the measurement of subjective sleepiness 
across a variety of sleep disorders; in particular in patients suspected of having 
obstructive sleep apnoea syndrome. Yet, it was never designed to be a screening 
instrument. In the absence of a simple tool to case find those at high risk of obstructive 
sleep apnoea syndrome, the Epworth is servicing a need for case finding and screening. 
161 162 163 Using the Epworth this way requires the patient to score in a ‘pathological’ 
band, often a score of ≥10/24, which then permits the patient access to testing or 
treatment. One problem with this approach is that excessive sleepiness during wake 
hours can be present for a variety of reasons, and without appropriate understanding 
or consideration of other clinical features or symptoms, a differential diagnosis may be 
missed. The lack of specificity means some people who don’t need testing are put 
through while others who may be excessively sleepy or have other symptoms related to 
the condition, may be passed over through inaccurately completing the scale or scoring 
≤10/24. Allan Pack and colleagues and Mondal and Lim and co–workers discuss a need 
for standards in sleep questionnaires and report a current lack in consensus in the 
terminology used and call for improvement in standards.  164 165 Lim found that there 
was a poor relationship between the Pittsburgh Sleep Quality Index and the Epworth 
Sleepiness Scale in a sleep laboratory referral population, each scale measuring 
different aspects of sleep. Hesselbacher found body mass index, gender and ethnicity 
altered the clinical implications of Epworth Sleepiness Scale scores.166 Ideally, 
screening and case finding for obstructive sleep apnoea syndrome should ask about 
risk of the condition as well as assessing the level of wake–time sleepiness. 
 
In chapter 2, I showed that not all patients easily complete the Epworth scale and 
described the common errors that patients can make. In chapter 3, some patients 
achieved scores in the rapid estimate of adult literacy in medicine test which suggest 
they would struggle with patient education materials and prescription labels.  
Problems with adult literacy and numeracy are a potential reason for poorly completed 
Epworth Sleepiness Scales. Producing material such as the Epworth Sleepiness Scale 
in alternative formats might improve understanding and in chapter 4, I pictorially 
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translated the scale with promising results. In addition to an effective screening and 
case finding tool being syndrome specific, the tool would ideally be simple enough for 
non–specialists to feel confident to use, be easy to administer to a wide client base, and 
suitable for people with varying degrees of functional health literacy.   
 
If screening and case finding for obstructive sleep apnoea is desired, then a useful tool 
needs to be identified.  
 
The pictorial Epworth Sleepiness Scale has some features which might be exploited, 
and a potential screening and case finding tool for obstructive sleep apnoea syndrome 
might be developed from sleepiness images in the pictorial scale; extracting useful 
items and coupling these with features associated with the condition.  An accessible 
tool that would be suitable for all, regardless of literacy would be a useful addition to 
the field of sleep medicine. In particular it might allow for easy case finding in 
communities at risk of obstructive sleep apnoea syndrome, such as those in bariatric 
surgery programmes or those with cardiovascular disease. An easy to use tool might 
also be of use in primary care or for the screening of commercial drivers. The next part 
of my thesis explores this theme and has the following aims: 
 
Aims 
1. To reduce items and develop sleepiness images from the pictorial Epworth 
Sleepiness Scale for a shortened pictorial sleepiness scale.  
 
2. To develop additional images that represent risk commonly associated with 
obstructive sleep apnoea syndrome. 
 
3. To combine the sleepiness and risk images in the development of a new screening 
and case finding instrument for obstructive sleep apnoea syndrome.  
 
 
Selecting sleepiness images from the pictorial Epworth Sleepiness Scale. 
 
The decision to reduce the number of sleepiness scenarios was partly motivated by a 
wish to create a simple and practical screening and case finding tool that could easily 
be reproduced. With a desire to add questions that represent risk of obstructive sleep 
apnoea syndrome, space on paper became a consideration and some questions from the 
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pictorial Epworth needed to be put aside. Perhaps one of the successes of the 
traditional Epworth is the format it takes; it fits easily onto one side of an A4 piece of 
paper which makes it easily reproducible, and a practical questionnaire to have in the 
clinic or community setting. Johns reports it takes 2–3 minutes to complete, which is 
convenient for the clinician as well as the patient (at least where literacy is not a 
problem). Earlier in chapter 4, I reported how the majority of patients had scored the 
pictorial and traditional Epworth as fairly easy to complete, despite in the previous 
study recording problems with how the questionnaire was filled in by a third of naïve 
patients.  
 
It was decided the new tool should fit onto one side of an A4 piece of paper. The images 
would be in black and white to be compatible with a standard printer or photocopier 
and the eight sleepiness scenarios would be reduced to four sleepiness scenarios to 
allow room for four additional new risk questions.  
 
Deciding which four sleepiness images to keep was not easy. In developing the 
Epworth Scale Murray Johns made reference to a New Mexico study by Schmidt–
Nowara that highlighted three situations which were considered most soporific: 1) 
inactive in a public place, 2) at work, and 3) in a moving vehicle as a passenger or 
driver.114  New Mexico question one features in the Epworth as item three, and New 
Mexico question three is represented in the Epworth as item 4, but only as a sleepy 
passenger. It is unclear where the remaining six items on the Epworth came from. 
Johns reports choosing similar soporific situations (to the New Mexico study) but does 
not specify how he chose the scenarios. The items were chosen a priori to represent 
different soporific situations and thus measure a person’s specific, average sleep 
propensity.158 Several studies have investigated the psychodynamic properties of the 
scale; one study from Edinburgh (of 129 patients under investigation for sleep apnoea) 
used Mokken scaling and found four of the eight items contributed to a single, 
cumulative continuum or hierarchical scale:  item 2 (watching TV), item 1 (sitting and 
reading), item 7 sitting quietly after lunch without alcohol) and item 6 (sitting and 
talking to someone).167 Thus if someone scores question 6 as having a high likelihood of 
sleepiness , there is a strong chance that questions 7, 2, and 1 will also be scored 
highly. However, if someone gives question 1 a high score, there is a significant 
likelihood that they may also score question 2 highly but not necessarily questions 6 or 
question 7.  
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Other psychometric properties of the Epworth which have been proposed are the scale 
comprises two different dimensions of sleep propensity; the ability to fall asleep in 
appropriate and soporific situations (questions 1, 2, 4, 5 and 7) and secondly the 
inability to resist falling asleep in less soporific situations which are inappropriate 
(questions 3, 6, and 8). This hypothesis suggests that patients with excessive sleepiness 
will be more familiar with the feeling of trying to resist sleep and therefore approach 
these sets of questions differently.167 
 
Several studies have found a consistent ranking amongst the eight items: item 5, 2 and 
1 are most soporific, items 3, 4 and 7 are intermediately soporific and items 8 and 6 are 
least soporific.158;160 168 160 There are a few exceptions to this finding and rankings are 
not completely universal; inconsistencies between some groups may be explained by 
cultural differences. In Murray Johns’ 1992 paper, medical students’ response to 
question 4, ‘as a passenger in a car for an hour without a break’ was scored highly and 
question 2, ‘watching TV’ was less sleep inducing. 160 Conversely, in a Spanish study by 
Izquierdo–Vicario question 7, ‘sitting quietly after lunch’ which typically falls in the 
middle of the rankings, ranked seventh (and had the second highest mean item 
score).169 In general though, rankings amongst many studies produce similar results. 
At the extremes these rankings appear to respond predictably irrespective of whether a 
person is considered pathologically sleepy or not. For example, question 5, which 
carries the highest soporific label, “lying down to rest in the afternoon”, is as likely to 
be scored highly by someone who does not have a sleep complaint, as it is for someone 
who does. It has been suggested this question may cause confusion as it can be a norm 
to rest or lie down for a nap in the afternoon in some cultures, whereas in others this is 
less acceptable. It also potentially represents the normal physiological nadir of 
afternoon sleepiness. 170  
 
In my own study, ranking questions from low to high scoring items, showed a 
consistency with other reported studies, including Johns’ original 1991 and later 2002 
paper of low, intermediate and high ranking answers. 152 160 Table 5.2 displays mean 
item scores ranked from low to high and figures 5.1 and 5.2 show histograms for each 
of the eight items in the pictorial and traditional Epworth. Mean item scores and 
rankings for the pictorial and traditional Epworth divided into Sleep and Lung 
Function patients are shown in appendix 3. These figures allow comparison of item 
responses across sleep and lung function patients.  
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Figure 5.1. Epworth Sleepiness Scale item scores for sleep (n=175, 1st row), lung 
function (n=106, 2nd row) and combined sleep and lung function groups (n=281, 3rd 
row). 
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Figure 5.2. Pictorial Epworth Sleepiness Scale item scores for sleep (n=175, 1st row), 
lung function (n=106, 2nd row) and combined sleep and lung function groups (n=281, 3rd 
row).  
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Table 5.2. Item rankings for the pictorial Epworth Sleepiness Scale and Epworth 
Sleepiness Scale (n=281 pooled data from chapter 4) and a summary of John’s 2002 
results which represent 23 Epworth studies, ranked in order of lowest to highest item 
score across the eight questions. Where available mean item scores plus SD are shown 
in parenthesis.160  
 
 
Rank 
(low to high 
score) 
 
Pictorial 
Epworth 
Sleepiness 
Scale (n=281 ) 
 
Epworth 
Sleepiness 
Scale (n=281 ) 
 
Johns 2002 
23 studies 
(n=2802)* 
 
suggested 
soporific 
value 
1 Q6  (0.29±0.63) Q8  (0.22±0.56) Q8  (0.30±0.68) Low 
2 Q8  (0.30±0.69) Q6  (0.30±0.59) Q6  (0.28±0.62) Low 
3 Q3  (1.02±1.06) Q3  (0.94±0.90) Q3  (0.85±0.93) Intermediate 
4 Q4  (1.10±1.06) Q4  (1.06±1.06) Q7  (0.85±0.96) Intermediate 
5 Q7  (1.15±1.03) Q1  (1.17±0.95) Q4  (0.96±1.03) Intermediate 
6 Q1  (1.19±0.99) Q7  (1.24±0.99) Q1  (1.21±1.04) High 
7 Q2  (1.50±0.97) Q2  (1.46±0.95) Q2  (1.40±1.04) High 
8 Q5  (2.19±0.92) Q5  (2.18±0.94) Q5  (1.86±1.08) High 
 
*Means and SD for Johns 2002 data, represent 987 / 2802 subjects from ten Australian 
studies, the remaining 13 studies coming from other countries have no representative 
means and SD. Q1 Sitting and reading, Q2 Watching TV, Q3 Sitting inactive in a 
public place (eg a theatre), Q4 As a passenger in a car for an hour without a break, Q5 
Lying down in the afternoon when circumstances permit, Q6 Sitting and talking to 
someone, Q7 Sitting quietly after lunch, Q8 In a car while stopped for a few minutes in 
traffic.  
 
Selecting Sleepiness Images – the final cut 
 
In deciding which questions to exclude, understanding how items ranked and 
contributed to the overall score was useful. For a scale with limited questions, it is 
perhaps useful to prefer questions with intermediate mean scores and larger standard 
deviations, over questions that lie at the extremes with lower mean scores and smaller 
deviations. The best questions for a scoring tool are ones that patients with a low 
propensity to sleepiness are likely to score 0 or 1 and that patients with a high 
propensity to sleepiness are likely to score 2 or 3.  
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I excluded question 5 ‘Lying down to rest in the afternoon when circumstances permit’ 
as it courted the most controversy in the literature and was likely to produce high 
scoring answers irrespective of a person’s overall sleep propensity, thus rendering it 
less discriminatory. I next excluded the two lowest scoring items, question 6 and 8. I 
understand this is perhaps controversial as question 6 was cited in the Mokken scaling 
as one of the four items contributing to a hierarchical continuum, but in my study so 
few people from either the sleep or the lung function groups answered this question 
with a score >0, that it had a very low value to the overall sleep score. In Kingshott’s 
study of Mokken scaling, question 6 had a slightly higher mean value. Question 8 is a 
difficult question for some patients to answer as it can elicit fear of losing ones driving 
licence. When I tried to improve on this and offer a choice of image as the driver or 
passenger, this made no difference to the overall Epworth score.  
 
This left questions 1, 2, 3, 4, and 7. Questions 1, 2, and 7 were hierarchical in the 
Mokken scaling. Questions 1, 2, 7, and 4 sat alongside each other in the ranking. I 
decided to remove question 3 ‘sitting inactive in a public place.’ The stigma of falling 
asleep publicly is difficult for some and this question in my study produced similar 
overall scores to question 4 ‘as a passenger in a car for an hour without a break.’ 
Question 3 may also be biased to a particular demographic; people of a certain age or 
social class who experience going to the theatre or public lectures.  
 
I chose question 4 ‘as a passenger in a car for an hour without a break’ as the fourth 
sleepiness image for the new scale. I considered this item pictorially stronger than the 
image of sitting inactive in a public place (e.g theatre of meeting) and applicable to a 
broader demographic group. During the development of the pictorial Epworth the 
kappa statistic for question 3 scored in the moderate range rather than the good range. 
Although this difference was very borderline, I felt overall for the development of the 
new scale that I wanted to work with the best images possible. 
 
The four sleepiness questions chosen to be developed for the new scale are highlighted 
in figure 5.3 of the pictorial Epworth, alongside images which were not developed.  
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Figure 5.3. Four questions from the pictorial Epworth Sleepiness Scale (highlighted by 
the grey arrows) were chosen to be developed for the new four question pictorial 
sleepiness scale.  
 
 
1 
4 
3 
2 
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One of the aspirations of the new screening and case finding tool was that it should be 
applicable to a wide range of individuals and for this to include potential use overseas. 
During this process of revision, I took into account the result of pilot testing the 
pictorial Epworth Sleepiness Scale by colleagues in Pakistan (for which thanks are due 
to Dr Javed Husain of the Aga Khan University Hospital, Karachi). It was reported by 
our Pakistan colleagues that not everyone has a TV at home nor experience of regular 
travel in a car and so question 2 watching TV was adapted to include a radio (figure 
5.4a) and question 4 as a passenger in a car  was adapted to include a bus (figure 5.4b). 
The new image of travelling as a passenger falling asleep in a vehicle, also had the 
time restriction removed.  
 
 
Figure 5.4. Adaptation of pictorial Epworth question 2 (5.4a) ‘watching TV’ to include a 
radio and question 4 (5.4b) ‘as a passenger in a car’, to include a person travelling in a 
bus, after colleagues in Pakistan offered feedback that not all persons attending their 
clinics will have a television set or regular access to travel in a car. 
 
5.4a. Watching TV or listening to the radio 
 
 
 
  
 
5.4b. Travelling as a passenger in a car or bus 
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Developing risk images 
 
A search of the literature suggested no previous pictorial material related to screening 
for disorders of breathing during sleep. Several daytime and night–time symptoms and 
anthropometric and clinical characteristics are common to those with the condition, 
and are summarised in table 5.3. 
 
Table 5.3. Clinical characteristics and patient reported symptoms commonly associated 
with obstructive sleep apnoea syndrome. 
 
Excessive daytime 
sleepiness 
Loud snoring Overweight or obesity 
Unrefreshing sleep Choking events at night 
Increased waist 
circumference 
 
Irritability or personality 
change 
Witnessed apnoea or 
breathing pauses 
Increased neck 
circumference 
 
Intellectual deterioration Disturbed sleep 
Craniofacial and 
pharygngeal abnormalities 
 
Decreased libido Nocturia 
Hypertension 
 
   
 
All factors listed in table four are commonly reported features of obstructive sleep 
apnoea syndrome reported in the literature. Young, along with others, has shown that 
male gender, age, body mass index, neck girth, snoring and witnessed apnoea are all 
good predictors of the condition in a community based population 68. Loud and 
disruptive snoring is a common cause of referral to clinics, and witnessed apnoea has 
been shown to be highly predictive in several studies. 171;172 Duran found the prevalence 
of habitual snoring to be 36% and breathing pauses 6%, in a sample population being 
screened for sleep disordered breathing. Both were highly related to the diagnosis and 
severity of obstructive sleep apnoea or hypopnoea syndrome; an odds ratio of 4.51 was 
found for breathing pauses in those with an apnoea–hypopnoea index of 5–14.9 events 
per hour and an odds ratio of 9.74 for an apnoea–hypopnoea index ≥15 events per hour. 
173 In the same study, the odds ratio for hypertension, when corrected for body mass 
index, smoking history and alcohol consumption also related to the condition, although 
the relationship was not linearly associated with severity of disease. Other studies 
have shown an index linked (AHI) rise in severity of obstructive sleep apnoea 
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syndrome with hypertension. 174 175 176 Lavie has shown that for each additional apnoeic 
event per hour of sleep, the odds of hypertension increase by 1%.177 Blood pressure is a 
good predictor of disease in those with the condition but who have less obesity. 171;172 
The dose–response relationship between obstructive sleep apnoea and obesity is highly 
correlated. Neck adiposity and abdominal waist circumference are particularly 
sensitive predictors of obstructive sleep apnoea syndrome. Davies made a prospective 
study of neck circumference and symptoms in those referred for the condition and 
found that neck circumference, adjusted for height, was the best clinical indicator. A 
neck size 105% greater than predicted, which is equivalent to a >16.5inch neck in a 5 
foot 10 inches man, offered a 66% predictive value of severe obstructive sleep apnoea 
syndrome.  82;178   
 
 
Four risk scenarios were chosen to be developed: 
1. increasing body size 
2. increasing neck size 
3. blood pressure high, low or don’t know, and  
4. a bed partner witnessing you stopping breathing. 
 
The decision to not include snoring was deliberate; most people with apnoea snore but 
the symptom of snoring is also high amongst the general population who do not have 
obstructive sleep apnoea syndrome. In an attempt to improve specificity of the new 
scale, witnessed apnoea was believed to be the better characteristic to try to represent.  
 
Creating images with the medical artist was a consultative process with images being 
drawn, reviewed with colleagues and returned to the artist for improvement or 
complete reworking. A group of seven sleep patients were helpful in the early 
development and offered their advice on how images were perceived to them. Later, I 
will describe validated methods I used to test and refine pictograms with patients in 
the UK and overseas. 
 
Examples of images developed in conjunction with the medical artist as part of the 
process of developing representative pictures for the new scale are shown in figure 5.6. 
These images were refined or not used and the four final images are shown in figure 
5.5. 
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Figure 5.5. The four risk images developed with the help of a medical artist for the new 
sleep apnoea scale. Two images of high blood pressure were trialled and two images of 
witnessed apnoea were trialled: 5.5a increasing body size, 5.5b increasing neck size, 
5.5c high blood pressure, 5d witnessed apnoea.  
 
 
 
                 
(5.5a) increasing body size                       (5.5b) increasing neck size  
 
 
 
 
                     
(5.5c) blood pressure 1          blood pressure 2  
 
 
 
 
                 
(5.5d) witnessed apnoea 1          witnessed apnoea 2 
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Figure 5.6. In the process of designing suitable images, pictures were passed back and 
forth between the medical artist and the clinical team. Some were discarded and some 
underwent several iterations, before they were suitable for testing with patients. 
Images 1–4 are a selection of pictograms which were not used but contributed to the 
final scale. 
 
1. People of increasing body size 
 
 
 
The thinnest body image here was perceived to be unrealistic and a slightly broader, 
image was ultimately chosen. 
 
2. Increasing neck size 
                  
 
The greying of the neck was trialled as well as differing neck widths. Here the smallest 
neck size was thought to look too unrealistic and neck length too long. Patient feedback 
reported the person looked like they were wearing a neck brace. In subsequent images 
the neck length was reduced by adding a collar, and an arrow pointing to the neck was 
added to stress the area of interest.  
 
 
3. Blood pressure images 
 
 
  
 
 
Images were trialled with different values 
or no values on the face of the electronic 
blood pressure machine. 
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4. Witnessed apnoea 
                               
 
 
 
 
 
 
 
 
 
 
 
 
Witnessed apnoea was perhaps the hardest image to portray. Trials of different apnoea 
images showing airflow moving in an out of the airway were considered. Many times it 
was felt these images elicited ‘snoring’ rather than ‘stopping breathing’. Conveying the 
bed partner in a sensitive manner was challenging. 
 
 
Two versions of the blood pressure image were developed: one with the traditional 
mercury sphygmomanometer and a second representing the newer electronic blood 
pressure device. Developing an image to depict witnessed apnoea proved to be 
problematic; two versions were ultimately developed and subjected to evaluation. The 
four new sleepiness scenarios and four risk factor scenarios were combined to produce 
the initially titled: Charing Cross Pictorial Sleep Apnoea Scale shown in figure 5.7. 
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Figure 5.7. The Charing Cross Sleep Apnoea Scale: a four point pictorial sleepiness 
questionnaire and four point screening and case finding tool designed to assess both 
sleepiness and likelihood of obstructive sleep apnoea syndrome. 
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Testing pictograms in the UK, Pakistan and Hong Kong 
 
Introduction 
Conveying the intended meaning with images was not always easy. To ensure that all 
eight image series in the new tool were understood by patients, and that pictures 
carried the best intended meaning, tests of image comprehensibility were undertaken.  
 
Methods  
 
The comprehensibility and understanding of sleepiness and risk images in the new tool 
was undertaken using the published methods of guessability and translucency 
testing.179 180  Patients attending the sleep and lung function services were recruited for 
the study.  
 
Guessability testing involves being shown individual pictograms, isolated from the 
context of the questionnaire and without a written definition; the subject is asked to 
describe their interpretation of the meaning of the picture.  
 
This is followed by translucency testing, where the isolated images are shown together 
with their intended written meaning and subjects rate the relationship between the 
image and definition on a Likert type scale of 1 to 7; where ‘1’ indicates no relationship 
and ‘7’ a very strong relationship. Mean translucency scores for each pictogram were 
produced. An a priori threshold translucency score of 5 out of 7 was set to represent 
good agreement between image and words, in accordance with previous published 
studies 181. Example guessability and translucency questionnaires are shown in figures 
5.8 and 5.9. 
 
Guessability answers were blindly, double–marked and themed into: correct, nearly 
correct, blank and wrong answers. A “nearly correct” answer would be one where the 
general meaning of the image has been given, for example a respondent gives the 
following answer for image 3: ‘sitting at the table falling asleep after dinner and head 
drops onto the dinner plate’ . Here the first part of the answer is essentially correct 
(the correct answer being ‘falling asleep sitting quietly after a meal’) but the answer 
has been further qualified by describing what they see in the image which is 
interpreted as the head slumping forward onto the dinner plate.   
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Figure 5.8. Example of the Guessability questionnaire cover sheet (page 1) and page 2. 
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Figure 5.9. Example of the Translucency questionnaire cover sheet (page 1) and page 6. 
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Where there was >80% agreement between the two scorers, the first scorer’s answers 
were taken. Where the agreement between scorers was <80%, images were openly re–
evaluated with a third marker and discussed until consensus on image interpretation 
was achieved. 
 
Images that scored less favourably in either: guessability or translucency testing, 
underwent further modification or were redrawn to improve understanding. 
 
1. falling asleep sitting quietly after a meal,  
2. blood pressure image 1,  
3. a bed partner witnessing you stopping breathing, image 1. (figure 5.10) 
4. a bed partner witnessing you stopping breathing, image 2  (figure 5.10). 
 
The new images were retested in a new set of sleep patients in the UK and in a further 
set of non–English speaking patients referred for sleep tests overseas: clinic 1) 
Pakistan and clinic 2) Hong Kong, where overseas physicians transcribed answers into 
English for analysis in the UK. The level of English language and the mother tongue 
were recorded for overseas recruits.  
 
Figure 5.10 Examples of two, new images for a bed partner witnessing you stopping 
breathing. These images were subject to a further set of guessability and translucency 
testing in the UK, Hong Kong and Pakistan. Further images are shown in appendix 4. 
 
Witnessed apnoea 1. 
 
Witnessed apnoea 2. 
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Results  
 
A total of 94 patients were studied in the UK: 33 in the sleep group, 30 in the non–
sleep group. An additional 31 sleep patients tested modified pictograms.  
 
In addition, 41 patients from outside the UK evaluated the modified pictograms: 21 in 
Karachi, Pakistan and 20 in Hong Kong, China. Instructions provided to the two 
overseas studies are shown in appendix 5. 
 
Guessability results showed a variety of responses across the five groups. Themed 
responses across the three UK groups and the Pakistan and Hong–Kong groups are 
shown in figure 5.11. Some images when shown without words and separate from the 
context of the questionnaire are better understood than others. For example, the image 
of falling asleep sitting and reading is well understood over the five groups, achieving a 
‘correct’ interpretation in >70% of respondents and the remaining respondents scoring 
mostly ‘nearly correct’ answers.  
 
Conversely, the first two versions of witnessed apnoea were poorly perceived and the 
percentage of ‘correct’ responses was <35% amongst the UK participants. 
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Figure 5.11. Guessability answers for the new tool, themed into: correct, nearly correct, blank, and wrong answers. 
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Figure 5.11. continued, Guessability answers for the new tool.
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Figure 5.12 Translucency scores for images in the new screening and case finding tool. 
Pictogram Falling asleep sitting 
and reading 
Falling asleep 
 watching TV or 
listening to the radio 
Falling asleep sitting quietly 
after a meal 
Falling asleep as a  
passenger in  a car 
or a bus 
People of increasing 
body size 
 
     
U.K Sleep 
(n=33) 
     
Mean ±SD 6.8 ± 0.61 6.8 ± 0.57 6.1 ± 1.12 6.6 ± 0.72 6.5 ± 0.85 
U.K Non–sleep 
(n=30) 
     
Mean ±SD  6.6 ± 1.13 6.6 ± 1.13 6.2 ± 1.49 6.1 ± 1.87 6.3 ± 1.12 
Pictogram Increasing neck size Your bed partner witnessing 
you stopping breathing 1 
Your bed partner witnessing 
you stopping breathing 2 
BP which is raised, 
normal, don’t know 
–mercury 
sphygmomanometer 
BP which is raised, 
normal, don’t know 
–electronic BP device 
 
     
U.K Sleep 
(n=33) 
     
Mean ±SD  6.2 ± 1.10 4.8 ± 1.91* 4.9 ± 1.94* 5.7 ± 1.50 5.4 ± 1.69 
U.K Non–sleep 
(n=30) 
     
Mean ±SD  6.3 ± 1.12 4.4 ± 2.11*  4.3 ± 2.07* 5.4 ± 1.27 6.0 ± 1.59 
Pictogram– 
revised images 
Falling asleep sitting quietly 
after a meal 
–revised image 
BP which is raised, 
normal, normal with 
medication, don’t know– 
revised image 
Your bed partner witnessing 
you stopping – 
revised image 1 
Your bed partner witnessing 
you stopping – 
revised image 2 
Falling asleep sitting and 
reading  
 
 
  
 
 
 
UK revised 
images (n=31) 
     
Mean ±SD  6.5 ± 0.96 6.1 ± 1.08 5.9 ± 1.69 6.1 ± 1.40 6.9 ± 0.40 
* = images with a translucency score ≤ 5 / 7 
 
Comprehensibility of images using translucency methods was good amongst both UK 
sleep and non–sleep patients; all achieving translucency scores ≥5/7, with the exception 
of witnessed apnoea images (mean scores achieved for both versions, ranged between 
4.3–4.8), figure 5.12. The two versions of blood pressure image tested achieved 
comparable results: the mercury sphygmomanometer mean translucency scores were 
5.7 (sleep group) and 5.4 (non–sleep group) vs. 5.4 (sleep group) and 6.0 (non–sleep) for 
the new electronic blood pressure machine.   
 
 
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
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Figure 5.13. Translucency scores from the Pakistan and Hong Kong study groups. 
Pictogram Falling asleep sitting 
and reading 
Falling asleep 
 watching TV or 
listening to the radio 
Falling asleep as a  
passenger in  a car 
or a bus 
People of increasing 
body size 
Increasing neck size 
 
     
Pakistan 
(n=21) 
     
Mean ±SD 6.3 ± 1.42 6.2 ± 1.57 6.2 ± 1.57  6.3 ± 1.15 6.1 ± 1.24 
Hong Kong 
(n=20) 
     
Mean ±SD  6.6 ± 0.88  6.7 ± 0.74 6.0 ± 1.62 6.8 ± 0.41 6.9 ± 0.31 
Pictogram– 
revised images 
Falling asleep sitting quietly 
after a meal 
–revised image 
BP which is raised, 
normal, normal with 
medication, don’t know– 
revised image 
Your bed partner witnessing 
you stopping – 
revised image 2 
  
 
 
 
 
 
  
Pakistan 
(n=21) 
   
  
Mean ±SD  6.3 ± 1.42  5.9 ± 1.95 6.0 ± 1.42   
Hong Kong 
(n=20) 
   
  
Mean ±SD  6.2 ± 1.43 6.7 ± 0.57 5.8 ± 1.51   
 
 
Images that were less well understood during guessability and translucency testing 
were revised and retested: ‘Falling asleep sitting quietly after a meal’, ‘BP which is 
normal, normal with medication, don’t know’, ‘your bed partner witnessing you 
stopping breathing’, and ‘falling asleep sitting and reading’. Two new versions of the 
witnessed apnoea image were produced; both achieved better results, with the second 
of the two images produced being correctly guessed by 87.1% of UK Sleep patients.  
Translucency scores were also improved and achieved mean scores ≥5. Figure 5.12 
shows mean translucency scores and their histograms for all images in the UK. 
Guessability and translucency scores for the Pakistan and Hong Kong study groups are 
shown in figures 5.11 and 5.13 respectively. Both showed fair responses to the 
questionnaire and acceptable results (i.e., in guessability testing, more than 80% of 
respondents gave a ‘correct’ or ‘nearly correct’ answer, and translucency scores were 
≥5/7). Some images appeared better understood than others; ‘sitting quietly after a 
meal’ gave fewer ‘correct’ answers compared to the UK study group, but overall 100% 
of Pakistan and Hong Kong participants  ‘correctly’ or ‘nearly correctly’ guessed the 
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1 2 3 4 5 6 7 1 2 3 4 5 6 7 1 2 3 4 5 6 7
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meaning of the image. When the meaning was given with the picture (translucency 
testing), both Pakistan and Hong Kong cohorts produced good results for all images 
with the majority scoring a ‘7’. Comments from the overseas researchers written on 
patient study sheets (an example of a blank study sheet is shown in appendix 5) were 
positive and supportive of the concept of including images in the tool. None of the Hong 
Kong cohort spoke English; all were native Cantonese speakers. Most had an education 
until high school age and three held a higher degree. In the Pakistan group 13/21 
spoke English and seven different mother tongues were represented. Overall 
educational level was higher in the Pakistan than the Hong Kong cohort; although two 
people in the Pakistan cohort were illiterate, ten people held higher degrees. 
 
As a result of translucency and guessability testing the original format of the scale was 
changed and the new improved scale is shown in figure 5.14: The pictorial sleepiness 
and sleep apnoea scale (pSSAS). 
 
Early pilot testing of the first version of the scale demonstrated that the scale might 
benefit from increasing the choice of answers and the series of sleepiness images and 
body and neck size images were scaled up to five images in each series. The new blood 
pressure image contained the option of ‘normal blood pressure on medication.’ 
 
 
Chapter 5 comments   
 
It is challenging to develop images that convey a consistent meaning and that can be 
correctly understood by all. Using methods such as translucency 179 and guessability 180 
testing allows images to be refined and retested.  Witnessed apnoea was the hardest 
image to portray pictorially. Reworking this image achieved improved guessability and 
translucency scores but it was interesting to observe that those with obstructive sleep 
apnoea syndrome appeared more likely to understand the image of witnessed apnoea, 
than those without obstructive sleep apnoea syndrome. Testing images in a diverse 
population, including patients from Pakistan and Hong Kong offers hope that the tool 
might have use outside of English speaking communities. 
 
Advice was sought from a scaling expert on what was an appropriate number images 
for each question. Typically in a Likert–style scale where the final score is a collection 
104 
 
of eight or more items, 5 or 7 points for each item are used. During the course of the 
study, the scaling of sleepiness questions and body and neck size images increased 
from 3 to 5 pictograms to reflect the advice we had received. Five points are thought to 
better represent behavioural style questions over 7 points which are more commonly 
used to represent for example a period of time.   Blood pressure images were modified 
to represent: normal blood pressure, normal blood pressure on medication, high blood 
pressure and not sure of blood pressure.  The witnessed apnoea image was redrawn 
and in response to comments from the guessability questionnaires, sitting quietly after 
a meal was revised to move the sleepy person further away from the dinner table, with 
a modified chair image.  
 
It is rare to find evaluations on the ease of use of questionnaires amongst patient 
groups; the next chapter explores this in the new scale. 
 
Chapter 5 key findings: 
 Comparing ordinal ranking of the pESS and ESS item scores with 23 other ESS 
studies demonstrates consistent ranking with few exceptions: items 5, 2 and 1 
are most soporific, items 3, 4 and 7 are intermediately soporific and items 8 and 
6 are least soporific. 
 Feasibility trialing of the pESS in Pakistan allowed the question 2 pESS image 
to be amended to include a radio and the question 4 pESS image to include a 
bus, after feedback that not all patients in Pakistan have regular access to a 
television set or travel in a car.   
 A new scale was devised, the pictorial Sleepiness and Sleep Apnoea Scale, by 
combining 4 images from the pESS and four new images associated with risk of 
obstructive sleep apnoea. 
 The new tool underwent an iterative process of development to create images 
that are best understood by patients. Guessability and translucency testing in 
the UK, Hong-Kong, and Pakistan allowed images to be refined and improved. 
Most images were correctly or nearly-correctly guessed by ≥80% of respondents 
during guessability testing and scored above the threshold 5/7 for translucency 
testing. Images that didn’t meet these criteria underwent further refinement.  
 Witnessed apnoea proved to be the hardest image to portray pictorially but an 
improved image was found that was correctly understood by 87.1% of 
respondents (guessability testing) and scored 6.1/7 (translucency testing). 
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Figure 5.14. The pictorial Sleepiness and Sleep Apnoea Scale. 
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Chapter 6 
 
Testing the ease of use of the new scale 
 
 
Introduction 
 
In the last chapter I described how four images depicting sleepiness from the pictorial 
Epworth Sleepiness Scale and four new risk images, representing associations with 
obstructive sleep apnoea syndrome were developed for use in a new tool, the pictorial 
Sleepiness and Sleep Apnoea Scale.  
 
Some images were better understood than others and some images needed reworking 
or complete redrawing to improve understanding. In the same way that the Epworth 
Sleepiness Scale was evaluated for ease of use in chapter 2, this chapter describes an 
evaluation of the ease of use of the pictorial Sleepiness and Sleep Apnoea Scale. In this 
chapter I investigate: 1) how easily patients complete the pictorial Sleepiness and 
Sleep Apnoea Scale; and 2) I investigate the test–retest reliability of the scale by 
asking some patients to repeat the scale on return to the hospital at the time of their 
sleep study. I compare these ease of use and test–retest reliabilities with the ease of 
use and the test–retest reliabilities of the written Epworth Sleepiness Scale.  
 
The different methods of measuring sleepiness have historically had poor or 
inconsistent correlation with each other. There is perhaps an acceptance that the 
different tools measure different aspects of sleepiness. As a side interest in this chapter 
I explore in a small subset of patients the relationship of the scale to an objective 
measure of daytime wakefulness, the Oxford Sleep Resistance test (OSLER), and the 
relationship of the new tool to patients’ own descriptors of sleepiness.  
 
The two principal studies – the ease of use the pictorial Sleepiness and Sleep Apnoea 
Scale and the test–retest reliability of the scale – are presented as studies 1 and 2. The 
exploratory studies of the relationship of the scale to the OSLER and the relationship 
of the scale to patient descriptors of sleepiness are studies 3 and 4.  
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Methods 
 
Scoring the new scale 
I decided that the scoring of the pictorial Sleepiness and Sleep Apnoea Scale, should in 
the first instance, be a simple summative process. Recommendation was made 
regarding how to handle the missing data or ‘don’t know’ answers. Each sleepiness 
image was scored from ‘0’ to ‘4’ on an ordinal scale, with ‘0’ representing the least 
sleepy and ‘4’ the sleepiest character. Risk images of ‘body size’ and ‘neck size’ have 
also been given a ‘0’ to ‘4’ range: with ‘0’ the thinnest body and neck images and ‘4’ the 
largest body and neck images. Blood pressure images are given a score of: ‘0’ for 
‘normal blood pressure’, ‘4’ for both ‘high blood pressure’ and ‘normal blood pressure on 
medication’. Blood pressure ‘don’t know’ is scored ‘1’. Ticking the image ‘no witnessed 
apnoea’ (breathing normally when asleep) is given ‘0’ and ticking the ‘yes, witnessed 
apnoea’ image (stopping breathing when asleep) is given a score of ‘4’. If neither 
witnessed apnoea image is ticked, absence of scoring the image is given a ‘1’ and 
treated as ‘don’t know’. This scoring system means the maximum sleepiness score is 
equal to the maximum risk score; the sleepiness component and the risk component 
both range from 0 to 16 and the total scale score ranges from 0 to 32.  Scores for the 
scale are summarised in table 6.1.  
 
It is possible that the new scale would serve as a better screening and case finding tool 
if some of the eight components had a greater weighting than others, but for the 
purpose of this thesis, I have treated the questionnaire as a Likert scale with uniform 
points between images. I do briefly discuss unequal weightings at the end of chapter 7. 
Collaborators in Switzerland who are interested in using the new scale to test 
occupational drivers in the Swiss army, are now investigating with me optimal 
weightings for the scale in a Swiss population. 
 
Study 1 
Patients attending the sleep clinic at Charing Cross Hospital for suspected obstructive 
sleep apnoea syndrome were asked to complete the scale. To avoid using patients who 
had participated in earlier studies, only new patients were recruited for the study.  
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Table 6.1. Scoring the pictorial Sleepiness and Sleep Apnoea Scale: sleepiness and risk 
components and total scale score. 
 
 Question Suggested scoring Maximum 
question 
score 
Total 
scores 
Sleepiness 
Component 
(Q 1–4) 
Q1 ‘0–4’ low to high sleepiness 
 
4  
Q2 ‘0–4’ low to high sleepiness 
 
4  
Q3 ‘0–4’ low to high sleepiness 
 
4  
Q4 ‘0–4’ low to high sleepiness 4  
 
Total sleepiness component  0–16 
   
Risk 
Component 
(Q 5–8) 
Q5 ‘0–4’ thin to large body size 
 
4  
Q6 ‘0–4’ thin to large neck size 
 
4  
Q7 ‘0’ normal blood pressure 
‘1’ don’t know blood pressure 
‘4’ high blood pressure and  
‘4’ high blood pressure on medication 
 
 
 
 
4 
 
Q8 ‘0’ no witnessed apnoea 
 ‘1’ don’t know witnessed apnoea 
      (question left blank) 
‘4’ yes witnessed apnoea 
 
 
 
4 
 
Total risk component  0–16 
Total whole scale  0–32 
 
 
During the clinical interview, the patient was given the pictorial Sleepiness and Sleep 
Apnoea Scale, asked to fill it in, and observed completing the scale. No additional 
instructions were given. A checklist of questions, shown in figure 6.1, was used to 
record how the scale was completed, whether any problems were encountered, and 
what help or support was given to complete the form. (Methods were kept as similar as 
possible to the evaluations of the ease of use of the Epworth presented in chapter 2.) 
The patient was then asked to complete a standard Epworth Sleepiness Scale form. 
Evaluations on the ease of completing the Epworth were not recorded, however 
patients were asked if they had previously completed an Epworth Sleepiness Scale.  
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A chi–squared test was used to test differences between naïve and previous users of the 
Epworth as well as to compare differences between results in this study and the 
evaluation of the Epworth in chapter 2.  
 
Figure 6.1. Checklist of questions used to evaluate the ease of use of completing the 
pictorial Sleepiness and Sleep Apnoea Scale. 
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Results 
 
The ease of use of the pictorial Sleepiness and Sleep Apnoea Scale. 
 
Three hundred and eighty five patients completed the pictorial Sleepiness and Sleep 
Apnoea Scale and an Epworth Sleepiness Scale in clinic. Of these, 349/385 (90.6%) 
reported they had never filled in the Epworth Sleepiness Form before (Epworth naïve 
users group). The 36/385 (9.4%) who had previously completed an Epworth were put 
into a second group (ESS previous users group) and analysis was performed for each 
group. Most patients were able to complete the form correctly: 85.1% of the ESS of the 
naïve group and 91.7% ESS previous users group (figure 6.2).  
 
Figure 6.2. The percentage (%) of correctly and incorrectly completed pictorial 
Sleepiness and Sleep Apnoea Scale forms for 389 patients (349 ESS naïve users group, 
36 ESS previous users group).  
 
 
 
                                                       
 
 
When examined further, more people correctly filled in the sleepiness part of the scale 
compared with the risk part of the scale. More people also needed help to complete the 
risk part of the scale compared to the sleepiness component (figure  6.3).  None of the 
differences observed in how the pictorial Sleepiness and Sleep Apnoea Scale was 
completed (between naïve and previous users of the Epworth Sleepiness Scale) had 
statistical significance.  
85.1 
14.9 
91.7 
8.3 
correct forms incorrect forms
ESS naive users group  
 
                ESS previous users group   
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Figure 6.3. Percentage (%) of patients who needed help on the sleepiness and risk 
components of the scale and whether explanations were needed for any of the images, 
in 389 patients (349 ESS naïve users group, 36 ESS previous users group). 
  
 
 
 
 
A comparable number of people asked for an explanation to help their understanding of 
the sleepiness and witnessed apnoea images: (sleepiness: 4.3% and 5.6% respectively of 
naïve and previous ESS users groups, and witnessed apnoea image: 4.6% and 5.6% 
respectively, naïve and previous ESS users group).  A smaller fraction of people asked 
for explanations regarding the body size, neck size and blood pressure images (figure 
6.3).  
 
Testing for differences using a chi–squared test shows significant differences between 
the two evaluations (pictorial Sleepiness and Sleep Apnoea Scale versus Epworth 
Sleepiness Scale) (table 6.2). 
 
A smaller fraction of patients made errors completing the new pictorial scale than 
when completing the Epworth Sleepiness Scale: 14.9% (pSSAS whole scale, ESS naïve 
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patients) and 5.7% (pSSAS sleepiness component, ESS naïve patients) versus 33.8% 
(ESS study chapter 2, ESS naïve patients).  
 
Both tools had patients who left questions blank, and in the pictorial Sleepiness and 
Sleep Apnoea Scale (ESS naïve patients), 9.2% left at least one question blank in the 
sleepiness part of the scale and 12.9% in the risk part of the scale (figure 6.4). This is 
compared with the Epworth where 10% of new users left out at least one question.  
 
Leaving a question blank was the biggest problem encountered with the pictorial 
Sleepiness and Sleep Apnoea Scale. The question that most users left blank was 
question 8, your bed partner witnessing you stopping breathing (9.5% ESS naïve and 
8.3% ESS previous users).  
 
The second most common question left blank was question 4, sitting as a passenger in 
a car or bus (3.2% ESS naïve and 2.8% ESS previous users). No patient who had 
previously completed an Epworth, left Q1, Q2, Q3, Q5, Q6, or Q7 blank on the new 
scale and amongst new users the percentage who did not complete Q1, Q2, Q5, Q6, or 
Q7 was low (figure 6.6). 
 
Despite these observations, there were no statistically significant differences between 
naïve and previous users of the ESS in completion of the pictorial Sleepiness and Sleep 
Apnoea Scale.  
 
There was no statistically significant difference between questions left blank on the 
Epworth and the Sleepiness component of the new scale (table 6.2). 
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Figure 6.4. Percentage (%) of problems encountered when completing the pictorial 
Sleepiness and Sleep Apnoea scale (pSSAS), in 389 patients (349 ESS naïve users 
group, 36 ESS previous users group). 
 
For comparison the main results of testing the ease of use of the written Epworth 
presented in chapter 2 are shown below in figure 6.5. 
 
Figure 6.5. Percentage (%) problems with completing the written Epworth Sleepiness 
Scale (ESS) in 201 patients attending the Sleep Centre (80 new patients and 121 
patients on treatment for obstructive sleep apnoea syndrome).  
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Table 6.2. Comparison of problems in completing the Epworth Sleepiness Scale (ESS) n=201, 80 naïve and 121 routine ESS users, and 
the pictorial Sleepiness and Sleep Apnoea Scale (pSSAS) n=385, 349 naïve, and 36 previous ESS users.  
 
Types of problems in completing the scales Epworth Sleepiness Scale evaluation (%) Pictorial Sleepiness and Sleep Apnoea Scale 
evaluation (%)# 
Chi–squared test 
results 
 naïve user routine user Total user 
group 
naïve user previous (ESS) 
user 
Total user 
group 
P value comparing 
total user groups 
problems or errors in completing the scale 
 
 
33.8 15.7 22.9α 
22.9β 
5.7 
(14.9) 
2.8  
(8.3) 
5.5*** 
(14.3)** 
0.00000000031 
0.0089 
needed help by a health professional to complete the form 
 
 
23.8 8.3 14.4α 
14.4β 
7.7   
(11.7) 
8.3   
(11.1) 
7.8** 
(11.7) 
0.01 
0.34 
needed help from a family member or friend 2.5 2.5 
 
2.5β (2.0) (2.8) (2.1) 0.75 
giving a fraction (ESS), ticking > 1 box (pSSAS) 
 
13.8 5.8 9.0β (0.9) (0) (0.8)*** 0.00000043 
annotating or writing other words 
 
7.5 8.3 9.0α 2.9 2.8 2.9** 0.0052 
tick or a cross (ESS), giving a numerical value (pSSAS) 
 
3.8 1.7 2.5β (0.3) (0) (0.3)* 0.011 
leaving questions blank 
 
 
10.0 3.3 6.0α 
6.0β ** 
9.2 
(12.9) 
2.8 
(8.3) 
8.6 
(13.0) 
0.26 
0.0088 
need to explain chances of dozing 
 
8.8 2.5 5.0β (0.9) (0) (0.8)* 0.011 
query time of day 5.0 2.5 3.5β (1.1) (0) (1.0)* 0.039 
could not read or write 3.8 0.8 2.0β (0.9) (0) 
 
(0.8) 0.20 
left spectacles at home 2.5 1.7 2.0β (0.6) (0) 
 
(0.5) 0.09 
suspected language difficulties 6.3 0.8 3.0β (1.7) (0) (1.6) 0.25 
# in parenthesis are shown percentages for the whole pictorial Sleepiness and Sleep Apnoea Scale (sleepiness and risk components). Where pictorial Sleepiness and Sleep Apnoea Scale results are 
not in parenthesis, these represent the sleepiness component only. α Comparisons of the ESS with the sleepiness component of the pSSAS.  β Comparisons of the ESS with the whole pSSAS.                      
*p≤0.05, **p≤0.01, ***p≤0.001 
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Figure 6.6. Breakdown of questions left blank on the pictorial Sleepiness and Sleep 
Apnoea Scale in 349 ESS–naïve patients and 36 previous ESS user patients. Questions 
1–4 represent sleepiness questions; questions 5–8 represent risk questions. 
 
 
 
 
 
 
 
 
 
Other problems, such as ticking more than one box or giving a numerical value were 
infrequent and occurred in less than 1% of users.  
 
The fraction of people with suspected language difficulties (1.7% naïve ESS users) was 
lower in this study compared to evaluations of the Epworth Sleepiness Scale but not 
statistically significantly different.  
 
The fractions of people who volunteered they could not read or write (0.9% naïve ESS 
users) or who asked family members or friends to fill in the form for them (0.6% naïve 
ESS users) were also lower but again this difference was not statistically significant.  
 
No actual measure of literacy was made in either study and the true extent of literacy 
problems in these subjects is therefore unknown.  
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Methods Study 2 
 
A group of patients (n=34) from study 1 were asked to repeat the pictorial Sleepiness 
and Sleep Apnoea Scale the morning after their sleep study, a time interval of between 
1 and 6 weeks. Pearson’s correlation coefficient was used to test for test–retest 
reliability. 
 
Results 
 
Test–retest reliability  
 
Thirty four patients completed the pictorial Sleepiness and Sleep Apnoea Scales at two 
different time points (test 1, in the sleep clinic and test 2, at time of sleep study). Mean 
number of days between tests was 25 (± 19) days. There was no therapeutic 
intervention between test 1 and test 2.  
 
Pearson’s correlation coefficient was calculated to compare test–retest reliability for 
the pictorial Sleepiness and Sleep Apnoea scales, a) sleepiness component, b) risk 
component and c) total scale score. Figures 6.7a–c show the scatter plots of test–retest 
data for the 34 patients and table 6.3 presents the mean scores and test–retest r 
values.  
 
Table 6.3. Mean pictorial Sleepiness and Sleep Apnoea Scale (SD in parentheses) and 
Pearson’s correlation coefficient r values for test–retest reliability of 34 patients who 
completed the pictorial Sleepiness and Sleep Apnoea Scale at two different time points. 
 
 
 
pictorial Sleepiness and Sleep Apnoea Scale 
n=34 
 mean sleepiness score:  /16 mean risk score:  /16 mean total score /32 
Test 1 
 
6.5 (3.5) 8.7 (3.0) 15.3 (5.0) 
Test 2 6.4 (4.0) 8.4 (3.2) 14.8 (5.7) 
    
r value 0.76 0.53 0.63 
0.95 CI    
lower 0.57 0.23 0.37 
higher 0.87 0.74 0.80 
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Figure 6.7a–c. Correlations between test1 and test 2 of the pictorial Sleepiness and 
Sleep Apnoea Scale in 34 patients: in the sleep clinic and at time of sleep study.  
 
a Sleepiness    b Risk 
  
c Total scale  
 
 
 
 
The pictorial Sleepiness and Sleep Apnoea Scale sleepiness component, had the best 
test–retest reliability r=0.76, compared to the risk component, r=0.53 and the scale as 
a whole r=0.63.   
 
To compare for interest how the new scale faired against the Epworth Sleepiness Scale 
in test–retest reliability, 19 patients completed an Epworth Sleepiness Scale at two 
time points: (test 1, in the sleep clinic and test 2, at time of sleep study). The mean 
number of days between tests was slightly shorter at 19 (± 16) days, and again there 
was no therapeutic intervention between test 1 and test 2. Table 6.4 presents mean 
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total scores and r values for the test–retest reliability of the Epworth Sleepiness Scale 
(n=19). Figure 6.8 a–d show scatter plots for this data. 
 
Table 6.4. 19 patients completed the Epworth Sleepiness Scales at two different time 
points. Mean scores (SD in parentheses) and Pearson’s correlation coefficient r values 
for test–retest reliability.  
 
 
 
Epworth Sleepiness Scale n=19 
 
mean total score 
  /24 
  
Test 1 
 
11.9 (3.9) 
  
Test 2 11.6 (5.1) 
  
r value 0.65 
  
0.95 CI  
lower 0.28 
higher 0.85 
 
Figure 6.8. Correlations between test 1 and test 2 of the Epworth Sleepiness Scale 
(n=19). 
 
 
 
Neither test had 100% test–retest reliability. The sleepiness component of the pictorial 
Sleepiness and Sleep Apnoea Scale produced a slightly higher r value (r=0.76) 
compared to the Epworth Sleepiness Scale (r=0.65).  
 
Thus the new scale appears as reproducible as the Epworth Sleepiness Scale. 
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Study 3 
 
Study 3 explores how the new scale measures against a laboratory evaluation of 
daytime wakefulness: the Oxford Sleep Resistance test (OSLER). Thirty new patients 
attending the sleep clinic and referred for an assessment for obstructive sleep apnoea 
syndrome were invited to participate. The OSLER is a simplified behavioural 
maintenance of wakefulness test and an alternative to the multiple sleep latency test 
(MSLT) or maintenance of wakefulness test (MWT) used to measure objective 
sleepiness or wakefulness in the daytime. 110;182 112 
 
All patients were asked to have normal sleep the week prior to attending the study and 
to keep a sleep diary (provided to them as an A4 diary page with set questions relating 
to their sleep each night of the week). Shift workers and those with poor sleep hygiene 
were excluded from the study. All patients had a cardio–respiratory sleep study the 
night before the OSLER, as part of their routine clinical care.  Patients were admitted 
at 9pm and settled in the individual sleep rooms of the Sleep Centre. Sleep studies 
were instituted and attended to by sleep physiology or sleep nursing staff and patients 
were woken at 7a.m. in preparation for the OSLER study.  
 
The OSLER test comprises four 40–minute mini–tests spread over 7 hours. The 
protocol was administered according to the methods described by Bennet.182 In each 
40–minute test the subject is instructed to lie dressed and semi recumbent on a bed, in 
a darkened environment conducive to sleep and isolated from external noise.  Subjects 
are instructed to remain awake but not to use additional measures (such as fidgeting) 
to do so.  During the study, patients are asked to respond to a flashing light emitting 
diode (LED) mounted on the opposite wall, by touching a proximity switch on a 
handheld unit each time the LED flashes. The LED flashes at a rate of once every 
three seconds. The subject is monitored by video and responses are recorded online in 
real time on a computer outside the bedroom. For each flash of the LED missed, an 
error is recorded, and after seven misses in a row (equalling 21 seconds in time) the 
test is terminated; this is equivalent to one epoch of stage 2–4 sleep as measured by the 
MWT or MSLT. OSLER tests were scheduled at 9.00am, 11.00am, 01.00pm and 
03.00pm. The time from test start (recorded on the computer) to either  a) 7 sequential 
misses or b) the 40 minutes, represent the test sleep latency and a mean latency across 
the four tests is calculated. In between tests, the participant is asked to stay awake in 
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the bedroom, which is normally lit and in our centre has a large window letting in 
natural light. In line with other tests of maintenance of wakefulness, no coffee or tea or 
other stimulant or hypnotic drink or drugs were permitted from midnight the day 
before testing. To standardise procedures, lunch was taken after the 11.00am test.  
 
A record of the subject’s educational level was taken and neck and lying abdominal 
girth measurements were made. Individual mean sleep latencies were plotted against 
the pictorial Sleepiness and Sleep Apnoea Scale, and the Epworth Sleepiness Scale 
scores and regression analysis used to test the relationship between the OSLER and 
the two scales. 
 
 
Results  
 
Testing the pictorial Sleepiness and Sleep Apnoea Scale against the OSLER. 
 
OSLER tests were completed on 28/29 patients. One patient was unable to complete 
the study owing to migraine. The male to female ratio was 22:6, mean age 47.9 years (± 
12.3), mean body mass index was 32.8 kg.m2 (±8.1) (table 6.5). Mean test scores over 
the four sleep–resistance tests ranged from 45 seconds to 40 minutes.  Only 4/28 
patients managed to stay awake for all four OSLER runs. Summary OSLER data is 
presented in table 6.6. Run three (at 1.00 pm) produced the shortest mean sleep 
latency of 18.82 minutes.  
 
Table 6.5. Participant information on gender, age and years of symptoms. SD shown in 
parenthesis. 
 
number of 
participants 
 
m:f 
ratio 
mean 
age 
years 
mean 
BMI 
kg.m
2
 
mean number of years: 
    snoring witnessed 
apnoea 
sleepiness 
28 22:6 47.9 
(±12.3) 
32.8 
(±8.1) 
20.3 
(±12.8) 
5.5 
(±6.9) 
7.0 
(±6.6) 
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Table 6.6. Mean data for the pictorial Sleepiness and Sleep Apnoea Scale: sleepiness 
component (pSSASs), Epworth Sleepiness Scores (ESS) and mean OSLER results with 
OSLER runs 1–4.  
 pSSASs ESS 
OSLER 
run 1 
OSLER 
run 2 
OSLER 
run 3 
OSLER 
run 4 
Mean OSLER 
sleep latency 
over 4 runs 
Mean 8.00 11.54 25.30 21.99 18.82 20.60  21.64 (±21.68) 
SD 3.33 5.01 13.00 13.55 14.01 13.99 12.26 (±12.25) 
25
th
 percentile 6.0 8.8 14.8 11.4 7.9 8.8 10.9 
75
th
 percentile 10.0 14.3 40.0 40.0 31.0 36.3 31.6 
IQR 4.0 5.5 25.2 28.6 23.1 27.4 20.7 
 
Scatter plots show the relationship of paired data for: 1) pictorial Sleepiness and Sleep 
Apnoea Scale: sleepiness component, with the Epworth Sleepiness Scale (figure 6.9), 2) 
pictorial Sleepiness and Sleep Apnoea Scale: sleepiness component, with OSLER sleep 
latencies (figure 6.10), and 3) Epworth Sleepiness Scale versus OSLER sleep latencies 
(figure 6.11). A linear trend line has been fitted to each of the figures and a Pearson’s 
correlation coefficient (r) produced. Neither, the pictorial Sleepiness and Sleep Apnoea 
Scale: sleepiness component (r = –0.40), or the Epworth Sleepiness Scale (r = –0.46) 
were strong at predicting mean OSLER sleep latencies: figures 5 and 6. The pictorial 
Sleepiness and Sleep Apnoea Scale: sleepiness component, and the Epworth Sleepiness 
Scale have a moderate association: Pearson’s correlation coefficient r value 0.66 (figure 
6.9). 
 
 
Figure 6.9. The pictorial Sleepiness and Sleep Apnoea Scale: sleepiness component 
scores plotted against the Epworth Sleepiness Scores n=28.  
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Figure 6.10. The pictorial Sleepiness and Sleep Apnoea Scale: sleepiness component 
scores plotted against the OSLER n= 28.  
 
 
 
  
 
Figure 6.11. The Epworth Sleepiness Scale scores plotted against the OSLER n=24.  
 
 
Study 4.  
 
The distinction between tiredness and fatigue, and propensity for sleepiness is 
important but not always easy to make. On a practical level it may affect the ‘medical 
work–up’ and decision on who to refer for sleep investigations and subsequent 
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treatment.  The use of scales to try and best represent these different states is helpful 
and the Epworth Sleepiness Scale is an example of such a scale whose questions 
represent a person’s propensity to sleepiness in the daytime or level of somnoficity. 160 
However, previously I have shown how some sleep patients tested had problems with 
literacy in medicine and these words (propensity to sleepiness, somnoficity) are rather 
technical terms perhaps most familiar to sleep practitioners.183 Use of medical jargon 
by health practitioners has been shown to impede patient and health practitioner 
communication.184;185 What patients mean by sleepiness is useful to recognise and it is 
interesting to find out the ways in which patients might describe sleepiness.  
 
In this study I explore how patients’ own descriptors of sleepiness relate to: 1) the 
pictorial Sleepiness and Sleep Apnoea Scale and, 2) the traditional Epworth Sleepiness 
Scale. Where possible, these descriptors were also compared with the OSLER mean 
sleep latencies from study 3. 24 patients (20 male and 4 female) participated in the 
study. Patients were asked: 
 
‘please describe in your own words what sleepiness means to you’.  
 
For each patient, remarks were transcribed by hand onto paper and then electronically 
transferred to a single word document, where descriptors from each individual were 
grouped together and anonymised. The pictorial Sleepiness and Sleep Apnoea Scale 
and the Epworth Sleepiness Scale were given to patients to complete afterwards.  
 
Three health professionals independently scored the sleepiness descriptors: 1) myself, 
2) a respiratory research nurse (who had no ‘sleep’ background), and 3) a sleep 
physician. Scorers were blinded to individual patient details and subjective and 
objective sleepiness levels.  
 
After review of all the descriptors, it was decided to theme answers into three 
categories. Each descriptor given by a patient was put into one of the following 
categories: ‘mental function (M)’, ‘physical sensation (P)’ or ‘related to sleep or actual 
sleep (S)’.  Where a scorer was unsure of which category the descriptor fell into, a 
‘question mark’ was used or the scorer submitted more than one answer, i.e. ‘M/P’.  
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Results were collated and a fourth academic referee helped to theme answers from the 
three scorers. Results are presented as the number of descriptors in each category 
(mental function, physical sensation and related to or actual sleep) associated with low, 
moderate or high propensity to sleepiness; ranges of Epworth Sleepiness Score (≤10, 
11–15 and 16–24) and ranges of pictorial Sleepiness and Sleep Apnoea Scale scores 
(sleepiness component): ≤4, 5–10 and 11–16. Mean OSLER scores are presented for 
each range. In addition, OSLER results are summarised into mean sleep latencies in 
the ranges of: ≤10 minutes, 11–20 minutes, 21–30 minutes and 31–40 minutes, and 
descriptors of sleepiness associated with these are shown for interest.  
 
 
Results  
 
The relationship of the new scale to patient descriptors of sleepiness 
 
Twenty four patients who participated in study 3 were also asked to describe in their 
own words what sleepiness means to them. The ratio of male to female was 22:2; mean 
data is shown in table 6.7. 
 
Table 6.7. Mean pictorial Sleepiness and Sleep Apnoea Scale (pSSAS): sleepiness 
component, Epworth Sleepiness Scale (ESS) and OSLER data for participants in   
study 4. 
 
                                         pSSAS 
                           sleepiness component    ESS         OSLER  
Mean   9.9 13.3 20.3 
Median 
 
9 13.5 14.96 
SD 
 
3.4 4.7 11.3 
25th percentile 7.0 9.0 10.9 
75th percentile 13.0 16.3 28.9 
IQR 
 
6.0 7.3 18.0 
  
 
 
A total of 130 descriptors of sleepiness were given by the 24 patients, using a mixture 
of short sentences and single words.  
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After an initial read through, descriptors were categorised into three main categories:  
related to mental function (M) (e.g. “mugginess”), physical sensation (P) (e.g. “even 
moving about is exhausting”) and related to sleep or actual sleep (S) (e.g. “I always fall 
asleep in the cinema”).   
 
The scorers’ labelling of each descriptor and the final (consensus) label (of mental 
function, physical sensation and related to or actual sleep) for each descriptor, are 
shown in appendix 6.  
 
Figure 6.12 shows the percentage of descriptors in each category: mental function 26%; 
physical sensation 35% and related to sleep or actual sleep 39%.  
 
The full list of descriptors grouped into their themes are shown in tables 6.8-6.10. 
 
Figure 6.12. In total 130 descriptors of sleepiness were given by 24 patients. 
Descriptors were put into three categories: mental function (M), physical sensation (P), 
and related to sleep or actual sleep (S). 
 
 
 
 
34 (26%) 
45 (35%) 
51 (39%) 
M P S
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Table 6.8. List of sleepiness descriptors given by 24 patients. Answers themed into mental function. 
 
Sleepiness descriptors – mental function 
 
leave me alone    
can't be bothered    
slowing down   
like an emptiness   
2–3 days of the week I'm not with it   
just not switched on   
I like reading but I don’t do it anymore 
lethargic 
mugginess 
slow thinking   
uneasy and out of kilter   
something wrong with reflexes  
inattentive   
irritable    
dull as in shine’s gone off   
slow to comprehend  
loss of listening  
less concentration   
 
less motivated 
my head feels funny    
not as sharp as I should be   
annoying 
every day is the same I go to bed early because I am tired, lie down but can't sleep 
my head goes screwy – I have headaches   
depressed 
just not wanting to do anything    
can't concentrate   
get irritated    
lose temper   
like my efficiency can't do job / work, up to required level   
feel down 
can't concentrate       
mind drifting     
switched off   
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Table 6.9.  List of sleepiness descriptors given by 24 patients. Answers themed into physical sensation. 
 
Sleepiness descriptors – physical sensation 
 
I'm not sleepy normally but I am often tired   
I generally feel tired which is cured by coffee    
tired  
fatigued  
drained (but don't feel sleepiness) after a long day at work on the train home   
knackered    
cream–crackered    
makes me tired   
dizziness 
short of breath   
sweating 
I yawn (yawning throughout the day) a lot throughout most days   
I am tired knackered   
I am really knackered   
I know that I'm tired   
I feel it makes things more difficult like going to the cinema 
it stops me doing what I want to do, I've run out of energy   
occasionally I have a day when I am the old me, but mostly I have no energy   
even moving about is exhausting 
days when I have complete lethargy – beyond sleepiness   
very strong sense of heaviness    
heavy 
lethargic 
 
 
lethargy 
tired 
debilitating 
fall asleep and can't breath   
choking 
I am really tired   
feel tired  
shattered   
knackered   
ready for the knackers yard   
I've really slowed down  
tired 
I need some extra stimulants, something to get me going   
I'd like to be able to do more   
it's costing me because I pay other people to do things I could do, like fixing the plumbing, boiler 
pressure etc 
different to normal tiredness    
uncontrolled tiredness     
feel tired   
feel dizzy   
natural talent’s gone   
like I'm shutting down      
I am tired    
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Table 6.10. List of sleepiness descriptors given by 24 patients. Answers themed into and related to sleep or actual sleep. 
 
Sleepiness descriptors – related to sleep or actual sleep 
my wife says go upstairs and have a rest 
sleeping like standing   
early evening heavy sleepiness 
I drink coffee in the morning – not having coffee makes me feel sleepy   
it's the impact of sleepiness   
I always fall asleep in the cinema   
more likely to fall asleep watching TV I find that frustrating   
there is the good side – I always fall asleep before take–off on long haul flights   
last 2–3 years difficult to work because of daytime sleepiness and migraine   
drowsy 
eyes feel heavy    
can't stay awake at work   
worse on buses / car   
can't keep eyes open   
get to the point it is out of control   
collapsing – you can't control it   
this sense of heavy  / not controlling my head 
just collapsing into sleep  
it feels like you can't control it  
if I do a big car journey I have to stop and rest. If I am at home, I can go to sleep  
overwhelming sense of heavy eyes    
I find myself nodding off  
micro–naps can be refreshing  
I am fine talking to someone   
if somewhere quiet / moving, I fall asleep    
 
I need to get some sleep   
if I travel somewhere I fall asleep on the bus, travelling, going on the computer  
going to the library I definitely fall asleep, librarian has to wake me up   
I fight the sleepiness   
I find myself sleeping at work it is really embarrassing   
I've become boring because sometimes I sleep when my wife talks to me   
I'm in a position of authority – I don't like to be seen falling asleep   
I get in the car drive around the corner where no one can see me and sleep for half an hour  
it is embarrassing when it happens with the clients 
you just can't help it  
when I'm relaxing that's when it gets me the most 
as soon as I start to relax, that's when I get too relaxed   
uncontrolled 
like having a general anaesthetic and trying to keep awake when getting to a stage    
back of the mind and washing over me   
eyes heavy    
neck falls down   
2–3 years sleepiness but used to napping 'siesta' in the afternoon in Dubai 
head's dropping     
I definitely will fall asleep  
I always say I'm tired and sleepy  
if I get adequate sleep then in the morning I am fine but always nod off in the afternoon  
can't even sit watch TV, I start a programme then on and off, not aware of the programme 
sit in the room and snore 
when I go in a meeting I feel sleepy, I try hard to keep awake  
I don't feel sleepy when I do things like DIY or work, only when I sit 
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On average each patient gave 5.4 descriptors relating to sleepiness (range 2–13 
descriptors). Some patients used very similar words (e.g. lethargy, lethargic) and some 
words were repeated by different patients and appear more than once in the list of 
results (i.e. knackered, tired). In general, most descriptors were negatively weighted 
e.g.: 
 
‘just not switched on’. 
 
Two comments had a positive association: 
 
‘there is the good side – I always fall asleep before take–off on long haul flights’ 
and ‘micro–naps can be refreshing’ . 
 
Some descriptors related to feelings of shame: 
 
  ‘I find myself nodding off at work it is really embarrassing’, 
 
‘I’m in a position of authority – I don’t like to be seen falling asleep ’, 
 
‘I get in the car and drive around the corner where no one can see me and sleep 
for half an hour ’.  
  
Epworth Sleepiness Scale scores were grouped into the following ranges: ≤10 (n=9),  
11–15 (n=7), 16–24 (n=8) and mean OSLER scores calculated for each group (table 
6.11).  
 
OSLER scores did not correlate well with Epworth Sleepiness Scale scores (see 
previous results) and there was great variability in levels of objective daytime 
wakefulness compared to Epworth Sleepiness Scale results (Figure 6.11).  
 
Patients with an Epworth Sleepiness Scale: ≤10 gave more descriptors relating to the 
physical sensations of sleepiness. Conversely patients with an Epworth Sleepiness 
Scale ≥11 gave more descriptors related to sleep or actual sleep (figure 6.13). 
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Figure 6.13. (a) ESS scores 0–10 (n=9) (b) ESS scores 11–15 (n=7) and (c) ESS scores 
16–24 (n=8): descriptors grouped into (M) mental function (P) physical sensation and 
(S) related to sleep or actual sleep and associated with different Epworth Sleepiness 
Score (ESS) ranges. 
a    b        c 
     
 
Table 6.11.  Descriptors of sleepiness themed and grouped with low, medium and high 
Epworth Sleepiness Scale (ESS) ranges. 
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Pictorial Sleepiness and Sleep Apnoea Scale scores were grouped into low medium and 
high sleepiness ranges: 0–7 (n=7), 8–12 (n=10) and 13–16 (n=7) and mean OSLER 
scores were calculated for each group. In the higher sleepiness range, more descriptors 
related to sleep or actual sleep were given, compared with those of mental function or 
physical sensation. In the lower sleepiness range, more descriptors related to mental 
function.  However, features of sleepiness related to physical sensation and related to 
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sleep or actual sleep in the lower range were also popular. The medium sleepiness 
range had a peak of descriptors related to physical sensation followed by descriptors 
related to sleep or actual sleep and then mental function (see figure 6.14).  
 
 
Figure 6.14. (a) pSSAS sleepiness scores 0–7 (n=7) (b) pSSAS sleepiness scores 8–12 
(n=10) and (c) pSSAS sleepiness scores 13–1’ (n=7): descriptors grouped into (M) 
mental function (P) physical sensation and (S) related to sleep or actual sleep and 
associated with different pictorial Sleepiness and Sleep Apnoea Scale ranges – 
sleepiness component (pSSAS). 
a    b    c 
   
 
 
Table 6.12. Descriptors of sleepiness grouped and themed with the Pictorial Sleepiness 
and Sleep Apnoea Scale: sleepiness component scores (pSSAS). OSLER data shown for 
comparison.   
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The data presented in ranges of low, medium and high propensities for sleepiness, 
might be of clinical interest. However, it is difficult to make comparisons between 
ranges, as each set contains a different number of patients and a different number of 
descriptors. Some patients who gave long lists of descriptors may dominate the group.  
 
Below in figures 6.15a–6.15i, the scatter graphs present the data: mental function, 
physical sensation and related to sleep or actual sleep as a fraction of the total number 
of descriptors for each patient.  
 
For example, if subject no.13 has 9 descriptors (3 mental function, 4 physical sensation 
and 2 related to sleep or actual sleep) the fraction that each represent of the 9 are 
shown in columns M %, P % and S % and these percentages are plotted against the 
individual’s total pictorial Sleepiness and Sleep Apnoea Scale sleepiness component 
score, Epworth Sleepiness Scale scores and OSLER results.  
 
 
  
Descriptors of sleepiness 
 
Total no. of 
descriptors 
Descriptors of sleepiness as a 
fraction of the total no. of 
descriptors 
 M P S (M+P+S) M % P % S % 
No.13 3 4 2 9 33.3 44.4 22.2 
 
 
 
Data points are very scattered and associations between descriptors and sleepiness 
measures are generally weak (figure 6.15a–6.15i). However, there are some general 
trends from the data which can be described. 
 
The association between descriptors and levels of sleepiness across the three measures 
improves as one moves from descriptors associated with mental function, to physical 
sensation and then to descriptors related to sleep or actual sleep.  
 
People with a high propensity to sleepiness and a lower wakefulness drive report more 
descriptors related to sleep and actual sleep compared with physical sensations and 
mental factors. Conversely descriptors related to physical sensation are more 
associated with a lower propensity to sleepiness (both subjective and objective 
measures).  
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Figure 6.15a–i: Descriptors of sleepiness as a fraction of the number of descriptors per person versus the pictorial Sleepiness and Sleep Apnoea Scale 
sleepiness component (row one, figures a–c), the Epworth Sleepiness Scale (row 2, figures d–f) and mean OSLER sleep latencies across 4 tests (row 3, 
figures g–i) in 24 subjects. Sleepiness data are presented on the horizontal axis. 
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Chapter 6 comments 
 
The pictorial Sleepiness and Sleep Apnoea Scale has undergone a series of 
developments with sleep and non–sleep patients to ensure that the images used are the 
images that best convey the intended meaning of the scale. The concept of ‘somnoficity’ 
may be familiar to those involved in sleep medicine and science but to the lay person on 
the street propensity to sleepiness may be a hard concept to understand especially if 
one has not had first–hand experience of the problem. Understanding how the pictorial 
Sleepiness and Sleep Apnoea Scale sleepiness component, the OSLER and the Epworth 
Sleepiness scale relate to each other is important but difficult to achieve.  
 
The association with the pictorial Sleepiness and Sleep Apnoea Scale sleepiness 
component and the Epworth sleepiness Scale scores were moderate and both scales had 
weaker associations with mean OSLER sleep latencies. This was not a great surprise 
as correlations between subjective sleepiness scales and objective sleepiness measures 
frequently report mixed results in the literature and vary widely from study to study.  
 
Testing for the ease of use of the pictorial Sleepiness and Sleep Apnoea Scale and 
comparing this with earlier work on the ease of use of the Epworth Sleepiness Scale 
highlighted that some patients still leave questions blank when asked to complete 
forms without help. Question 8 (witnessed apnoea) was the question that most people 
left blank when evaluating the ease of use of the pictorial Sleepiness and Sleep Apnoea 
scale and there is no option for ‘don’t know’ which may be affecting results.  Some 
report they are unable to answer this question because they do not have a current bed 
partner or sleep separately from their partner.   
 
Overall the new scale compared favourably in comparison to the ease of use of the 
Epworth. Statistically significant differences were found in the number or correct 
forms completed without assistance and fewer people needing help to complete the 
pictorial Sleepiness and Sleep Apnoea Scale.  
 
Test–retest reliability is probably underpowered in this study. Preliminary results 
were a little disappointing however overall the pictorial Sleepiness and Sleep Apnoea 
Scale was as reproducible as the Epworth Sleepiness Scale. Repeatability of the risk 
part of the scale was marginally less favourable in comparison. 
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Asking patients to describe in their own words what sleepiness means to them 
provided some interesting descriptors. It was difficult to quantify descriptors for 
comparison with the subjective and objective measures of sleepiness.  
 
Expressing descriptors as a fraction of the overall number of descriptors provided per 
person seemed the most equitable method. This showed descriptors had weak 
associations with the pictorial Sleepiness and Sleep Apnoea Scale sleepiness 
component, the Epworth Sleepiness Scale and the OSLER but trends suggested that 
those with a higher propensity to sleepiness gave more descriptors related to sleep or 
actual sleep and those with lower propensities to sleepiness gave more descriptors 
related to physical sensations.  
 
This information may be helpful in understanding what it is that clinicians are 
assessing when they interview the sleepy patient and why measuring and comparing 
sleepiness between individuals and groups is complex.  
 
Chapter 6 key findings: 
 
 385 patients were observed completing the pictorial Sleepiness and Sleep 
Apnoea Scale (pSSAS) and evaluations made on the ease of use of the new scale. 
 85.1% of naïve users and 91.7% of routine users were able to correctly complete 
the pSSAS. This was a statistically significantly improvement on the number of 
people who were able to correctly complete the word-only ESS (p≤0.001). 
 Fewer people needed help explaining the time of day (1.0%) and the chances of 
dozing (0.8%) with the pSSAS compared with the ESS (3.5% and 5.0% 
respectively) (p=0.039 for “time of day” and p=0.011 for “chances of dozing”). 
 With the pSSAS, 9.2% of patients left a sleepiness question blank and 12.9% left 
a risk question blank. The question most patients left blank was Q8. Witnessing 
your bed partner stopping breathing. This was not a statistically different 
number of missed responses compared with the ESS.  
 Overall, evaluations of the pSSAS were favourable compared to the word-only 
ESS evaluations (presented in chapter 2) and fewer people needed help from a 
health professional in completing the pSSAS compared to the ESS (7.8% versus 
14.4%; p=0.01). 
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 Using a Pearson’s correlation coefficient, the test-retest reliability of the pSSAS 
was better for the sleepiness component of the scale (r = 0.76) than for the risk 
component of the scale (r = 0.53). Test-retest reliability of the total pSSAS  (r = 
0.63) was comparable to the ESS’s (r = 0.65). 
 OSLER testing indicated the pSSAS sleepiness component and the ESS have a 
moderate association: Pearson’s correlation coefficient r = 0.66. 
 Asking patients to describe sleepiness in their own words produced 130 
descriptors of sleepiness which were categorized into those associated with: 
mental function, physical sensation, and related to sleep or actual sleep. People 
with a high propensity to sleepiness and lower wakefulness-drive reported more 
descriptors related to sleep and actual sleep compared with physical sensations 
and mental function. Conversely those with a lower propensity to daytime 
sleepiness used more descriptors related to physical sensation. 
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Chapter 7 
 
Using the new scale with patients 
 
Introduction 
 
In this last experimental chapter, I present two studies testing the pictorial Sleepiness 
and Sleep Apnoea scale in the hospital setting. The first study trials the scale in the 
Sleep clinic where new referrals for obstructive sleep apnoea syndrome were asked to 
complete the scale. These patients are a select group, by virtue of the fact that they 
have reached the sleep clinic; thus to some degree they have already undergone case 
finding for obstructive sleep apnoea by another health practitioner.  It would be 
interesting to trial the scale as a screening tool in a general population; this population 
is not ideal for testing that idea. It seems plausible that in a general population the 
scale might be a more powerful discriminator, but this is yet to be confirmed. The 
biggest referral sources to the sleep clinic are: 1) general practitioners, 2) the local (and 
very active) bariatric surgery service and, 3) local ENT surgeons and practitioners.  
Patients are followed through their sleep study, and study outcomes are compared with 
sleepiness and risk components as well as total pictorial Sleepiness and Sleep Apnoea 
Scale results. This study examines whether the scale is a useful addition to the field of 
measuring sleepiness and risk in obstructive sleep apnoea syndrome in a sleep clinic 
population.  
 
The second study is a pilot case finding for sleepiness and witnessed apnoea in a naïve 
population of patients with cardiac disease. Over the last fifteen years acute coronary 
care has dramatically improved survival of coronary patients with the advent of acute 
thrombolysis and primary angioplasty.186 In addition where available, cardiac 
prevention and rehabilitation programmes (CPRP) may reduce mortality and 
morbidity in the recovery phase.187   
 
We were approached by the Cardiac Prevention and Rehabilitation team at Charing 
Cross and Hammersmith Hospitals for advice on case finding amongst their patient 
group for obstructive sleep apnoea syndrome. A growing body of evidence suggests that 
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cardiology patients share some risk factors and features of patients with obstructive 
sleep apnoea syndrome. Hypertension and an increased BMI are two commonly shared 
traits.188 Those with unknown or untreated obstructive sleep apnoea syndrome are 
more likely to have cardiovascular or cerebrovascular events, compared to those 
without the condition.32 189 Thus recognising the condition in high–risk patients such as 
those with known heart disease would seem desirable. A prompt diagnosis of 
obstructive sleep apnoea syndrome in these patients and early institution of treatment 
can lead to improved health and improved quality of life.188 
 
The relationship between obstructive sleep apnoea syndrome (as an independent risk 
factor for high blood pressure) and resistant hypertension may additionally be 
important in cardiac patients.190  In one case report concerning a 42 year old woman 
with resistant hypertension and symptoms of heart failure who was asymptomatic of 
obstructive sleep apnoea syndrome and had an Epworth of 7 / 24, the diagnosis of 
severe obstructive sleep apnoea and implementation of CPAP treatment helped reduce 
her blood pressure from 200/120 mmHg to 134/82 mmHg.191 There is currently debate 
whether hypertensive obstructive sleep apnoea patients who are not sleepy reap the 
protective cardiovascular benefits their sleepy counterparts derive from CPAP 
therapy.192  
 
We responded to the CPRP team’s request for advice as follows. We were not in a 
position to offer all rehabilitation patients a sleep study and whilst theoretically an 
attractive proposition, evidence that this would be beneficial is uncertain in the 
published literature.  We suggested a pilot study to assess the feasibility of case finding 
for obstructive sleep apnoea syndrome using the Epworth Sleepiness Scale and the 
pictorial Sleepiness and Sleep Apnoea Scale and obtained ethical approval to do so, 
with the aim of determining the prevalence of obstructive sleep apnoea syndrome 
amongst this group of patients. 
 
Methods  
Sleep clinic study 
 
Methods in this section follow the routine clinical pathway of a patient referred to the 
Sleep Centre for investigation of obstructive sleep apnoea syndrome.  
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Two hundred and thirty four patients attending the sleep clinic took part in the study.  
During their first clinical consultation the patient was asked to complete a pictorial 
Sleepiness and Sleep Apnoea Scale and the Epworth Sleepiness Scale.  
 
Each patient underwent a routine cardio–respiratory sleep study in the Sleep centre 
typically within 6 weeks of the first clinic visit.  
 
Sleep studies were conducted using the Embletta sleep recording system (Embletta 
PDS X10 proxy, Embla Sleep Systems). Standard measurements were made: nasal flow 
and snoring from cannula (pressure transducer), thoracic and abdominal effort (Xact 
TraceTM disposable respiratory effort belts), oxygen saturation and pulse rate (XPOD 
oximeter), and body position (internal accelerometer in the Embletta recorder). Studies 
were set up and supervised overnight by sleep physiological and nursing staff. 
 
Studies were manually scored the morning after the sleep study (using Somnologica for 
Embletta version 3.3) and analysed according to the practice parameters set out  in the 
American Association Sleep Medicine Manual for Scoring Sleep, 2007, section VIII 
Respiratory Rules. Please refer to appendix 7 for a summary of criteria.26  
 
I evaluated the positive predictive value of the pictorial Sleepiness and Sleep Apnoea 
Scale and the Epworth Sleepiness Scale in two ways. First I computed the mutual 
information between each of the two scores and five clinical outcomes:  
 
1) The Apnoea–Hypopnoea Index (AHI) 
2) The Oxygen Desaturation Index (ODI) 
3) The decision to treat with continuous positive airway pressure therapy 
(CPAP)  
4) The supine Apnoea–Hypopnoea Index and 
5) The clinician’s opinion on the presence of sleep disordered breathing during 
sleep following sleep study, ‘yes’ or ‘no’ (determined from the clinic letter).  
 
Second, for each of the two scales, receiver operating characteristic (ROC) curves were 
drawn for the same five clinical outcomes of the sleep study. 
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The number of patients offered continuous positive airway pressure therapy and the 
number of patients who received ‘other recommendations’ following sleep study was 
calculated. Finally, logistic linear regression analysis was explored to optimise the 
scoring weight of the pictorial Sleepiness and Sleep Apnoea Scale. 
 
 
 
Results 
 
Sleep clinic study 
 
The results in this section are presented under the following title headings: 
 
1. Describing the pictorial Sleepiness and Sleep Apnoea Scale and Epworth Sleepiness  
    Scale data. 
2. Sleep study results, body mass index and gender. 
3. Sleep study results and the severity of disease. 
4. The severity of disease and treatment with continuous positive airway pressure 
therapy. 
5. The severity of disease and the pictorial Sleepiness and Sleep Apnoea Scale. 
6. Testing the strength of relationship between the severity of disease and the pictorial 
    Sleepiness and Sleep Apnoea Scale. 
 
 
 
Two hundred and thirty four patients (71 female, 163 male) completed pictorial 
Sleepiness and Sleep Apnoea Scales in the clinic and had accompanying sleep studies. 
Mean age was 47.0 years ± 12.05 (female: 48.2 ± 9.17, male: 46.5 ± 12.93); mean BMI 
was 33.6 kg.m2 ± 9.14 (female: 37.84 ± 10.7, male: 31.79 ± 8.08) (figure 7.1). 
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Figure 7.1. a) Mean age (years) and b) mean BMI (kg.m2) for 234 patients who 
completed pictorial Sleepiness and Sleep Apnoea Scales and had an accompanying 
sleep study.      
a       b 
   
  
1. Describing the Pictorial Sleepiness and Sleep Apnoea Scale and Epworth Sleepiness 
Scale data. 
Item responses for questions 1–8 of the pictorial Sleepiness and Sleep Apnoea Scale are 
shown in Figure 7.2 and Table 7.1. For questions 1 to question 6, where questions offer 
the choice of five images (from left to right): low to high propensity of sleepiness or thin 
to large body and neck size, the middle image (image 3) collected the most responses, 
with the exception of question 4. Response rates to the ‘least sleepy’ images varied from 
13.7% (Q2, watching TV or listening to the radio) to 33.3% (Q4, as a passenger in a car 
or bus). Response rates for the ‘most sleepy’ images varied between 11.1% (Q4, as a 
passenger in a car or bus) and 14.1% (Q2, watching TV or listending to the radio). The 
thinnest body size and neck size images (Qs 5 and 6) each collected 9% and 2.1% of 
responses respectively. The largest body and neck size images collected 16.7% and 
14.5% of responses respectively. More than half the study group reported a bed partner 
observing them stopping breathing during sleep: 62.4% (146 patients) ticked ‘yes’ to 
having ‘witnessed apnoea’ during sleep, 32.9% (77 patients) ticked ‘no’ to ‘witnessed 
apnoea’ and 4.7% (11 patients) left the question blank. 
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Figure 7.2. Histograms displaying the frequency of responses (percentage) to each item 
of the pictorial Sleepiness and Sleep Apnoea Scale. Qs1–4 represents the Sleepiness 
component of the scale; Qs5–8 represents the risk component of the scale.  
Q1   Q2   Q3   Q4 
 
Q5   Q6   Q7   Q8 
 
Table 7.1. the percentage (and the actual number of respondents) for each pictorial 
Sleepiness and Sleep Apnoea Scale (pSSAS) score (0–4), questions 1 – 8. 
 Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 
 
sitting and 
reading 
watching tv 
sitting after 
lunch 
passenger 
in a car 
body size neck size 
blood 
pressure 
witnessed 
apnoea 
pSSAS 
score 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
0 
22.2 
(52) 
13.7 
(32) 
15.8 
(37) 
33.3 
(78) 
9.0 
(21) 
2.1 
(5) 
51.7 
(121) 
32.9 
(77) 
         
1 
23.5 
(55) 
25.6 
(60) 
24.8 
(58) 
19.2 
(45) 
21.8 
(51) 
14.1 
(33) 
9.0 
(21) 
4.7 
(11) 
         
2 
30.3 
(71) 
26.9 
(63) 
28.6 
(67) 
18.8 
(44) 
30.3 
(71) 
35.9 
(84) 
– – 
         
3 
11.1 
(26) 
19.7 
(46) 
17.1 
(40) 
17.5 
(41) 
22.2 
(52) 
33.3 
(78) 
– – 
         
4 
12.8 
(30) 
14.1 
(33) 
13.7 
(32) 
11.1 
(26) 
16.7 
(39) 
14.5 
(34) 
39.3 
(92) 
62.4 
(146) 
 
For interest the distribution of responses to the Epworth Sleepiness Scale are shown in 
Figure 7.3. The four pictorial sleepiness questions (Q1–Q4) relate to questions Q1, Q2, 
Q7 and Q4 of the Epworth respectively.  
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More respondents (33.3%) ticked the first image on Q4 of the pictorial scale ‘travelling 
as a passenger in car or a bus’ than scored ‘0’ for Q4 (23.5%) ‘as a passenger in a car for 
1hr’ of the Epworth.  
Figure 7.3. Histograms displaying the percentage of people responding in each category 
(0–3) to questions 1 to 8 of the Epworth Sleepiness Scale. 
Q1   Q2   Q3   Q4 
 
Q5   Q6   Q7   Q8 
    
Table 7.2. Item responses to the Epworth Sleepiness Scale. 
 Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 
 
sitting and 
reading 
watching tv 
inactive in 
a public 
place 
passenger 
in a car 1 
hr 
lying down 
to rest 
sitting and 
talking 
sitting after 
lunch 
in a car at 
traffic 
lights 
ESS score 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
% 
(no.) 
0 
17.5 
(41) 
9.8 
(23) 
35.5 
(83) 
23.5 
(55) 
4.3 
(10) 
65.0 
(152) 
20.5 
(48) 
67.9 
(159) 
         
1 
27.8 
(65) 
22.6 
(53) 
28.2 
(66) 
28.6 
(67) 
15.4 
(36) 
24.4 
(57) 
32.1 
(75) 
20.9 
(49) 
         
2 
32.9 
(77) 
37.6 
(88) 
21.4 
(50) 
24.4 
(57) 
22.6 
(53) 
9.0 
(21) 
24.4 
(57) 
9.0 
(21) 
         
3 
21.8 
(51) 
29.9 
(70) 
15.0 
(35) 
23.5 
(55) 
57.7 
(135) 
1.7 
(4) 
23.1 
(54) 
2.1 
(5) 
 
The mean item scores for the pictorial Sleepiness and Sleep Apnoea Scale questions are 
represented in figure 7.4, along with gender mean item scores. Men and women 
respond similarly to questions 1–4, and question 6 and 7. Women have a higher mean 
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item score than men for question 5 representing ‘body size’, and fewer women 
compared to men responded ‘yes’ to question 8, ‘witnessed apnoea’.  
Question 8 ‘witnessed apnoea’ had the highest mean item score of the eight questions, 
with 62.4% ticking ‘yes’ to ‘witnessed apnoea’.  
Of the four sleepiness questions, question 2 ‘watching TV or listening to the radio’ and 
question 3 ‘sitting quietly after lunch’ had slightly higher mean item scores than 
question 1 ‘sitting and reading’ and question 4 ‘sitting as a passenger in a car or a bus’.  
Figure 7.4. Mean item scores for the pictorial Sleepiness and Sleep Apnoea Scale, 
whole group (diamond), female (square) and male (triangle) mean item scores. Error 
bars show one SD. 
 
 
Mean pictorial sleepiness scores for the 234 patients were: ∑Q1–4 sleepiness 
component (maximum score=16) 7.1 ± 3.97 (female 6.63 ± 4.14, male 7.24 ± 3.89); ∑Q5–
8 risk component (maximum possible score=16) 8.8 ± 3.74 (female 8.94 ± 3.56, male 
8.74 ± 3.83), ∑Q1–8 (maximum possible score=32) 15.9 ± 6.1 (female 15.58 ±5.75, male 
15.98 ± 6.25.  
The total mean Epworth Sleepiness Scale score (maximum possible score=24) for the 
234 patients was 10.9 ± 5.11 (female 10.59 ± 5.0, male 10.99 ± 5.17) (figures 7.5a–d).  
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Figure 7.5a–d. Mean pictorial Sleepiness and Sleep Apnoea Scale scores (sleepiness, 
risk and total scale scores) and mean Epworth Sleepiness Scale scores for 234 patients. 
Error bars are one SD. 
a       b 
   
c       d 
    
 
When total scores from the Pictorial Sleepiness and Sleep Apnoea Scale are plotted 
against the Epworth Sleepiness Scale (figures 7.6a–c), the two scales show some 
relationship and there is a trend for 1) the total pictorial Sleepiness and Sleep Apnoea 
Scale (sleepiness component) and 2) the total pictorial Sleepiness and Sleep Apnoea 
Scale (questions 1–8) to increase as Epworth Sleepiness scores increase.  
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The Epworth and the pictorial Sleepiness and Sleep Apnoea scale risk component show 
much less dependence (figure 7.6b). 
Figure 7.6a–c. Pictorial Sleepiness and Sleep Apnoea Scale (pSSAS) score correlations 
with the Epworth Sleepiness Scale (ESS) scores: a) total pSSAS Q1–4 versus total ESS 
score; b) total pSSAS Q5–8 versus total ESS score; c) total pSSAS Q1–8 versus total 
ESS score. 
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2. Sleep study results, body mass index and gender. 
The majority of the 234 people studied had some evidence of sleep disordered 
breathing. Mean results for apnoea–hypopnoea index (AHI), oxygen desaturation index 
(ODI), and other study outcomes are shown in table 7.3 along with the mean scores for 
male and female gender. 
 The mean apnoea–hypopnoea index was 26.4 events per hour (± 22.91). Men had a 
higher mean AHI compared to women: 28.30 (± 22.94) events per hour versus 22.10  (± 
23.39) events per hour. The mean ODI (20.8 ± 24.16) was slightly lower than the mean 
AHI and there was less gender difference in the mean oxygen desaturation index.  
For interest I have reported the supine apnoea hypopnoea index; mean supine AHI was 
33.1 events per hour (± 25.93) as the gender difference here was quite marked, with 
men having a mean supine AHI of 37.19 (± 25.4) events per hour, compared to women 
24.0 (± 37.19) events per hour of sleep. 
 
Table 7.3. Group data and sleep study outcomes in 234 patients who completed a 
pictorial Sleepiness and Sleep Apnoea Scale prior to sleep study. *Mean oxygen 
saturation overnight, AHI apnoea–hypopnoea index, ODI oxygen desaturation index, 
Min SaO2=minimum oxygen saturation. 
 Mean scores  
 
AHI 
(± SD) 
ODI 
(± SD) 
supine AHI 
(± SD) 
*SaO2  
(± SD) 
Min. SaO2 
(± SD)  
Total group 
(n=234) 
26.4 
(22.91) 
20.8 
(24.16) 
33.1 
(25.93) 
92.95 
(5.45) 
81.4 
(10.37) 
 
Female 
(n=71) 
22.10 
(23.39) 
19.13 
(24.00) 
24.0 
(24.97) 
93.59 
(11.77) 
80.96 
(17.21) 
 
Male 
(n=163) 
28.30 
(22.94) 
21.51 
(24.14) 
37.19 
(25.54) 
92.67 
(13.87) 
81.65 
(17.21) 
 
 
 
There was a relationship between recorded body mass index and both the apnoea–
hypopnoea and oxygen desaturation indices, with a trend for scores to be higher with 
an increase in weight (figures 7.7 a and b). The minimum, oxygen saturation also 
tended to be lower with an increased body mass index (figure 7.8a). In contrast, mean 
overnight oxygen saturation (figure 7.8b) and age had less of an effect on these 
outcomes (figure A8.1 in the appendix 8). 
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Figure 7.7. Body Mass Index (BMI) correlations with a) apnoea–hypopnoea and b) 
oxygen desaturation indices (AHI and ODI). 
a      b 
   
 
Figure 7.8. Body Mass Index (BMI) correlations with a) mean minimum oxygen 
saturation (minimum SaO2) and b) mean overnight oxygen saturation (mean SaO2). 
a      b 
 -  
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3. Sleep study results and severity of disease. 
 
Of the 234 patients, 85.5% (200 people) had an apnoea–hypopnoea index greater than 5 
events per hour, and 14.5% (34 patients) had an apnoea–hypopnoea index less than 5 
events per hour.  
 
Figure 7.9. Percentage of people with obstructive sleep apnoeas (OSA) according to: a) 
apnoea-hypopnoea index (AHI), b) oxygen desaturation index (ODI) and c) clinician 
review of sleep disordered breathing (SDB) after the sleep study. 
               a            b                 c 
   
 
The fraction of the group that were diagnosed to have obstructive apnoeas during sleep 
differed depending on whether diagnosis was defined by the apnoea–hypopnoea index, 
oxygen desaturation index and clinician decision of ‘yes sleep-disordered breathing’ or 
‘no sleep disordered breathing’ (taken from reviewing the clinic letter following the 
sleep study) (figure 7.9a–c). 
 
If only oxygen desaturation index was used, 66.2% (151 patients) had a problem with 
breathing during sleep. After review of the sleep study, the clinician assessment was 
that 88.9% (209 patients) had problems with obstructive sleep apnoea. This does not 
mean that all (88.9%) had symptoms sufficient to warrant treatment with CPAP 
therapy. 
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Examining the results further, figure 7.10(a–c) shows the percentage of people with ‘no 
disease’, ‘mild disease’, ‘moderate disease’ and ‘severe disease’ for apnoea–hypopnoea 
index, oxygen desaturation index and supine apnoea–hypopnoea index.  
 
 
Figure 7.10. Percentage of people with no disease (<5 events per hour), mild disease  
(5–14.9 events per hour), moderate disease (15–29.9 events per hour) and severe 
disease (≥30 events per hour of sleep): a) apnoea–hypopnoea index (AHI), b) oxygen 
desaturation index (ODI) and c) supine apnoea–hypopnoea index. 
 
a) AHI             b) ODI          c) supine AHI 
    
 
More people fell into the ‘severe’ range for apnoea–hypopnoea index (32.9%) than fell 
into the ‘severe’ range for oxygen desaturation index (23.7%). 46.5% of those studied 
had a supine apnoea–hypopnoea index in the severe category.  
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4. The severity of disease and treatment with continuous positive airway therapy. 
116 / 234 (49.6%) people were offered continuous positive airway pressure (CPAP) 
therapy (figure 7.11). 51 people were considered not suitable for CPAP or required 
further study before treatment could be decided. 67 / 234 (28.6%) were discharged 
home with no ‘explicit’ further action required. Some of these patients will have 
received lifestyle modification advice such as weight control when they received their 
study results.  
Figure 7.11. The number of CPAP prescriptions, ‘other treatments and 
recommendations’ and those who had no further actions (NFA) taken, following sleep 
study (234 patients). 
 
Of the 51 patients who had a positive sleep study but did not receive CPAP therapy, 17 
received a recommendation to sleep on their side and avoid the supine sleep position. 
Two patients received an alternative machine to CPAP, one receiving non–invasive 
ventilation (NIV) and one servo–assisted ventilation. Four people needed to repeat 
their respiratory screening study; 7 people were recommended for a repeat of their 
respiratory study with the addition of transcutaneous CO2 measurements and 8 people 
required full attended polysomnography, 4 of these to be followed with a multiple sleep 
latency test; see figure 7.12 for full details.  
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Figure 7.12. A breakdown of the 51 / 234 patients who received ‘other treatments and 
recommendations’ following their respiratory sleep study. Information taken from the 
clinic letter, following review of study results by the clinician. 
 
 
Reviewing the CPAP treatment group and comparing results with those that tested 
positive according to the clinician but did not receive CPAP, the CPAP treatment group 
had a higher apnoea–hypopnoea index (40.3 ± 22.7) events per hour of sleep than the 
no-CPAP group (15.5 ± 12.9), p≤0.001 (Mann-Whitney test).  
The CPAP treatment group also had a statistically significant higher total pictorial 
Sleepiness and Sleep Apnoea Scale score: 17.6 (± 5.9 ) versus 14.4 (± 6.0), P≤0.001 
(Mann-Whitney test); and a higher Epworth Sleepiness Scale score: 12.1 (± 5.2) versus 
9.5 (± 4.8), than the no–CPAP group (figure 7.13a and b), P≤0.001 (Mann-Whitney 
test). 
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Figure 7.13. Differences in the mean apnoea–hypopnoea index (AHI), mean pictorial 
Sleepiness and Sleep Apnoea Scale (pSSAS) and mean Epworth Sleepiness Scale (ESS) 
scores, based on: a) treatment with CPAP therapy or b) no CPAP treatment group, in         
208 / 234 patients who the clinician considered to have a positive sleep study. Error 
bars show one SD. Mann-Whitney test result on the median *** : differences in AHI 
CPAP vs no CPAP treatment group p ≤ 0.001; differences in pSSAS score CPAP vs no 
CPAP treatment group p ≤ 0.001; differences in ESS score CPAP vs no CPAP 
treatment group p ≤ 0.001,    = median values. 
a       b 
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5. The severity of disease and the pictorial Sleepiness and Sleep Apnoea Scale. 
The pictorial Sleepiness and Sleep Apnoea Scale total score results (∑ Q1–8) show a 
very loose association with the apnoea–hypopnoea and oxygen desaturation indices. 
The scatter plots show data is broadly spread, but those with the most severe disease 
(AHI ≥ 70 events per hour and ODI ≥ 80 events per hour) have higher pictorial 
Sleepiness and Sleep Apnoea Scale scores (figure 7.14).  
Figure 7.14. Scatter plots of pictorial Sleepiness and Sleep Apnoea Scale total of Q1–8 
with a) apnoea–hypopnoea index (AHI) and b) oxygen desaturation index (ODI). 
a      b 
  
 
Separating the sleepiness and risk components of the scale, the risk component (Q 5–8) 
correlates better with disease severity than the sleepiness component (figures 7.15 and 
7.16). This is perhaps not surprising as two of the four risk questions ask about body 
size and neck size and recorded body mass index is positively correlated with sleep 
study outcomes. Indeed, question 5 ‘body size’ and question 6 ‘neck size’ show a positive 
association with recorded body mass index. However, for each body or neck size image 
the range of recorded body mass index is broad (figure 7.17). 
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Figure 7.15. Scatter plots of Pictorial Sleepiness and Sleep Apnoea Scale total Q1–4 
(sleepiness component) with a) apnoea–hypopnoea index (AHI) and b) oxygen 
desaturation index (ODI). 
a      b 
  
 
Figure 7.16. Scatter plots of pictorial Sleepiness and Sleep Apnoea Scale total Q1–5 
(risk component) with: a) apnoea–hypopnoea index (AHI) and b) oxygen desaturation 
index (ODI).  
a      b  
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Figure 7.17. The relationship between body mass index and respondents’ choice of 
score for:   a) Q5. ‘body size’ images and b) Q6 ‘neck size’ images. 
a       b 
        
For interest the scatter plots of the Epworth Sleepiness Scale results with 
apnoea-hypopnoea index and oxygen desaturation index are presented in figure 7.18. 
The Epworth score and disease severity are weakly correlated.  
 
Figure 7.18. Scatter plot of Epworth Sleepiness Scale total scores Q1–8 with a) apnoea–
hypopnoea index (AHI) and b) oxygen desaturation index (ODI). 
a      b 
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In figure 7.19, the histograms show the number of people with no disease, mild, 
moderate and severe disease at each point on the pictorial Sleepiness and Sleep 
Apnoea Scale, and each point on the Epworth Sleepiness Scale. 
 It is evident from the scatter plots and these histograms that those with different 
levels of sleep–disordered breathing have a broad range of responses to the 
questionnaires. 
Figure 7.19. Histogram showing severity of disease defined by AHI range, against total 
pictorial Sleepiness and Sleep Apnoea Scale scores (range 0–32) and total Epworth 
Sleepiness Scale scores (range 0–24). 
 
 
 
 
Pictorial Sleepiness and Sleep Apnoea Scale total scores and Epworth Sleepiness Scale 
total scores are shown against the decision to treat with continuous positive airway 
pressure therapy in figures 7.20 and 7.21 respectively.  
CPAP was provided to patients with a range of total pictorial scores from 4 to 32 and a 
range of Epworth Sleepiness Scale total scores from 0 to 24. 
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Figure 7.20. Decision to treat with CPAP against total pictorial Sleepiness and Sleep 
Apnoea Scale Scores, n=116 / 234.  
 
Figure 7.21. Decision to treat with CPAP against total Epworth Sleepiness Scale 
Scores, n=116 / 234. 
 
 
6. Testing the strength of relationship between the severity of disease and the pictorial 
Sleepiness and Sleep Apnoea Scale. 
 
The estimation of the mutual information is illustrated below in steps A–D, using the 
example of severity of disease of obstructive sleep apnoea in the categories: ‘none’ AHI 
<5 events per hour (0), ‘mild disease’ AHI ≥5–14.9 events per hour (1), ‘moderate 
disease’ AHI ≥15–29.9 events per hour (2) and ‘severe disease’ AHI ≥30 events per hour 
(3).   
 
(A) A frequency table is made for the number of people in each disease category 
(0,1,2,3) achieving each total sleepiness score (0–16) on the sleepiness component scale, 
table 7.4. 
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Table 7.4. Frequency table for the four categories of severity of disease: none (0), mild 
disease (1), moderate disease (2) and severe disease (3), and for each sleepiness score. 
  Severity of disease  
  None Mild Moderate Severe  
 
 
0 1 2 3 SUM 
S
le
e
p
in
e
ss
 s
co
re
 0
–
1
6
 
0 2 5 2 2 11 
1 0 2 3 3 8 
2 1 6 3 6 16 
3 1 7 4 3 15 
4 3 4 5 4 16 
5 4 5 3 8 20 
6 2 8 3 8 21 
7 5 2 8 8 23 
8 1 6 2 9 18 
9 6 4 8 3 21 
10 2 5 3 4 14 
11 1 6 5 6 18 
12 2 5 2 2 11 
13 2 1 0 6 9 
14 2 0 2 1 5 
15 0 1 0 2 3 
16 0 2 1 2 5 
 SUM 34 69 54 77 234 
 
 
(B) These scores are simplified into four sleepiness ranges: 0–4, 5–8, 9–12 and 13–16 
(table 7.5). 
 
Table 7.5. Frequency table for the Sleepiness component scores simplified into four 
ranges. 
  Severity of disease  
  None Mild Moderate severe  
 
 
0 1 2 3 SUM 
S
le
e
p
in
e
ss
 
sc
o
re
 
total 0–4 7 24 17 18 66 
total 5–8 12 21 16 33 82 
total 9–12 11 20 18 15 64 
total 13–16 4 4 3 11 22 
 SUM 34 69 54 77 234 
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(C) For each range of sleepiness score (0–4, 5–8, 9–12 and 13–16) and level of disease, 
an estimate of the probability is calculated, by dividing the number of people within 
each sleepiness range and level of disease, by the total number of people in the study 
(234) (table 7.6). 
 
Table 7.6. Estimate of probabilities. 
P(x,y)  X P(y) 
  0 1 2 3  
y 
total 0–4 0.030 0.103 0.073 0.077 0.282 
total 5–8 0.051 0.090 0.068 0.141 0.350 
total 9–12 0.047 0.085 0.077 0.064 0.274 
total 13–16 0.017 0.017 0.013 0.047 0.094 
 P(x) 0.145 0.295 0.231 0.329 1 
 
 
(D) In the final step the mutual information I(X;Y) is computed using the formula: 
 
I(X;Y)     =   ∑      P(x,y)    log   P(x,y)             
              x,y                       P(x) P(y) 
 
 
The bigger the mutual information the more information is conveyed about the clinical 
outcome by the sleepiness score. It can be summarised as, “how good is the sleepiness 
score at predicting the level of disease?” 
The p–value associated with the mutual information statistic was computed using the 
permutation method with 5000 permutations 193. 
 
  
log 2  . 
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Table 7.7. Mutual information scores in bits for the pictorial Sleepiness and Sleep 
Apnoea Scale: sleepiness and risk components and total scores for different clinical 
outcomes. Also shown are the mutual information scores for the Epworth sleepiness 
scale.  
 
 
Mutual Information scores in bits 
 
 
 
Pictorial Sleepiness and Sleep Apnoea Scale 
 
 sleepiness component      risk component            total scale        
 
Epworth 
Sleepiness 
Scale 
 
 Q1–4 Q5–8 Q1–8 Q1–8 
AHI severity  
total group 
Female 
Male 
 
0.036 
0.089 
0.034 
 
0.079*** 
0.164* 
0.086** 
 
0.054** 
0.060 
0.071* 
 
0.044* 
0.045 
0.066* 
ODI severity  
total group 
Female 
Male 
 
0.078** 
0.1901 
0.074 
 
0.119*** 
0.202** 
0.111** 
 
0.072*** 
0.150* 
0.072* 
 
0.031 
0.029 
0.045 
CPAP treatment  
total group 
Female 
Male 
 
0.037** 
0.024   
0.042* 
 
0.058*** 
0.049 
0.072*** 
 
0.054*** 
0.038 
0.063*** 
 
0.043*** 
0.054 
0.050*** 
Supine AHI severity  
total group 
Female 
Male 
 
0.034 
0.135 
0.054 
 
0.0402 
0.077 
0.070** 
 
0.023 
0.051 
0.046 
 
0.019 
0.115 
0.027 
OSA ‘yes’/ ‘no’ by clinician  
Total group 
Female 
Male 
 
0.0025 
0.028 
0.004 
 
0.041** 
0.056 
0.055** 
 
0.0183 
0.022 
0.0272 
 
0.031** 
0.030 
0.031* 
 
AHI Apnoea Hypopnoea Index, ODI Oxygen Desaturation Index, CPAP Continuous Positive Airway Pressure , OSA 
obstructive sleep apnoea, 1. p=0.055, 2. p=0.059, 3. P=0.061 *p≤0.05, **p≤0.01, ***p≤0.001 
 
 
Overall all mutual information scores were low. This is perhaps not so surprising given 
the entire population has already been through a doctor–led case finding for 
obstructive sleep apnoea on referral from primary care or elsewhere. With a positive 
diagnostic rate of 88.9% of patients with obstructive sleep apnoea it is questionable 
how much further information any tool can add in this population. P-values have been 
calculated and mutual information scores that are statistically significant are shown in 
table 7.7.  
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Table 7.8. P–values for the mutual information scores in table 7.7. 
 
 P–values for mutual information scores  
 
 
 
Pictorial Sleepiness and Sleep Apnoea Scale 
 
sleepiness component      risk component            total scale 
 
Epworth 
Sleepiness 
Scale 
 
 Q1–4 Q5–8 Q1–8 Q1–8 
AHI severity  
total group 
Female 
Male 
0.247 
0.558 
0.618 
p<0.001 
0.022 
0.005 
0.008 
0.494 
0.014 
0.033 
0.701 
0.025 
ODI severity  
total group 
Female 
Male 
0.005 
0.055 
0.084 
p<0.001 
0.007 
0.001 
p<0.001 
0.042 
0.017 
0.145 
0.886 
0.141 
CPAP treatment  
total group 
Female 
Male 
0.007 
0.516 
0.027 
p<0.001 
0.093 
p<0.001 
 
p<0.001 
0.175 
0.001 
0.001 
0.079 
0.004 
Supine AHI severity  
total group 
Female 
Male 
0.321 
0.270 
0.244 
0.059 
0.399 
0.010 
0.316 
0.639 
0.132 
0.454 
0.142 
0.458 
OSA ‘yes’/ ‘no’ by clinician  
Total group 
Female 
Male 
0.858 
0.546 
0.830 
0.001 
0.109 
0.002 
0.061 
0.441 
0.059 
0.009 
0.308 
0.042 
 
The risk component of the pictorial Sleepiness and Sleep Apnoea Scale appears to 
convey more information about the five chosen clinical outcomes than the sleepiness 
component of the pictorial scale or the Epworth Sleepiness Score.  
Receiver operating characteristic (ROC) curves 209 have been drawn for clinical 
outcomes with the pictorial Sleepiness and Sleep Apnoea Scale. For each ROC curve, 
the area under the curve is reported, along with the p-value associated with that area -  
that is, the probability that the area under the curve would be that large (or larger) 
under the null hypothesis that there is no association between the score and the 
outcome. The p-values were computed using the permutation method with 10000 
permutations 193. For interest the ROC curves for the Epworth are also shown. Where 
gender differences were observed, the ROC curves for men and women have been 
drawn and are available in appendix 8 (figures A8.2–A8.6). The tables of the 
sensitivities and specificities for each threshold on the pictorial scale are available in 
appendix 8 (tables A8.1–A8.4). The sensitivities and specificities for the Epworth (0–
24) are also shown (tables A8.5–A8.8). 
  
 165 
 
Figure 7.22. ROC curve of pictorial Sleepiness and Sleep Apnoea Scale score as a 
predictor of apnoea–hypopnoea index (AHI) severity: condition 1 (AHI >5 events per 
hour), condition 2 (AHI >15 events per hour) and condition 3 (AHI >30 events per 
hour). Below are the ROC curves for prediction of the same outcomes with the Epworth 
Sleepiness Scale.  
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Figure 7.23. Comparison of pictorial Sleepiness and Sleep Apnoea Scale and Epworth 
Sleepiness Scale ROC curves, for an AHI >15 events per hour (condition 2 in figure 
7.22). Error bars are one SD. For areas under the curve and p-values see Figure 7.22. 
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Figure 7.24. ROC curve of pictorial Sleepiness and Sleep Apnoea Scale score as a 
predictor of Oxygen Desaturation Index (ODI) severity: condition 1 (ODI >5 events per 
hour), condition 2 (ODI >15 events per hour) and condition 3 (ODI >30 events per 
hour). Below are the ROC curves for the prediction of the same outcomes with the 
Epworth Sleepiness Scale.  
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Figure 7.25. Comparison of pictorial Sleepiness and Sleep Apnoea Scale and Epworth 
Sleepiness Scale ROC curves for an ODI >30 events per hour (condition 3 in figure 
7.24). Error bars are one SD. For areas under the curve and p-values see Figure 7.24. 
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Figure 7.26. Comparison of pictorial Sleepiness and Sleep Apnoea Scale and Epworth 
Sleepiness Scale ROC curves for decision to treat with CPAP. Error bars are one SD.  
 
 
 
Figure 7.27. Comparison of pictorial Sleepiness and Sleep Apnoea Scale and Epworth 
Sleepiness Scale ROC curves as a predictor of clinician decision on ‘yes’ or ‘no’ 
obstructive sleep apnoea following sleep study. Error bars are one SD.  
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The ROC curves indicate that the pictorial Sleepiness and Sleep Apnoea Scale has only 
weak power at predicting apnoea–hypopnoea index, oxygen desaturation index and 
decision to treat with CPAP in the population studied.  The best ROC curve is shown in 
figure 7.27, the clinician’s decision to whether a patient has obstructive apnoeas during 
sleep following sleep study.  
However in most cases the ROC curve for the pictorial scale was an improvement on 
the ROC curve of the Epworth Sleepiness Scale, which was only about as good as 
chance at predicting the outcome. The error bars and p-values indicate that some of 
these differences are significant. 
Gender differences were noted on the ROC curves for the oxygen desaturation index, 
supine AHI and clinician’s decision on whether the patients had obstructive sleep 
apnoea (appendix 8 figures A8.3, A8.4 and A8.6), with the predictive power of the tool 
possibly being greater for the male population, albeit a weak association in most cases. 
The sensitivities and specificities of the pictorial scale tended to be comparable around 
the mid–point of the total score range 0–32. For example for “clinician’s decision on 
obstructive sleep apnoea”, a pictorial score of ≥ 16 / 32 has a sensitivity of 60.3% and 
specificity of 60.2%.  For “decision to treat with CPAP”, a pictorial score ≥ 15 / 32 gives 
a sensitivity of 60.6% and a specificity of 65.4%. At total scores < 10 the sensitivities 
were often > 90% but the specificities were poor. Conversely at higher total scores such 
as ≥ 24 / 32 the specificities were often >90% but the sensitivities were very low. In the 
case of the Epworth Sleepiness Scale, using the threshold ≥ 10 / 24, which is considered 
the clinical point of interest for a suggestion of excessive daytime sleepiness, and 
“clinician’s decision on obstructive sleep apnoea”, the Epworth had a sensitivity of 57% 
and a specificity of 32.4%. For “decision to treat with CPAP” at an Epworth threshold 
of  ≥ 10 / 24 the sensitivity was 65.5% and the specificity 48.5%. 
The pictorial Sleepiness and Sleep Apnoea Scale gives equal weight to all eight items. 
It is conceivable that a better predictor of disease might be obtained if unequal weights 
were used. I explored this possibility for the prediction of the clinician’s decision of 
whether the patient had obstructive sleep apnoea following sleep study. Using linear 
logistic regression analysis on the data representing clinician’s decision, optimised 
weightings for the eight pictorial Sleepiness and Sleep Apnoea Scale questions were 
produced (table 7.9). Two questions (Q1 and Q2) received negative weightings and Q5 
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(body size) received the biggest positive weighting, followed next by Q8 (witnessed 
apnoea), Q4 (travelling as a passenger in a car or bus), Q6 (neck size), and Q7 (blood 
pressure). Question 3 (sitting quietly after a meal) received the lowest weighting. 
Table 7.9. The optimised weights for the eight pictorial Sleepiness and Sleep Apnoea 
Scale questions produced by linear logistic regression of the data on diagnosis of 
obstructive sleep apnoea during sleep (clinician decision).  
 Pictorial Sleepiness and Sleep Apnoea Scale 
 Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 
Optimisation 
weight 
–0.950 –0.203 0.251 1.193 2.249 1.1338 1.059 1.367 
 
Optimising the scoring of the pictorial Sleepiness and Sleep Apnoea Scale using these 
weightings, a new ROC curve of clinician’s opinion on whether the patient has 
obstructive sleep apnoea following sleep study was drawn, figure 7.37. This improved 
the ROC curve, shifting it up and to the left.  
Figure 7.29. The ROC curve (pSSAS–opt) for clinician diagnosis of obstructive sleep 
apnoea using the pictorial Sleepiness and Sleep Apnoea Scale with optimised weights. 
Overlaid are the ROC curves from figure 7.29 (pSSAS and ESS).  
 
 
0
0.2
0.4
0.6
0.8
1
0 0.2 0.4 0.6 0.8 1
pSSAS-opt
pSSAS
ESS
Se
n
si
ti
vi
ty
 
1-Specificity 
172 
 
I believe this modest enhancement of the ROC curve motivates further work on the 
optimisation of the scale’s weights for a broader population. Clearly more work on 
weighting of our scale would be of interest and be likely to improve its usefulness. Such 
work would need to be undertaken in a more diverse population and one less selected 
than in our studies of those attending a sleep study. Our collaborations with colleagues 
in Switzerland (see page 106) may go some way towards progressing such weighting.  
 
 
Cardiac Prevention and Rehabilitation Programme Study 
 
Methods 
Patients suitable for cardiac prevention and rehabilitation programmes were identified 
by cardiac nurse specialists at the time of admission for myocardial infarction or on 
admission to hospital with a cardiovascular complication. Once stabilized, the patient 
was offered a place on the eight to twelve week rolling programme. 
101 patients accepting a place on the cardiac prevention and rehabilitation programme 
over three months were sent the pictorial Sleepiness and Sleep Apnoea Scale and an 
Epworth Sleepiness Scale, along with other forms relevant to the CPRP programme. 
Patients were asked to complete the forms at home prior to attending the CPRP clinic. 
Questionnaires were checked on attendance at the clinic and where help was needed, 
this was given by the cardiac nurse specialist.   
Those scoring an Epworth Sleepiness Score greater than or equal to 10 / 24 or ticking 
yes to ‘witnessed apnoea’ on the pictorial Sleepiness and Sleep Apnoea Scale were 
referred for overnight, attended cardio–respiratory monitoring in the sleep centre 
(using the Embletta PDS, as per methods for the sleep clinic study, page 132). Tests 
were offered within 6 weeks after receipt of the referral forms.80 
The sleep study was analysed the following morning (according to criteria used in the 
methods – sleep clinic study - on page 137 and appendix 7). Patients were grouped into 
none, mild, moderate and severe disease.  
After the patient had breakfasted, they saw the sleep clinician to receive their study 
results. Those that had a positive test for obstructive sleep apnoea syndrome and were 
considered symptomatic by the clinician were offered continuous positive airway 
pressure therapy and given an auto–titrating machine to take home. 
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In essence the cardiac prevention and rehabilitation programme patients omitted the 
primary referral and sleep consultation step that patients with suspected obstructive 
sleep apnoea referred from the community receive and this was replaced by the two 
questionnaires.  Any additional clinical input from the Sleep Centre was received post 
study.  
 
 
Results Cardiology Study 
 
81 of 101 (80.2%) sequential attendees to the programme consented to participate. 61 
participants (75.3%) were male and the participants mean age was 64.4 (± 10.1) years 
(62.8 ± 15.5 years male, 65.5 ± 16.8 years female). Mean body mass index for the group 
was 28.8 (± 5.1) kg.m2. Mean pictorial Sleepiness and Sleep Apnoea Scale total scores 
for the 81 patients were: ∑ Q1–4: 4.1 (±3.3), ∑ Q5–8: 6.8 (± 3.5) and ∑Q1–8: 10.8 (± 5.2) 
and total Epworth Sleepiness Scale scores ∑ Q1–8: 6.8 (± 3.9); full results are shown in 
table 7.10. 
Table 7.10. 101 participants were invited to take part; 82.2% (81 patients) consented. 
Mean age, gender and pictorial Sleepiness and Sleep Apnoea Scale data and Epworth 
Sleepiness Scale data are shown.  
 
 
Number 
(%) 
M:F 
 
Mean age 
(years, 
SD) 
 
Mean BMI 
(kg.m2) 
Total 
pSSAS 
 Q1–4 (SD) 
Total 
pSSAS  
Q5–8 (SD) 
Total 
pSSAS  
Q1–8 (SD) 
 ‘yes’ to 
witnessed 
apnoea 
Total 
ESS 
score 
(SD) 
 
Total group 
 
 
81 
(100) 
 
61:20 
 
 
64.4 
(10.1) 
 
28.8 
(5.1) 
4.1 (3.3) 6.8 (3.5) 10.8 (5.2) 
 
13/81 
 
6.8 
 (3.9) 
 
female 
 
 
20 
(24.7) 
– 
 
65.5 
(16.8) 
 
28.6 
(8.1) 
4.5 (4.1) 6.8 (3.2) 10.9 (5.6) 
 
2/81 
 
5.8  
(3.3) 
 
male 
 
 
61 
(75.3) 
– 
 
62.8 
(15.5) 
 
28.7 
(9.4) 
4.2 (3.0) 7.0 (3.6) 11.0 (5.1) 
 
11/81 
 
6.5  
(4.1) 
 
not referred for 
sleep studies 
 
58 
(71.6) 
41:17 
 
64.6 
(9.6) 
28.5 
(4.4) 
 
3.5 (2.9) 
 
5.8 (2.7) 
 
9.1 (3.9) 
 
0/81 
 
 
5.1 
 (2.3) 
 
referred for 
sleep studies 
 
23 
(28.4) 
20:3 
 
63.8 
(11.4) 
 
29.6 
(6.6) 
 
5.8 (3.7) 
 
9.3 (4.1) 
 
15.1 (5.6) 
 
13/81 
 
 
11.1 
(3.8) 
M=male, F=female, pSSAS=pictorial sleepiness and Sleep Apnoea Scale, ESS=Epworth Sleepiness Scale 
 
23 patients of the 81 (28.4%) had either hypersomnolence on the Epworth or answered 
‘yes’ to witnessed apnoea on the pictorial Sleepiness and Sleep Apnoea Scale (figure 
7.30). Mean body mass index of those referred for sleep studies was 29.6 (± 6.6) kg.m2 
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compared with a body mass index of 28.5 (± 4.4) kg.m2 for those who did not meet the 
criteria for referral. 
Figure 7.30. Patients that had an Epworth Sleepiness Score ≥ 10 or ticked ‘yes’ to 
witnessed apnoea on the pSSAS, were invited to have a cardio–respiratory sleep study. 
 
12 of the 23 patients (52.2%) consented to have a sleep study, 6/23 patients (26.1%) 
declined and a further 5/23 (21.7%) did not respond to repeated attempts by letter and 
telephone to book a study (figure 7.31). 
Figure 7.31. 23 patients met the symptom criteria (ESS ≥ 10 or witnessed apnoea on 
the pSSAS) to refer for a sleep study. 12 consented to be studied. 
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All twelve (100% of those studied) tested positive for sleep–disordered breathing; a 
positive diagnostic rate of 14.8% (12 / 81 patients). Eleven were predominantly 
obstructive in origin, making the prevalence of obstructive sleep apnoea in this study 
population at least 13.6% (11 / 81 patients). Four patients were in the severe category, 
3 patients were in the moderate category and 4 patients had mild pathology. One 
person was considered to have mainly central sleep apnoea (figure 7.31). In total 3 
patients (25% of those tested) had, to differing degrees, some evidence of central 
apnoeas during sleep.  
 
Figure 7.31. The severity of disease in 12 / 81 patients (14.8%) who received a sleep 
study. OSA=obstructive sleep apnoea, CSA=central sleep apnoea. 
 
Six patients were offered continuous positive airway pressure (CPAP) therapy. Mean 
BMI of those offered CPAP was 32.7 (± 12.5) kg.m2. Five of the remaining six patients 
with positive sleep studies were not considered symptomatic enough for CPAP by the 
clinician: one patient was advised to sleep on his side and four were offered lifestyle 
modification advice. The BMI of the no-CPAP group was 28.2 (± 1.9) kg.m2. The 
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remaining one patient was offered a clinic appointment with a view to continuing sleep 
investigations and had a query of Cheyne–Stokes breathing. A summary of the 
pictorial Sleepiness and Sleep Apnoea Scale and Epworth Sleepiness Scale scores for 
the 23 patients who were invited to have a sleep study is shown in table 7.11. Results 
are divided into those that attended for a study, those that declined and those that 
were not contactable.  
Table 7.11. Pictorial Sleepiness and Sleep Apnoea Scale scores for the 23 patients who 
met the symptom criteria for testing, according to whether they came for a sleep study, 
declined or were not contactable.  
 
 
 
Number 
 (%) 
M:F 
 
Mean age 
(years, SD) 
 
Mean BMI 
(kg.m2, SD) 
Total 
pSSAS 
 Q1–4 (SD) 
Total 
pSSAS  
Q5–8 (SD) 
Total 
pSSAS  
Q1–8 (SD) 
 ‘yes’ to 
witnessed 
apnoea 
 
Total ESS 
score (SD) 
Accepted 
sleep studies 
 
12 / 23 
(53.2) 
 
11:1 
 
66.3 (10.3) 
 
30.1 (7.6)* 
5.9 
(3.4) 
8.3 
(4.7) 
14.3 
(6.0) 
5 / 12 
12.1 
(3.7) 
Declined sleep 
studies 
 
6 / 23 
(26.1) 
 
5:1 
 
61.5 (6.3) 
 
30.7 (3.9) 
6.5 
(2.6) 
8.8 
(3.9) 
15.3 
(4.4) 
3 / 6 
10.5 
(4.3) 
Not 
contactable 
for sleep 
studies 
5 / 23 
(21.7) 
 
4:1 
 
58.6 (15.7) 
 
26.7 (0.9) 4.6 
(5.3) 
10.4 
(3.5) 
15.0 
(6.5) 
5 / 5 
9.2 
(3.0) 
M=male, F=female, pSSAS=pictorial sleepiness and Sleep Apnoea Scale, ESS=Epworth Sleepiness Scale 
 
A difference is observed in mean total Epworth Sleepiness Scale scores between 
patients that had a sleep study, and those that either declined or were not contactable: 
ESS score 12.2 versus 10.5 versus 9.2 respectively. 8 / 12 patients that ‘declined’ or 
‘were not contactable’ for a study, had ticked ‘yes’ to having witnessed apnoeas during 
sleep. 
Plotting the histograms of pictorial Sleepiness and Sleep Apnoea Scale total scores for 
those who were recommended for a sleep study and those who were not shows a range 
of total scores from 4 to 24 for the ‘sleep referral group’ and 1 to 16 for the ‘no sleep 
study referral group’ figure (7.31) . 
 
Reviewing the total scores for the 6 patients that received CPAP therapy and the 5 
that did not receive CPAP therapy was interesting (figure 7.32).  
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Figure 7.31. pSSAS scores for the sleep referral group (n=23) and those not referred for 
study (n=58). 
 
There is little difference in the Epworth Sleepiness score between these two groups,     
Mann-Whitney test statistic P = 0.159. Indeed the mean Epworth in the ‘CPAP 
treatment group’ was 11 (± 4.6), 1.6 points lower than the ‘no CPAP group’ (12.6 ± 2.2). 
In contrast the pictorial Sleepiness and Sleep Apnoea scores were higher in the ‘CPAP 
treatment group’, mean total pSSAS score of 17.2 (± 3.9) compared with the ‘no-CPAP 
group’ 9.0 (± 3.8) figure 7.32. The difference in medians (CPAP pSSAS 18.5 vs no-CPAP 
pSSAS 11.0) was significant with a Mann-Whitney test statistic p = 0.018. 
 
Figure 7.32. Total mean pictorial Sleepiness Scale and Epworth Sleepiness Scale scores 
for patients treated with CPAP therapy (n=6) and without CPAP therapy (n=5). Error 
bars are one SD. Mann-Whitney statistics are p=0.018 and p=0.159 respectively. 
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Chapter 7 comments 
  
Case finding for obstructive sleep apnoea syndrome in a cardiac prevention and 
rehabilitation clinic appears feasible. These pilot data suggests a minimum prevalence 
of sleep–disordered breathing in a cardiac prevention and rehabilitation programme 
clinic of 14.8%; with 13.6% diagnosed with obstructive sleep apnoea. This is 
significantly higher than that reported in the general population. 59 
Evaluations of the pictorial Sleepiness and Sleep Apnoea Scale in a sleep clinic 
population that has a positive diagnosis rate of 89% indicate that the relationship of 
the scale to severity of disease was weak. Evaluating the scale in a population that 
includes more people without a diagnosis of obstructive sleep apnoea is needed before 
the scale can be truly tested as a case finding or screening tool.  
Looking at the ROC curves the study outcome that was best predicted by the new scale 
was clinician decision following sleep study on whether the patient had obstructive 
sleep apnoea. Including risk factor questions such as body size, neck size, presence of 
high blood pressure and witnessed apnoea with sleepiness questions improves the 
predictive relationship between the scale and outcomes compared to using the 
sleepiness component of the scale only or the Epworth Sleepiness Scale. In this study 
the Epworth Sleepiness Scale was often as bad as chance at predicting severity of 
disease and who might benefit from treatment with CPAP.  
I did not keep track of the primary referral source of the 234 patients in the sleep clinic 
study. In hindsight it would have been interesting to review how patients from 
different referral sources completed the scale, how their sleep study results differed to 
that of the rest of the group, and specifically what range of sleepiness levels these 
patients exhibited. For example it is likely that the proportion of bariatric surgery 
patients attending for pre–op sleep studies in this study is higher than normally seen 
in a routine sleep clinic. The heterogeneity of the sleep clinic group is reflected in the 
options that were offered to patients following their sleep study. Not all patients with a 
positive study were supplied with CPAP. Indeed one patient received non-invasive 
ventilation and one servo–assisted ventilation. A proportion of patients needed to 
repeat the routine sleep study; this is not unusual in itself as sometimes patients 
report that they did not sleep during the first night of study (first night effect), 
technical problems warrant repeating the test, or additional measures are needed such 
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as transcutaneous CO2 monitoring to investigate obesity–related hypoventilation 
syndrome. For a percentage of patients, the cardio–respiratory sleep study did not fully 
explain their symptoms and patients were considered for polysomnography with or 
without multiple sleep latency testing. A number of patients were advised to sleep on 
their side, thus implying their sleep apnoea was predominantly in the supine sleep 
position. These patients are likely to have had relatively mild or even normal apnoea–
hypopnoea indexes for the whole night with minimal symptoms and a higher apnoea–
hypopnoea index when sleeping supine. The amount of time spent sleeping supine will 
have affected their overall apnoea–hypopnoea index. When I started working in the 
sleep centre all patients were routinely studied for two nights to minimise the first 
night effect and the night to night variability of sleep study results.  
The results in this chapter confirm that the prevalence of disease is dependent on the 
definition and the methods used to survey disease. Some practitioners recommend full 
polysomnography as the primary method for evaluating obstructive sleep apnoea 
syndrome, but this is technically impractical in the UK (and unnecessary for the 
majority). However, Recording EEG does help to understand the extent that EEG 
arousals result from apnoeas, hypopnoeas and increases in upper airway resistance, 
and fragmentation of sleep from other causes such as periodic limb movements (that 
can also affect the respiratory recording channel). It also helps to evaluate the 
relationship between sleep state and breathing. At the other extreme oximetry is 
widely available and relatively inexpensive but used alone it can underestimate 
disease especially in those that desaturate less readily (often younger and thinner 
patients), or the saw–tooth dips in oxygen saturation can be confused with changes 
resulting from other pathologies. Multi–channel sleep recording (as defined in the 
introduction) is a common compromise between polysomnography and simple oximetry. 
It was reassuring that patients were reasonably good at reflecting their body size in 
the pictorial images according to their recorded body mass index. Again it would be 
interesting to investigate how different groups (e.g. the bariatric patient group versus 
routine sleep referrals) respond to this question (Q5).  The body size images were 
purposefully drawn to have more weight around the abdomen representing a central 
distribution of fat as patients with central adiposity are more likely to have obstructive 
sleep apnoea syndrome. It would be interesting to know how the chosen neck size 
images (Q6) relate to actual neck girth.  
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In the cardiac study the 11 patients with hypersomnolence or witnessed apnoea who 
declined or were not contactable were sent a follow–up questionnaire. This enquired if 
they were willing to say why they did not want the sleep test. Understanding why 
patients decline investigations and hospital care is vital in understanding how best to 
help patients take up needed investigations and in planning how best to structure 
services. Despite sending a follow–up questionnaire and attempting to follow this up by 
telephone, no response was received from these patients. People identified at risk of 
obstructive sleep apnoea syndrome during a case finding programme and declining a 
confirmatory sleep study have been reported in other studies.194  
Measuring Health Literacy in this population would have been interesting but this was 
not feasible. Language and literacy barriers may have played a part in the decisions of 
patients who declined to be studied.  Recent published work by Rowlands found 15.4% 
of patients on a primary care register for coronary heart disease in South London had 
impaired or low literacy levels. 195  
Patients had received the pictorial Scale and the Epworth scale by post, along with the 
required ethics information and consent form, plus a routine batch of cardiology based 
questionnaires and forms. It was a lot of information to receive and the clinical team 
speculate the load of information was perhaps too much for some patients. The initial 
thought had been to give patients the questionnaires when they attended the 
rehabilitation clinic. However the cardiology team advised time was limited and they 
favoured posting pre–clinic questionnaires, which fitted with their routine model of 
care.  
Some people reported at the time of attempted telephone booking for a sleep study that 
they had other health complaints that were more pressing. For example two of the 
eleven reported they were undergoing treatment for cancer. Other hypotheses for the 
50% uptake of sleep study are that patients did not want to spend another night in 
hospital so close to a recent hospitalisation for a major cardiovascular illness; patients 
may be poor attendees of healthcare services; the distance from home to hospital was 
inconvenient or follow-up care was being received closer to home or not at all (the 
catchment for intake to the CPRP clinic reached beyond the normal local PCT 
catchment area). Similar themes for declining participation in a pulmonary 
rehabilitation study were found by Taylor and colleagues.196 
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Of the eleven patients that were not contactable by the sleep service, 3 had also 
dropped out of the cardiac prevention and rehabilitation programme. Overall, uptake 
to the CPRP programme at the time of testing was 79% and of those that started, 85% 
finished the 8–12 week course.  
Perhaps there was a positive responder bias, in that those who suspected that they had 
something wrong with their breathing during sleep responded whilst the others 
doubted there was a problem and therefore didn’t want to participate. Epworth 
Sleepiness Scores were lower in those that declined or were not contactable. Entry into 
this study excluded those with heart failure but patients were recruited soon after 
their coronary event and their hearts as a result are likely to have some damage and 
thus be pumping less efficiently.  It is conceivable that witnessed apnoeas reported in 
this group of patients include more central events than a standard population. Central 
apnoeas were recorded in 3 / 11 patients that had sleep studies (and witnessed apnoeas 
were reported in 8 / 11 patients that ‘declined or were not contactable’ for sleep study). 
It would be interesting to know whether these patients experience less dramatic sleep 
apnoea attacks, following a pattern of sleep–disordered breathing more often observed 
in heart failure patients (with a crescendo and decrescendo pattern of breathing), 
compared to the abrupt waking, gasping or choking following an apnoea often 
described by obstructive apnoea patients. 197;198 This is highly speculative but 
nevertheless an area which might be explored in the future. In a case report of a 
patient with ischaemic stroke an acute change from moderate obstructive sleep apnoea 
to severe central sleep apnoea has been reported.199 Does this population show 
variability in the ratio of central to obstructive sleep apnoea events recorded over 
different nights’ sleep studies, as observed in heart failure patients?198  Additionally it 
would be interesting to know if there is an optimal time following recruitment into a 
cardiac prevention and rehabilitation programme for offering sleep studies to this 
patient group. Would results be significantly different 6 months or 1 year following the 
coronary event, and to what extent would symptoms such as witnessed apnoea and 
excessive sleepiness be present at the time? 
Further work and a larger study is clearly needed to establish whether the 14.8% with 
sleep–disordered breathing is repeatable. Following a larger cohort of cardiac 
prevention and rehabilitation programme patients and reviewing markers of 
cardiovascular disease in relation to the presence of obstructive sleep apnoea syndrome 
and treatment would be useful in evaluating whether continuous positive airway 
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pressure therapy can reduce resistant hypertension and improve markers of 
cardiovascular function in patients who are already vulnerable to disease. Pedrosa and 
colleagues recently showed, in a small cohort of patients with resistant hypertension, 
that CPAP therapy led to improvements in daytime, but not nocturnal blood 
pressure.200 Allan Pack argues that longitudinal studies support the risk of 
cardiovascular disease in untreated sleep apnoea and he reports that sceptics remain 
unconvinced because this evidence is not through randomised controlled trials. It is 
highly contentious to randomise the treatment of people with severe disease and 
sleepiness as those who are untreated put themselves and others at risk of road traffic 
accidents. Until randomised controlled trials can establish the evidence of 
cardiovascular endpoints in patients with severe and untreated obstructive sleep 
apnoea, Pack argues all patients with severe obstructive sleep apnoea ought to be 
treated with CPAP in the interim years, regardless of whether they have excessive 
daytime sleepiness.188 
Chapter 7 key points: 
 The pictorial Sleepiness and Sleep Apnoea Scale was applied to case finding for 
obstructive sleep apnoea in 234 patients attending the sleep clinic. 
 62.4% of patients answered ‘yes’ to the witnessed apnoea pictogram and 39.3% 
of patients answered ‘yes’ to the pictogram representing high blood pressure. 
 There was a positive association between recorded BMI and how patients scored 
themselves on the body image pictogram. 
 85.5% of patients had an apnoea-hypopnoea index ≥5 events per hour, and on 
physician review of sleep studies 88.9% (209/234) of patients had evidence of 
sleep-disordered breathing. 
 49.6% (116/234) were given CPAP therapy, 21.8% (51/234) were offered other 
treatments and recommendations, and 28.6% (67/234) were discharged under 
‘no further action’.  
 Those with a positive sleep study and who received CPAP therapy had a 
significantly higher pictorial Sleepiness and Sleep Apnoea Scale score than 
those who had a positive sleep study and who didn’t receive CPAP therapy: 
17.6/32 versus 14.4/32 (p<0.001, Mann-Whitney test of medians); a higher AHI: 
40.3 events per hr versus 15.5 events per hr (p<0.001, Mann-Whitney test of 
medians); and higher ESS scores: 12.1 versus 9.5 (p<0.001, Mann-Whitney test 
of medians). 
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 Mutual-information and ROC-curve analysis showed the pictorial Sleepiness 
and Sleep Apnoea Scale had only a weak predictive power for study outcomes in 
this population. However, these associations were often statistically significant 
(that is, different from a ‘chance’ effect), and the predictive power of the pSSAS 
was generally better than the predictive power of the ESS.  
 On ROC analysis the best association was between physician opinion on 
whether the patient had sleep-disordered breathing and the pSSAS. 
 The pSSAS “witnessed apnoea” question and the ESS score were tested together 
as a case-finding tool for obstructive sleep apnoea syndrome in 101 cardiac 
prevention and rehabilitation patients. 81/101 (80.2%) patients consented to 
take part and 23/81 (28.4%) answered ‘yes’ to witnessed apnoea or had an 
elevated ESS score (≥10/24). Of these 23 selected by the case-finding tool, 12 
(52.2%) consented to have a sleep study, 6/23 (26.1%) declined and 5/23 (21.7%) 
were lost to follow up. 
 Sleep-disordered breathing was found in all 12 of those who had a sleep study, a 
positive diagnosis rate of 14.8% in the original population (12/81 patients). 
 CPAP was offered to those who were judged by the clinician to be symptomatic 
and likely to benefit from therapy (6/12 patients); a statistically significant 
difference was found between the pSSAS of the CPAP and no-CPAP groups: 
pSSAS 17.2/32 vs 11.0/32 (p=0.018, Mann-Whitney test of medians). 
 There was no statistically-significant difference between the ESS score of the 
CPAP and no-CPAP groups: ESS 9.0/24 vs 12.6/24 (p=0.159); indeed the mean 
ESS score was higher in the no-CPAP group. 
 To truly test the pSSAS tool as a case finder, an in-patient population that does 
not have such a high positive diagnosis rate of OSAS is needed. Testing the tool 
amongst a ‘sleep naïve’ group such as a primary care population would be 
helpful to measure the value of the pSSAS in population screening. 
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Chapter 8 
 
Discussion and future directions 
 
Developing pictorial tools for obstructive sleep apnoea syndrome has been an 
interesting journey. At the beginning of this thesis I set out to try and understand 
what errors people commonly made when completing the Epworth Sleepiness Scale, a 
tool used daily in sleep clinics and laboratories. The thesis ends with a trial of a new 
pictorial Sleepiness and Sleep Apnoea Scale amongst patients in the Sleep clinic and 
the case finding of cardiac rehabilitation patients using symptoms of witnessed apnoea 
and sleepiness.  
 
Over the duration of this thesis I was able to quantify some of the difficulties that 
patients had with completing the Epworth Sleepiness Scale. I found that patients 
struggled in a variety of ways: some left questions blank; some could not decide 
between points on the scoring scale and gave answers as fractions; some wanted to 
qualify responses, such as ‘I only fall asleep if the person I am talking to is boring’. 
Some did not understand the scoring system of numerically valuing the chance of 
sleepiness (from low to high chance) with a score of 0–3, instead giving ticks or writing 
‘okay’. In total a third of new users of the scale had some difficulty in completing the 
Epworth and needed assistance. Since I published these results a group in France have 
documented in 104 non–demented elderly subjects that 60% of participants missed at 
least one question from the Epworth Sleepiness Scale; despite all 104 complainants 
reporting excessive daytime sleepiness, excessive sleepiness was only reflected by the 
Epworth in a quarter of the population.201 
 
Why might patients have such difficulties? One cause I explored is that poor health 
literacy contributes to problems with completing medical forms. To investigate this, I 
evaluated literacy levels in patients using the Rapid Assessment of Adult Literacy in 
Medicine questionnaire (REALM). It was not always an easy test to administer, or for 
the patient to complete, as poor health literacy carries social stigma. Even for some of 
those who achieved perfect test scores, the testing of their literacy level was an 
uncomfortable experience and they did not want to ‘fail’ the test. Five patients changed 
their mind and declined to be tested once they realised what the test involved. The 
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results were interesting: 16% of the sleep group and 10% of the non–sleep group had 
scores equivalent to a reading age of 12–14 year olds or younger. 1.2% of sleep and 
3.3% of non–sleep patients had a reading age equivalent to a 9–12 year old child.  
 
There was sufficient motivation from these two studies to improve on the word–only 
Epworth Sleepiness Scale and produce a sleepiness scale that would be easy for all to 
use irrespective of level of literacy. I was encouraged by evidence in the literature that 
suggested combining words with pictures enhanced the transfer of medical 
information. The pictorial Epworth Sleepiness Scale that was subsequently produced 
was well received by patients and gave equivalent total sleepiness scores to the 
traditional Epworth Sleepiness Scale. 97% of people who were asked reported it was 
easy to complete and 54.9% of patients showed a preference for the pictorial Epworth 
Sleepiness Scale over the traditional Epworth Sleepiness Scale. 
 
While making these studies of how patients complete the Epworth and the pictorial 
Epworth I noticed item responses to the eight questions followed a similar pattern, 
with mean item scores falling into low, intermediate and high ranking answers. One 
question in particular, question 8 ‘in a car while stopped for a few minutes in traffic’, 
produced consistently low mean item scores in 23 different Epworth studies, 
encompassing 2802 patients. 160 It was difficult to know how to portray the sleepy 
person in question 8 as Johns has never explicitly indicated whether the sleepy person 
is the driver or a passenger in the vehicle. I tested two versions of question 8; one 
version showed a sleepy passenger image, the other showed a sleepy driver image. 
People who held a current driving licence were more likely to record feeling sleepy as a 
passenger than as a driver of the vehicle. For this reason, the sleepy person in question 
8 of the pictorial Epworth Sleepiness Scale is represented as a passenger and not the 
driver.  
 
At the time of this research, waiting time targets were introduced for NHS diagnostic 
tests. We were a busy sleep service with an increasing number of new referrals; by 
2009 referrals to the sleep service represented more than 50% of all new referrals being 
made to the Respiratory Medicine department. We were expanding into new premises 
and had streamlined the service as best we could, introducing a one–stop shop for 
diagnostic testing of obstructive sleep apnoea syndrome and CPAP provision. However, 
we still had large waits for some studies such as polysomnography and multiple sleep 
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latency tests and meeting the new targets was a challenge. At a similar time, the 
bariatric surgery clinic was co–located onto the same floor as the sleep clinic. We 
started to see an increase in referrals for pre–op sleep studies for bariatric surgery 
patients.  
 
My colleagues in the department had been developing expertise in the use of pictures 
in other areas of Respiratory Medicine and forging links with local GPs.  Asthma and 
chronic obstructive pulmonary disease action plans were being well received by local 
primary care physicians. 202 203 204 We were promoting the sleep service through local 
talks and education sessions for general practitioners to try to highlight the 
importance of an early diagnosis of obstructive sleep apnoea syndrome. We wanted to 
promote testing of the condition to help reduce the burden of disease but we had a 
potential issue with meeting the increase in demand for sleep studies. Combining 
sleepiness questions from the 8–item pictorial Epworth with pictorial questions that 
asked about risk factors in obstructive sleep apnoea syndrome seemed like an exciting 
and novel way to approach a case finding and screening problem.  
 
How successful has the pictorial Sleepiness and Sleep Apnoea Scale been at predicting 
disease? The decision to test the scale in a sleep clinic population was a practical 
choice. We had a group of people with suspected disease in whom the scale could be 
easily measured against sleep study outcomes. I did not expect that 89% of patients 
tested would have a positive outcome for problems with breathing in their sleep. This is 
rather a good result for the sleep service and its referring partners as it indicates they 
are remarkably successful at choosing who needs a sleep study! However the lack of 
patients with normal sleep studies has made it hard to fully evaluate the scale’s power 
as a case finding tool. 
 
There are clearly areas where the new scale could be improved. The question of 
witnessed apnoea was always a difficult image to portray. In the evaluation of the ease 
of use of the pictorial Sleepiness and Sleep Apnoea Scale, 12.9% of patients left this 
question blank, and in the sleep clinic study, 4.7% of respondents left this question 
blank. A statistician specialising in questionnaire design and analysis advised us 
against having ‘don’t know’ options in the questionnaire as patients can favour ‘don’t 
know’ choices even when they have a suspicion of how they would answer a binary 
question such as ‘yes’ or ‘no’ to witnessed apnoeas. Omitting a choice of ‘don’t know’ but 
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providing a scoring system for a blank answer to question 8 was one way of trying to 
address this issue of blank answers. Alternatively using the scale in an electronic 
format where respondents cannot leave questions blank is an option that some might 
prefer.  
 
In the cardiology study, all patients who completed the scales had a full set of answers. 
Witnessed apnoea was a key referral indicator. Combining the Epworth Sleepiness 
Scale with the pictorial Sleepiness and Sleep Apnoea Scale enabled the case finding for 
obstructive sleep apnoea syndrome amongst a cardiology rehabilitation population for 
two symptoms of obstructive sleep apnoea syndrome: excessive sleepiness in the 
daytime and witnessed apnoea during sleep. At the time (and possibly even now), it 
was hard to know where the threshold for referral with the pictorial Sleepiness and 
Sleep Apnoea Scale should be. Of the 23 patients who met the symptom criteria for 
referral (from the group of 81 patients screened), just over half consented to have a 
sleep study. A positive diagnosis of sleep–disordered breathing was found in all of those 
studied, which gives a prevalence of 14.8%. 13.6% (11 patients) were diagnosed with 
obstructive sleep apnoea syndrome, and 1 patient with central sleep apnoea and 6 
patients went on to treatment with CPAP therapy. The true positive diagnosis rate in 
this study was not measured as those who did not meet the criteria for testing were not 
offered a sleep study. Nevertheless, it is an important result. This study suggests a 
minimum prevalence of sleep–disordered breathing of 14.8% in a population of patients 
who are vulnerable to the effects of undiagnosed sleep apnoea. If this result is 
replicable, it would suggest that cardiac rehabilitation patients ought, as a minimum, 
to be routinely questioned about risk of obstructive sleep apnoea syndrome, and 
perhaps should all be screened for the condition.  
 
The clinicians who reviewed the cardiology patients the morning after their sleep study 
had pertinent feedback regarding the process. Not having a full sleep history in the 
medical notes (as they would for routine patients from the sleep clinic) made the 
decision of how best to treat these patients harder. Whether the lack of a sleep history 
could be rectified by allowing more time with the patient the morning after their test is 
uncertain in the current service design. Some sleep services clearly prefer the patient 
to have their sleep study first before they are seen in the sleep clinic and a good history 
from the primary referral source often helps with this. The different models reflect 
  
 189 
different clinical cultures and ways of streamlining the process from diagnosis to 
treatment for those with obstructive sleep apnoea syndrome. 
 
The cardiology nurse specialists worked hard to incorporate the study into an already 
busy and overstretched clinic. Some patients needed extra time in the clinic to help 
complete the tool and informed–consent forms. During the study I started to give a 
‘sleep–well’ talk to the cardiac rehabilitation patient groups as part of their education 
package with the aim of engaging patients, nursing and auxiliary staff (dieticians and 
exercise trainers) with the case finding programme. I continued to deliver the ‘sleep–
well’ talk long after the study had finished. Overall the sleep programme was 
favourably received by the cardiac prevention and rehabilitation team. Cardiac nurse 
specialists now deliver the ‘sleep–well’ talk to their patient group themselves. Routine 
case finding for obstructive sleep apnoea has not yet been adopted but nurse specialists 
report feeling empowered to make referrals to the sleep clinic if they suspect a patient 
of having obstructive sleep apnoea syndrome.  
 
Is just asking about sleepiness ‘good enough’ when reviewing who is at risk of 
obstructive sleep apnoea syndrome? One of the revelations for me from testing the 
pictorial Sleepiness and Sleep Apnoea Scale in the sleep clinic population was the 89% 
with positive sleep studies and the spread of subjective sleepiness scores amongst 
them. I hope I represent the clinicians with whom I worked accurately when I say they 
share the view that patients who benefit the most from CPAP therapy are those that 
are symptomatic and sleepy, as laid out in the NICE CPAP technology appraisal. When 
I reviewed those who had received CPAP therapy, the CPAP treatment group had more 
severe disease (higher mean AHIs), higher mean total pictorial Sleepiness and Sleep 
Apnoea Scale scores and higher Epworth Sleepiness Scale scores than the non–CPAP 
group. However, a significant proportion of those who received CPAP treatment had 
Epworth Sleepiness scores of less than 10/24 and some low total pictorial Sleepiness 
and Sleep Apnoea Scale scores. This suggests that either clinicians perceive the patient 
to be sleepy and this sleepiness is not reflected in the Epworth sleepiness scores, or 
that symptoms other than sleepiness are also driving the decision to treat with CPAP.  
 
Asking patients to describe what sleepiness means to them and theming these 
descriptors into those that related to mental function, physical sensation and related to 
sleep or actual sleep was an attempt to bridge the gap in knowledge between what 
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patients experience by sleepiness (and thus what we hear and observe in the clinic and 
base our judgements on) and formal sleepiness measures. Excessive sleepiness means 
different things to each of us. I am a parent of a small child who wakes in the night. I 
don’t get enough hours of sleep or enough consolidated sleep to feel routinely refreshed 
on waking.  A family member of mine who is retired complains of insomnia; they use 
the internet until 2 or 3 a.m., fall asleep in the early hours of the morning, and wake 
after midday, then repeat the same pattern the next night. We both feel excessively 
sleepy but our lifestyles and personalities dictate how we cope with our sleepiness in 
our waking hours. Subjective sleepiness scales don’t always account for these 
differences of behaviours and good sleep clinicians, who ask the right questions and 
review all the information available, are valuable barometers of excessive sleepiness 
and the context in which it occurs.  
 
The pictorial Sleepiness and Sleep Apnoea Scale might not yet be the finished article. 
Its best association (in the clinical group studied) was with a clinician’s decision on 
whether someone had sleep apnoea or not.  In a small number of patients who needed 
CPAP therapy in the cardiology pilot study, mean pictorial Sleepiness and Sleep 
Apnoea Scale scores were 5.2 points higher in the CPAP treatment group compared to 
those that didn’t receive CPAP. There was not such a significant difference for the 
Epworth Sleepiness Scale scores. I suggest that the pictorial Sleepiness and Sleep 
Apnoea Scale is better representative of a clinician’s interpretation of need for therapy 
than the Epworth Sleepiness Scale because in addition to evaluating sleepiness it also 
evaluates risk.   
 
The pictorial Epworth Sleepiness Scale is currently being used by the Department of 
Sleep Medicine, Edinburgh Royal Infirmary, in a national study examining sleep–
disordered breathing in Adults with Down’s Syndrome (who often have diminished 
literacy so easy–to–read documents combining pictorial and word formats are 
recommended). 205 This work is the PhD research of Lizzie Hill (RPSGT). The group 
have also been evaluating the pictorial Epworth Sleepiness Scale in their routine sleep 
clinic and early intimations suggest their work might strongly corroborate my own. 206 
 
In 2011 we were approached by the British Lung Foundation to use the pictorial 
Epworth Sleepiness Scale on their website as part of a national awareness campaign 
on obstructive sleep apnoea syndrome. Over an 18 month period between June 2011 
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and the end of 2012, 29,105 online pictorial Epworth Sleepiness Scales were completed; 
39% of respondents had an online pictorial Epworth Score >10/24. In collaboration with 
Dr Joerg Steier and colleagues at St Thomas’s Sleep Centre, the British Lung 
Foundation have additionally been collecting demographic data since March 2012, to 
benchmark age and gender differences in (online recording of) excessive daytime 
sleepiness using the pictorial Epworth Sleepiness Scale.207  
 
In the last month (June 2013) we have been contacted by researchers at Santosh 
Medical College and Hospital, New Delhi, India who would like to develop the pictorial 
Epworth Sleepiness Scale to include scenarios specific to an Indian population.   
 
A Swiss group based at the University of Basel have been interested in the 
development of the pictorial Sleepiness and Sleep Apnoea Scale and have been trialling 
the scale in a hospital clinic for minor (non–driving related) occupational accidents and 
in a general sleep clinic. The validation of the pictorial Sleepiness and Sleep Apnoea 
Scale in a German speaking population is the PhD research of Dr Cathrin Edelmann. 
The group have adapted the questionnaire to include a ‘don’t know’ option for question 
8 ‘witnessed apnoea’ and we are collaborating to try to optimise the scoring system by 
weighting questions.  
 
If I were asked ‘on the basis of all you have learned, how would you effectively screen 
for obstructive sleep apnoea syndrome?’ I would ask in return, ‘who do we want to 
screen?’ If I wanted to screen a population with a low risk of cardiovascular disease, 
then I might consider a two–step approach such as that used by Chai–Coetzer in 
Australia, using a questionnaire, followed by oximetry. If I wanted to screen a 
population with a history or high risk of cardiovascular disease, I would use a sleep 
questionnaire and multi-channel sleep recording; using oximetry alone risks 
intermittent dips in oxygen saturation, which might be caused by congestive heart 
failure and central sleep apnoea or respiratory disease such as COPD, being wrongly 
interpreted. I think it is essential that case finding and screening programmes are 
supported by specialist sleep centres whose brief extends beyond obstructive sleep 
apnoea syndrome. The 51 patients who did not receive CPAP therapy in the sleep clinic 
study are a good example. Those with positive studies are a heterogeneous group of 
patients. The root causes of their sleep apnoea and sleepiness are likely to be varied. 
The obstructive sleep apnoea patient who is left breathless by bending down to tie their 
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shoe laces may need a different sleep study and treatment to the man in the street who 
complains of snoring and witnessed apnoeas, or a patient who has a normal BMI but a 
recessed lower mandible.  
 
To conclude, this thesis highlights deficits in functional health literacy amongst 
patients attending a sleep clinic in a West London teaching hospital. These deficits 
may be a contributory factor to the observed frequent errors made in completing the 
traditional word-only Epworth Sleepiness Scale shown in chapter 2. To address the 
need for material that is easy to understand by all, irrespective of level of functional 
health literacy, a pictorial Epworth Sleepiness Scale has been produced. This has been 
tested against the traditional Epworth, including testing variations on the depiction of 
a sleepy passenger or sleepy driver in question 8 of the scale. The thesis has extended 
the use of pictorial scales in sleep medicine by the development of a pictorial case-
finding and screening tool: the pictorial Sleepiness and Sleep Apnoea Scale.  This 
incorporates images from the pictorial Epworth with new images representing risk 
factors for obstructive sleep apnoea syndrome. The pictorial Sleepiness and Sleep 
Apnoea tool was thoroughly tested for comprehensibility by patients. Early testing of 
the tool in a clinical context has shown differences in scores between those who were 
treated with CPAP for obstructive sleep apnoea syndrome and those who were not 
treated in both a sleep clinic population and a cardiac prevention and rehabilitation 
population. In the cardiac prevention and rehabilitation group, a minimum prevalence 
of sleep-disordered breathing of 14.8% was found, suggesting that this group of 
patients are particularly vulnerable to obstructive sleep apnoea and routine case 
finding for sleep apnoea should be considered. Cardiac patients were less sleepy than 
the sleep clinic population and the new tool may have particular value in populations 
at risk of obstructive sleep apnoea syndrome with limited daytime sleepiness. Gender 
differences were observed in the sleep-clinic population, which indicate the tool has 
stronger case-finding power in men compared to women; this finding warrants further 
exploration in future trials. Further clinical testing and refinement are needed before 
the tool is proven as a case-finding or screening tool.  
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Appendices 
 
 
Appendix 1 
 
Summary of The American Academy of Sleep Medicine (AASM), classification of the 
severity of excessive daytime sleepiness in the International classification of sleep 
disorders, revised: Diagnostic and coding manual: 208 
 
Mild sleepiness: 
Sleep episodes at times of rest or when little attention is required, lying down in a 
quiet room, watching TV or reading, being a passenger in a moving vehicle. Not 
present every day. Minor disruption of social or occupational function. 
 
Moderate sleepiness: 
Sleep episodes present daily and at times of physical activities that require at most a 
moderate degree of attention (e.g. when driving, when attending theatre or cinema). 
Moderate impairment of social or occupational function. 
 
Severe sleepiness: 
Sleep episodes present daily and at times of physical activities that require mild to 
moderate attention (e.g. eating, direct personal conversation, driving, walking or other 
physical activity). Marked impairment of social or occupational function. 
  
208 
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Appendix 2 
 
 
Estimation of the number of people with obstructive sleep apnoea syndrome in the UK. 
 
 
2011 Census Population data, United Kingdom, Office for National Statistics office 
87
 
Age  Persons Males  Females 
35 ‒ 39 4194000 2082000 2112000 
40 ‒ 44 4626000 2283000 2341000 
45 ‒ 49 4643000 2293000 2350000 
50 ‒ 54 4095000 2029000 2066000 
55 ‒ 59 3614000 1785000 1829000 
60 ‒ 64 3807000 1869000 1939000 
65 ‒ 69 3017000 1464000 1555000 
70 ‒ 74 2463000 1163000 1300000 
75 ‒ 79 2006000 904000 1102000 
80 ‒ 84 1496000 615000 883000 
85 ‒ 89 918000 324000 594000 
90 and over 476000 127000 349000 
 
35,355,000 16,938,000 18,420,000 
  
 
 
1. Estimated number of women in the UK aged 35 and over with estimated obstructive sleep 
apnoea syndrome = 2%: 
59
 
 
(18 420 000/ 100) x 2 = 368 400 women . 
 
2. Estimated number of men in the UK aged 35 and over with estimated obstructive sleep 
apnoea syndrome = 4%:
59
 
 
(16 938 000 / 100) x 4 = 677 520 men . 
 
3. Total number of people in the UK aged 35 and over with estimated obstructive sleep apnoea 
syndrome: 
368 400 + 677520 = 1 045 920 people . 
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Appendix 3 
 
 
Mean item scores and SD for pictorial Epworth Sleepiness Scales (pESS) and 
traditional Epworth Sleepiness Scales (ESS) from chapter 4. Study numbers combined. 
 
  
Pictorial Epworth Sleepiness Scale, Sleep group n = 175 
pESS q1 q2 q3 q4 q5 q6 q7 q8 
Mean 1.42 1.66 1.18 1.22 2.33 0.36 1.38 0.37 
SD 1.00 0.89 0.93 1.08 0.81 0.68 1.02 0.78 
Rank 
low to high 6 7 3 4 8 1 5 2 
 
 
Pictorial Epworth Sleepiness Scale, Lung function group n = 106 
pESS q1 q2 q3 q4 q5 q6 q7 q8 
Mean 0.82 1.25 0.67 0.90 1.96 0.16 0.77 0.17 
SD 0.84 1.04 0.80 1.00 1.02 0.48 0.93 0.49 
Rank 
low to high 6 7 3 4 8 1 5 2 
 
 
Epworth Sleepiness Scale, Sleep group n = 176 
ESS q1 q2 q3 q4 q5 q6 q7 q8 
Mean 1.35 1.65 1.10 1.21 2.38 0.38 1.46 0.28 
SD 0.95 0.88 0.94 1.12 0.84 0.63 0.93 0.63 
Rank 
low to high 5 7 3 4 8 2 6 1 
 
Epworth Sleepiness Scale, Lung function group n = 106 
ESS 1 2 3 4 5 6 7 8 
Mean 0.87 1.16 0.67 0.81 1.86 0.17 0.89 0.12 
SD 0.87 0.99 0.75 0.91 1.01 0.49 0.98 0.38 
Rank 
low to high 5 7 3 4 8 2 6 1 
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Appendix 4 
 
 
Figures A4.1 – A.4.7 examples of pictograms that were considered during the 
development of images for the pictorial Sleepiness and Sleep Apnoea Scale (following 
the first round of guessability and translucency testing, chapter 4), but not used in the 
final scale.  
 
Figure A4.1. The electronic blood pressure machine in the four options for blood 
pressure, plus a small image of the old mercury sphygmomanometer to aid 
comprehensibility. Ultimately the additional image was thought too confusing and 
removed. 
 
 
 
Figure A4.2. Electronic blood pressure machine images, with the text ‘OK’ written 
alongside the first two images in the sequence. No text was used in the final images. 
 
 
 
 
Figures A4.3, A4.4 and A4.5. Witnessed apnoea images, experimenting with the size of 
the image on the left representing the ‘the bed partner and the person with query 
apnoea during sleep’. Image A4.4 contains additional ‘bed partner’ images over each 
‘breathing / not breathing during sleep’ image. Image A4.5 places a box around the 
‘breathing during sleep images’. 
 
A4.3. 
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A4.4. 
 
 
 
A4.5. 
 
 
 
 
Figure A4.6. Witness apnoea image: a similar image to this was used in the final scale. 
Here there are additional ‘bed partner’ images looking over the ‘breathing during sleep’ 
image and the ‘apnoea’ image. 
 
 
 
Figure A4.7. Witnessed apnoea image: a similar image to this was used in the final 
scale. In this image there is no image on the left of a ‘bed partner watching the person 
breathing during sleep’.  
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Appendix 5 
 
The instruction sheet for the Hong–Kong and Pakistan study groups – guessability and 
translucency testing of pictograms for the pictorial Sleepiness and Sleep Apnoea Scale 
– including example guessability and translucency questionnaires and patient study 
sheet. 
 
 
Completion of the questionnaires takes on average 30 minutes per patient. However, some patients 
may need longer. Each pack contains: 
1. Patient study sheet 
2. Guessability Questionnaire 
3. Translucency Questionnaire 
4. Charing Cross Pictorial Sleep Apnoea Scale 
5. Epworth Sleepiness Scale 
 
Step 1 – Recruitment 
Patients are eligible to take part if: 
 They are attending a clinic and have been diagnosed with or are suspected of having 
obstructive sleep apnoea. 
 
 Patients must be 18 years or over and may be female or male. 
 
 Patients should preferably not be English speakers. If an English speaker please indicate on 
the Patient Study Sheet. 
 
 Patients must be visually sighted in order to look at the pictograms. 
 
Step 2 – Information given to the patient. 
Enclosed are two information sheets: 
 Information sheet 1 – brief overview of the study. 
 Information sheet 2 – more detailed explanation of the study. 
 
You may want to translate these sheets for the patient and verbally explain to them the information 
they contain. 
 To avoid biasing the answers when testing pictograms, I try not to give more information 
than that provided on the information sheets. 
 
Step 3 – If the patient is happy to participate in the study I ask them to sign a consent form. 
Enclosed is a consent form which you are welcome to translate and use, if this is necessary at The 
Chinese University of Hong Kong 
 
Step 4 – Testing the pictograms. 
We are using two methods of testing our pictograms: 
1. Guessability – where the participant is asked to guess the meaning of a picture or 
sequence of pictures and write their definition under the picture. See appendix a. for an 
example. 
 
2. Translucency – where the participant is given a picture or sequence of pictures plus the 
written meaning of the picture and is asked to score the relationship between the picture and 
the word, on a score of 1–7, with ‘1’ for poor and ‘7’ for a good relationship between picture 
and word. See appendix b. for an example. 
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Guessability testing has one test picture on the front cover. 
Translucency testing has one test picture on the front cover and five practice symbols before the 
sleep pictograms. 
 
Start with the Guessability questionnaire. 
 
1. Sit with the patient and use the front cover to explain what the patient has to do.  
2. Be available to answer questions as they arise. There are no right or wrong answers. 
3. Reassure patients to say what they best think describes the picture or sequence of pictures. 
4. Write the answer in the same words used by the patient (but in English). The instructions 
say to write one or two words but for many of these pictograms a short sentence or two is 
sometimes more appropriate. 
5. Once the questionnaire is finished, check that all questions have been answered. 
6. Fill in the demographic details for the patient at the bottom of the page, including education 
details. 
7. The age left school should be recorded as age leaving secondary or equivalent schooling. If 
the person went onto university this is recorded separately. 
8. Go onto the translucency questionnaire. 
 
Follow with the Translucency questionnaire. 
 
1. Sit with the patient and use the front cover to explain what the patient has to do. 
2. Go through the five practice symbols, circling the number which the patient thinks best 
describes the relationship. 
3. Check that the patient understands that ‘1’ is a poor relationship and ‘7’ depicts a good 
relationship between picture and word. 
4. Go through the rest of the questionnaire. 
5. Patients may comment that they gave different answers in the first questionnaire. 
Reassure them that this is ok. There are no right or wrong answers. Encourage them to 
try and avoid comparing their answers given in the Guessability questionnaire and 
concentrate on scoring the picture with the written meaning given here. 
6. Once finished, check that all questions have been answered. 
 
Go on to the Charing Cross Pictorial Sleep Apnoea Scale. 
1. Explain that this questionnaire uses the pictures they have been looking at to try and 
describe themselves. 
2. Page 1 describes falling asleep in four different scenarios and page 2 is about perceived 
body size, neck size, blood pressure and witnessed apnoea. 
3. Go through the questionnaire with the patient. On page 1 ask them to tick one picture in 
each scenario that best describes them. They may feel this is difficult to do or feel that 
sleepiness varies with time of day. Acknowledge this and repeat that they must try to 
identify which pictures describe them best overall.  
4. They must tick only one picture in each scenario. 
5. Repeat steps 3 and 4 for page 2. 
 
Finish with the Epworth Sleepiness Score (ESS). 
 Complete this written sleepiness questionnaire with the patient last of all. 
 Record at the bottom of the questionnaire whether the patient has ever filled in 
an ESS before or whether they are Epworth naïve. 
 
Record any observations or problems encountered on the Patient Study Sheet provided 
(example shown below): 
 Fill in a separate sheet for each patient.  
 Allocate each patient a study number, using the letters HKONG before the number e.g. 
HKONG # 1, HKONG # 2 etc. 
 Label all paperwork and questionnaires with the study number. 
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Example of the patient study sheet                                                                                             
Please circle 
Does the patient speak English?:                                                                                                     
Yes / No   
 
mother tongue:  
 
Please state here any difficulties you had using any of the questionnaires: 
Please circle 
1. Guessability:                                                                                                                               
Yes  /  No 
If yes please provide details below  
 
2. Translucency:                                                                                                                              
Yes  /  No  
If yes please provide details below  
 
3. Charing Cross Pictorial Sleep Apnoea Scale                                                                              
Yes  /  No  
If yes please provide details below  
4. Epworth Sleepiness Score:                                                                                                      
Yes  /  No  
If yes please provide details below  
 
Please add any further comments you wish to below:                                                                
Thank you                    
 
 
 
 
Thank you for following these instructions. 
 
Following these instructions means we can minimise the inter–tester differences and bias to 
answers between the two countries. 
 
If there are any particular difficulties that you have found with a patient or if you have more general 
questions regarding the questionnaires please do not hesitate to contact me: 
r.ghiassi@imperial.ac.uk . 
 
 
With thanks, 
 
Ramesh  
 
Ramesh Ghiassi and Professor Martyn Partridge, 
Imperial College London
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(Example Guessabilty and Translucency documents sent to the Pakistan and Hong–Kong study groups.) 
 
Instruction cover sheet, followed by an example of a completed guessability questionnaire page 
Pictogram assessment questionnaire 1 
 
Guessability test instructions: please write one or two words on the line below each picture or sequence that you feel best 
describes the meaning of the symbols. 
 
 
     For example, if you think this symbol represents daytime, write the word ‘daytime’ on the dotted line, as below: 
 
 
 
daytime 
 
 
Do the same for all the symbols on the following pages.  Try not to leave any blanks; always have a go at guessing the 
meaning.  Do not refer back to earlier symbols once you have completed a page.  At the end, please fill in the demographic 
detail questions.   
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Example page from the Guessability questionnaire 
 
 
1. What does this sequence mean? 
        People with different size necks 
 
 
 
2. What do each of these images mean? 
 Taking blood pressure ok, blood pressure ok with 
tablets,  
                                                                                                                                          blood pressure high, don’t know my blood pressure 
 
 
3. What does this sequence mean? 
      People with different body sizes, some thin, some 
                                                                                                                                       fat 
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Instruction cover sheet, followed by an example of a completed translucency questionnaire page 
 
Pictogram assessment questionnaire 2 
 
Translucency Test Instructions 
 
You will see a series of symbols and their corresponding word meanings.  Please rate how closely the symbol and its word 
meaning are related.  A rating of 1 indicates there is no relationship between the symbol and its meaning.  A rating of 7 indicates a 
very strong relationship.  The numbers 2–6 indicate some degree of relationship between ‘none’ and ‘very strong’.  There is no 
correct or incorrect response. 
 
For example:   
 
  daytime 
 
Do the same for all the symbols on the following pages.  Try not to leave any blanks; always have a go at rating your choice.  Do 
not refer back to earlier symbols once you have completed a page.  At the end, please fill in the demographic detail questions.   
 
  
 
 no relationship 1 2 3 4 5 6 7       very strong relationship 
PKSTN # 
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Example page from the Translucency questionnaire 
 
 
 
 
 People of increasing body size 
   no relationship 1 2 3 4 5 6 7       very strong relationship                   
                                                            
 
 
 
 
People of increasing neck size 
                                                                                               
                                     no relationship 1 2 3 4 5 6 7       very strong relationship                    
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Appendix 6 
 
Labelling descriptors of sleepiness  (Study 4, Chapter 5) into mental function (M), 
physical sensation (P) and related to sleep or actual sleep (S). Scored by three 
individuals (scorer 1, 2, & 3), plus an independent academic referee (r) who helped to 
theme answers. Where the scorer was unsure of a category, a question mark (?) was 
used or the scorer gave a mixed answer, e.g. M/P (number of patients=24). 
                      
S
u
b
je
ct 
 
sco
re
r  1
 
sco
re
r  2
 
sco
re
r  3
 
A
ca
d
e
m
ic 
re
fe
re
e
 (r) 
1 
I'm not sleepy normally but I am often tired   
 
I generally feel tired which is cured by coffee    
 
P 
 
P 
P 
 
P 
P 
 
P 
P 
 
P 
2 
Lethargic     
 
leave me alone    
 
can't be bothered    
 
P 
 
M 
 
M 
M 
 
M 
 
M 
P 
 
M 
 
M 
M 
 
M 
 
M 
3 
Tired    
 
Fatigued   
 
drained (but don't feel sleepiness) after a long day at work on the train 
home   
 
P 
 
P 
 
P 
P 
 
P 
 
P 
P 
 
P 
 
P 
P 
 
P 
 
P 
4 
Knackered     
 
cream–crackered    
 
P 
 
P 
P 
 
P 
P 
 
P 
P 
 
P 
5 
Makes me tired   
 
slowing down   
 
dizziness  
 
short of breath   
 
sweating   
 
like an emptiness  
 
my wife says go upstairs and have a rest   
 
Sleeping like standing   
 
I like reading but I don't do it anymore.   
 
P 
 
M 
 
M 
 
P 
 
P 
 
M 
 
S 
 
S 
 
M 
P 
 
P 
 
P 
 
P 
 
P 
 
M 
 
P 
 
S 
 
S 
P 
 
P 
 
P 
 
P 
 
P 
 
P? 
 
S? 
 
S 
 
M 
P 
 
M 
 
P 
 
P 
 
P 
 
M 
 
S 
 
S 
 
M 
6 
I yawn (yawning throughout the day) a lot throughout most days   
 
Early evening heavy sleepiness   
 
P 
 
S 
 
S 
 
S 
 
P 
 
S 
 
P 
 
S 
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I drink coffee in the morning – not having coffee makes me feel sleepy   
 
S S S S 
7 
I am tired, knackered   
 
I am really knackered   
 
P 
 
P 
S 
 
S 
P 
 
P 
P 
 
P 
8 
It's the impact of sleepiness   
 
I know that I'm tired   
 
 
I feel it makes things more difficult like going to the cinema  
 
 
I always fall asleep in the cinema  
 
More likely to fall asleep watching TV I find that frustrating  
 
 
It stops me doing what I want to do. I've run out of energy   
 
 
There is the good side – I always fall asleep before take–off on long 
haul flights   
 
P 
 
M/P 
 
 
P 
 
 
S 
 
S 
 
 
P 
 
 
S 
S 
 
P 
 
 
S 
 
 
S 
 
S 
 
 
P 
 
 
S 
 
 
S 
 
P 
 
 
P/M
? 
 
S 
 
S 
 
 
P 
 
 
S 
S 
 
P 
 
 
P 
 
 
S 
 
S 
 
 
P 
 
 
S 
 
 
9 
2–3 days of the week I'm not with it   
 
Last 2–3 years difficult to work because of daytime sleepiness and 
migraine   
 
Just not switched on   
 
Occasionally I have a day when I am the old me, but mostly I have no 
energy   
 
Days when I have complete lethargy – beyond sleepiness   
 
 
Even moving about is exhausting   
 
M 
 
S 
 
 
M 
 
P 
 
 
P 
 
 
P 
M 
 
M 
 
 
M 
 
S 
 
 
M 
 
 
P 
 
M 
 
S 
 
 
M 
 
P 
 
 
S 
 
 
P 
M 
 
S 
 
 
M 
 
P 
 
 
P 
 
 
P 
10 
very strong sense of heaviness    
 
get to the point it is out of control   
 
Collapsing – you can't control it   
 
This sense of heavy  / not controlling my head   
 
just collapsing into sleep   
 
It feels like you can't control it   
 
If I do a big car journey I have to stop and rest. If I am at home, I can 
go to sleep   
P 
 
S 
 
S 
 
P 
 
S 
 
S 
 
S 
M 
 
M 
 
S 
 
S 
 
S 
 
S 
 
S 
P 
 
? 
 
P 
 
P 
 
S 
 
S? 
 
S 
P 
 
S 
 
S 
 
S 
 
S 
 
S 
 
S 
11 
overwhelming sense of heavy eyes   
 
mugginess   
 
I find myself nodding off (demonstrates)    
 
micro–naps can be refreshing   
 
S 
 
M 
 
S 
 
S 
S 
 
M 
 
S 
 
S 
S 
 
M 
 
S 
 
S 
S 
 
M 
 
S 
 
S 
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12 
Drowsy   
 
Heavy   
 
Lethargic   
 
slow thinking   
 
uneasy and out of kilter   
 
something wrong with reflexes   
 
inattentive   
 
irritable   
 
dull as in shines gone off    
 
Slow to comprehend   
 
Loss of listening   
 
Less concentration    
 
less motivated  
 
S 
 
P 
 
P 
 
M 
 
M 
 
P 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
S 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
S 
 
P 
 
P 
 
M 
 
M 
 
P 
 
M 
 
M 
 
M? 
 
M 
 
M 
 
M 
 
M 
S 
 
P 
 
P 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
 
M 
13 
Lethargy    
 
my head feels funny    
 
Tired  
 
Eyes feel heavy 
 
Not as sharp as I should be   
 
P 
 
M 
 
P 
 
S 
 
M 
M 
 
M 
 
P 
 
S 
 
M 
P 
 
P 
 
P 
 
S 
 
M 
P 
 
M 
 
P 
 
S 
 
M 
14 
Annoying    
 
Debilitating   
 
can't stay awake at work   
 
worse  on buses / car   
 
Can't keep eyes open   
 
I am fine talking to someone    
 
If somewhere quiet / moving, I fall asleep    
 
M 
 
P 
 
S 
 
S 
 
S 
 
? 
 
S 
M 
 
M 
 
S 
 
S 
 
S 
 
S 
 
S 
? 
 
P 
 
S 
 
S? 
 
S 
 
? 
 
S 
M 
 
P 
 
S 
 
S 
 
S 
 
S 
 
S 
 
15 
Every day is the same I go to bed early because I am tired, lie down 
but can't sleep 
 
fall asleep and can't breathe 
 
choking   
 
My head goes screwy – I have headaches  
 
I need to get some sleep  
  
I am really tired   
 
If I travel somewhere I fall asleep on the bus, travelling, going on the 
computer   
 
going to the library I definitely fall asleep, librarian has to wake me up   
S 
 
 
S 
 
? 
 
M 
 
S 
 
P 
 
S 
 
 
S 
M 
 
 
P 
 
P 
 
P 
 
S 
 
P 
 
S 
 
 
S 
P 
 
 
P 
 
P 
 
M 
 
S 
 
P 
 
S 
 
 
S 
M 
 
 
P 
 
P 
 
M 
 
S 
 
P 
 
S 
 
 
S 
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I fight the sleepiness   
 
S 
 
S 
 
 
S 
 
S 
16 
Feel tired   
 
Shattered  
 
Knackered   
 
Ready for the knackers yard   
 
P 
 
P 
 
P 
 
P 
M 
 
M 
 
M 
 
M 
P 
 
P 
 
P 
 
P 
P 
 
P 
 
P 
 
P 
17 
I find myself sleeping at work it is really embarrassing   
 
I've really slowed down   
 
Tired 
 
 depressed 
 
 just not wanting to do anything    
 
I've become boring because sometimes I sleep when my wife talks to 
me   
 
I need some extra stimulants, something to get me going  
 
I'd like to be able to do more   
 
It's costing me because I pay other people to do things I could do, like 
fixing the plumbing, boiler pressure etc.   
 
S 
 
P 
 
P 
 
M 
 
M 
 
S 
 
 
P 
 
P 
 
P 
S 
 
M 
 
M 
 
M 
 
M 
 
S 
 
 
M 
 
P 
 
P 
 
S 
 
P/M 
 
P 
 
M 
 
M 
 
S 
 
 
P 
 
P 
 
P 
S 
 
P 
 
P 
 
M 
 
M 
 
S 
 
 
P 
 
P 
 
P 
18 
I'm in a position of authority – I don't like to be seen falling asleep    
  
I get in the car drive around the corner where no one can see me and 
sleep for half an hour   
 
It is embarrassing when it happens with the clients   
 
You just can't help it   
S 
 
S 
 
 
M 
 
S 
S 
 
S 
 
 
S 
 
S 
S 
 
S 
 
 
S? 
 
S? 
S 
 
S 
 
 
S 
 
S 
19 
When I'm relaxing that's when it gets me the most  
 
As soon as I start to relax, that's when I get too relaxed   
 
Uncontrolled    
 
Different to normal tiredness    
 
Like having a general anaesthetic and trying to keep awake when 
getting to  a stage    
 
uncontrolled tiredness     
 
back of the mind and washing over me   
 
S 
 
S 
 
S 
 
P 
 
S 
 
 
P 
 
M 
S 
 
S 
 
S 
 
S 
 
S 
 
 
S 
 
S 
 
S? 
 
S/P? 
 
S/P? 
 
P 
 
  S 
 
 
P 
 
M 
S 
 
S 
 
S 
 
P 
 
S 
 
 
P 
 
S 
20 
Feel tired   
 
eyes heavy    
 
can't concentrate  
 
neck falls down  
 
get irritated   
  
lose temper   
P 
 
S 
 
M 
 
P 
 
M 
 
M 
S 
 
S 
 
M 
 
S 
 
M 
 
M 
P 
 
S 
 
M 
 
P 
 
M 
 
M 
P 
 
S 
 
M 
 
S 
 
M 
 
M 
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21 
Like my efficiency can't do job / work, up to required level  
 
feel down 
 
feel dizzy  
 
natural talents gone  
 
(2–3 years sleepiness but used to napping 'siesta' in the afternoon in 
Dubai)  
 
P 
 
M 
 
 
P 
 
M 
 
S 
M 
 
M 
 
 
P 
 
M 
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like I'm shutting down       
 
can't concentrate      
 
mind drifting    
 
head's dropping     
 
switched off    
 
P 
 
M 
 
M 
 
P 
 
M 
S 
 
S 
 
M 
 
S 
 
M 
P 
 
M 
 
 M 
 
S 
 
M 
P 
 
M 
 
 M 
 
S 
 
M 
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I am tired    
 
I definitely will fall asleep   
 
I always say I'm tired and sleepy   
 
If I get adequate sleep then in the morning I am fine but always nod 
off in the afternoon   
P 
 
S 
 
P 
 
S 
P 
 
S 
 
S 
 
S 
P 
 
S 
 
S 
 
S 
 
P 
 
S 
 
S 
 
S 
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can't even sit watch TV, I start a programme then on and off, not 
aware of the programme  
 
Sit in the room and snore    
 
When I go in a meeting I feel sleepy, I try hard to keep awake   
 
I don't feel sleepy when I do things like DIY or work, only when I sit   
 
S 
 
S 
 
S 
 
 
S 
S 
 
S 
 
S 
 
 
S 
M 
 
S 
 
S 
 
 
S 
S 
 
S 
 
S 
 
 
S 
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Appendix 7 
 
 
Respiratory scoring rules 
Summary of respiratory scoring rules adapted from the American Association of Sleep 
Medicine Manual for Scoring Sleep, 2007. 26  
 
Scoring of Apnoeas:  
1) A drop in the nasal pressure signal to ≤10 % the baseline amplitude. 
 
2) The event lasts for ≥ 10 seconds. 
 
The event duration is measured from the nadir of the preceding breath that is clearly 
reduced to the beginning of the first breath that represents baseline breathing 
amplitude. 
 
3) At least 90% of the event duration meets the amplitude reduction criteria. 
 
 
A classification of apnoeas as obstructive 
The apnoea meets the above criteria and is associated with continued or increased 
inspiratory effort, throughout the period of reduced airflow. 
 
Scoring of Hypopnoeas:  
1) The nasal pressure signal drops to ≤ 50% of the baseline amplitude. 
 
2) The event lasts ≥ 10 seconds. 
 
3) The event is essentially accompanied by a ≥ 4% desaturation in the SaO2 or an 
associated arousal. 
 
Scoring Oxygen Desaturations 
1) A drop in saturation ≥ 4% from the baseline. 
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Appendix 8 
 
 
 
Additional figures and tables relating the Chapter 7, sleep clinic study. 
 
 
   
Figure A8.1. Age correlations with a) apnoea–hypopnoea and b) oxygen desaturation 
indices (AHI and ODI) 
a      b  
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Figure A8.2. Gender ROC curves for the pictorial Sleepiness and Sleep Apnoea Scale 
and apnoea–hypopnoea index: a) AHI ≥ 5 events per hour, b) AHI ≥ 15 events per hour 
and c) AHI ≥ 30 events per hour; x axis = sensitivity, y axis = 1 – specificity. 
     
a. AHI ≥ 5 events per hour   b. AHI ≥ 15 events per hour 
                        
c. AHI ≥ 30 events per hour  
 
 
 
The areas under the curve (and p-values) are as follows: 
 
Gender Female (N=71): 
(a) Area =   0.566 (p = 0.227) 
(b) Area =   0.617 (p = 0.044) 
(c) Area =   0.550 (p = 0.264) 
 
Gender Male (N=163): 
(a) Area =   0.568 (p = 0.152) 
(b) Area =   0.630 (p = 0.002) 
(c) Area =   0.623 (p = 0.005)  
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Figure A8.3. Gender ROC curves for the pictorial Sleepiness and Sleep Apnoea Scale 
and oxygen desaturation index: a) ODI ≥ 5 events per hour, b) ODI ≥ 15 events per 
hour and c) ODI ≥ 30 events per hour; x axis = sensitivity, y axis = 1 – specificity. 
a. ODI ≥ 5 events per hour      b. ODI ≥ 15 events per hour  
                    
c. ODI ≥ 30 events per hour  
 
 
The areas under the curve (and p-values) are as follows: 
 
Gender Female (N=69): 
(a) Area =   0.546 (p =  0.273) 
(b) Area =   0.586 (p =  0.118) 
(c) Area =   0.638 (p =  0.065) 
 
Gender Male (N=159): 
(a) Area =   0.653 (p < 0.001) 
(b) Area =   0.664 (p < 0.001) 
(c) Area =   0.693 (p < 0.001) 
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Figure A8.4. Gender ROC curves for the pictorial Sleepiness and Sleep Apnoea Scale 
and supine apnoea–hypopnoea index: a) supine AHI ≥ 5 events per hour, b) supine AHI 
≥ 15 events per hour and c) supine AHI ≥ 30 events per hour;                                           
x axis = sensitivity, y axis = 1 – specificity. 
a. Supine AHI ≥ 5 events per hour  b. Supine AHI ≥ 15 events per hour 
 
                  
c. Supine AHI ≥ 30 events per hour 
 
 
The areas under the curve (and p-values) are as follows: 
 
Gender Female (N=67): 
(a) Area =   0.367 (p =  0.939) 
(b) Area =   0.539 (p =  0.293) 
(c) Area =   0.536 (p =  0.309) 
 
Gender Male (N=161): 
(a) Area =   0.666 (p =  0.021) 
(b) Area =   0.582 (p =  0.056) 
(c) Area =   0.597 (p =  0.017) 
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Figure A8.5. Gender ROC curves for the pictorial Sleepiness and Sleep Apnoea Scale 
and decision to treat with CPAP; x axis = sensitivity, y axis = 1 – specificity. 
 
   
 
 
Figure A8.6. Gender ROC curves for the pictorial Sleepiness and Sleep Apnoea Scale 
and clinician’s decision of obstructive sleep apnoea following sleep study,                       
x axis = sensitivity, y axis = 1 – specificity. 
 
  
The areas under the curve (and p-values) are 
as follows: 
 
Female (N=71): 
Area = 0.644 (p =  0.019). 
 
Male (N=163): 
Area = 0.674 (p <  0.001). 
The areas under the curve (and p-values) are 
as follows: 
 
Female (N=71): 
Area = 0.557 (p = 0.290). 
 
Male (N=163): 
Area = 0.693 (p =  0.004). 
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Table A8.1. The sensitivity and specificity of predicting apnoea–hypopnoea index (AHI) 
severity: condition 1 AHI ≥ 5 events per hour, condition 2 AHI ≥ 15 events per hour and 
condition 3 AHI ≥ 30 events per hour for the pictorial Sleepiness and Sleep Apnoea 
scale at each threshold for total score. 
 
 
condition 1 condition 2 condition 3 
threshold sensitivity specificity sensitivity specificity sensitivity specificity 
0 100.0 0.0 100.0 0.0 100.0 0.0 
1 100.0 0.0 100.0 0.0 100.0 0.0 
2 100.0 0.0 100.0 0.0 100.0 0.0 
3 99.5 0.0 100.0 1.0 100.0 0.6 
4 98.5 0.0 99.2 1.9 100.0 1.9 
5 97.0 0.0 98.5 3.9 98.7 3.2 
6 95.0 0.0 96.9 5.8 97.4 5.1 
7 94.5 2.9 96.9 7.8 97.4 6.4 
8 93.0 5.9 96.2 10.7 96.1 8.3 
9 89.5 17.6 93.9 18.4 94.8 14.6 
10 84.5 20.6 89.3 23.3 88.3 18.5 
11 80.0 29.4 86.3 31.1 85.7 24.8 
12 77.0 41.2 83.2 36.9 83.1 29.9 
13 70.5 44.1 77.1 42.7 77.9 36.3 
14 65.5 52.9 71.0 47.6 70.1 40.8 
15 60.0 55.9 64.9 51.5 64.9 45.9 
16 51.5 58.8 57.3 59.2 57.1 53.5 
17 45.5 58.8 53.4 66.0 53.2 59.2 
18 40.0 64.7 47.3 70.9 48.1 65.0 
19 35.0 70.6 41.2 74.8 48.1 72.6 
20 30.0 79.4 35.1 79.6 41.6 77.7 
21 23.5 82.4 27.5 83.5 31.2 81.5 
22 18.0 85.3 19.8 85.4 23.4 85.4 
23 15.5 85.3 17.6 87.4 20.8 87.3 
24 13.5 88.2 16.8 91.3 19.5 89.8 
25 8.5 91.2 10.7 94.2 13.0 93.6 
26 7.0 94.1 9.2 96.1 11.7 95.5 
27 5.0 97.1 6.1 97.1 6.5 96.2 
28 3.5 97.1 5.3 99.0 5.2 97.5 
29 2.0 100.0 3.1 100.0 5.2 100.0 
30 0.5 100.0 0.8 100.0 1.3 100.0 
31 0.5 100.0 0.8 100.0 1.3 100.0 
32 0.5 100.0 0.8 100.0 1.3 100.0 
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Table A8.2. The sensitivity and specificity of predicting oxygen desaturation index 
(ODI) severity: condition 1 ODI ≥ 5 events per hour, condition 2 ODI ≥ 15 events per 
hour and condition 3 ODI ≥ 30 events per hour for the pictorial Sleepiness and Sleep 
Apnoea scale at each threshold for total score. 
 
condition 1 condition 2 condition 3 
threshold sensitivity specificity sensitivity specificity sensitivity specificity 
0 100.0 0.0 100.0 0.0 100.0 0.0 
1 100.0 0.0 100.0 0.0 100.0 0.0 
2 100.0 0.0 100.0 0.0 100.0 0.0 
3 100.0 1.3 100.0 0.7 100.0 0.6 
4 99.3 2.6 100.0 2.2 100.0 1.7 
5 98.0 3.9 100.0 4.5 100.0 3.4 
6 95.4 3.9 97.9 6.0 100.0 5.7 
7 94.7 5.2 97.9 7.5 100.0 6.9 
8 93.4 7.8 96.8 9.7 98.1 8.6 
9 92.1 18.2 95.7 16.4 96.3 13.8 
10 86.8 22.1 92.6 22.4 94.4 19.5 
11 84.1 31.2 90.4 29.1 92.6 25.3 
12 81.5 39.0 87.2 34.3 88.9 29.9 
13 74.8 44.2 80.9 40.3 87.0 37.4 
14 70.2 50.6 75.5 45.5 79.6 42.0 
15 62.3 50.6 70.2 50.7 77.8 48.3 
16 55.6 59.7 59.6 56.0 68.5 55.2 
17 51.0 66.2 56.4 62.7 68.5 62.1 
18 45.7 72.7 48.9 67.2 61.1 67.2 
19 40.4 76.6 45.7 73.1 55.6 71.8 
20 34.4 80.5 40.4 78.4 50.0 77.0 
21 27.2 84.4 31.9 82.8 40.7 82.2 
22 21.2 88.3 23.4 85.8 27.8 85.1 
23 18.5 89.6 20.2 87.3 24.1 86.8 
24 15.9 90.9 19.1 90.3 22.2 89.1 
25 11.3 96.1 11.7 93.3 14.8 93.1 
26 9.3 97.4 9.6 94.8 13.0 94.8 
27 6.0 97.4 5.3 95.5 7.4 96.0 
28 4.6 98.7 4.3 97.0 5.6 97.1 
29 2.6 100.0 4.3 100.0 5.6 99.4 
30 0.7 100.0 1.1 100.0 1.9 100.0 
31 0.7 100.0 1.1 100.0 1.9 100.0 
32 0.7 100.0 1.1 100.0 1.9 100.0 
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Table A8.3. The sensitivity and specificity of predicting decision to treat with CPAP 
therapy (condition 1) for the pictorial Sleepiness and Sleep Apnoea scale at each 
threshold for total score. 
 
 
condition 1 
threshold sensitivity specificity 
     0 100.0 0.0 
1 100.0 0.0 
2 100.0 0.0 
3 100.0 0.8 
4 100.0 2.5 
5 99.1 4.2 
6 98.3 6.8 
7 97.4 7.6 
8 95.7 9.3 
9 94.0 16.9 
10 90.5 22.9 
11 87.9 30.5 
12 86.2 37.3 
13 78.4 41.5 
14 76.7 50.8 
15 69.0 53.4 
16 60.3 60.2 
17 56.9 66.9 
18 51.7 72.9 
19 44.8 76.3 
20 39.7 82.2 
21 31.0 85.6 
22 24.1 89.0 
23 21.6 90.7 
24 19.0 92.4 
25 12.1 94.9 
26 10.3 96.6 
27 6.9 97.5 
28 5.2 98.3 
29 3.4 100.0 
30 0.9 100.0 
31 0.9 100.0 
32 0.9 100.0 
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Table A8.4. The sensitivity and specificity of predicting clinician decision of obstructive 
sleep apnoea ‘yes’ , or  ‘no’ following sleep study for the pictorial Sleepiness and Sleep 
Apnoea scale at each threshold for total score. 
 
 
condition 1 
threshold sensitivity specificity 
0 100.0 0.0 
1 100.0 0.0 
2 100.0 0.0 
3 99.5 0.0 
4 98.6 0.0 
5 97.1 0.0 
6 95.2 0.0 
7 94.7 3.8 
8 92.8 3.8 
9 89.4 19.2 
10 84.6 23.1 
11 80.3 34.6 
12 77.9 53.8 
13 71.6 57.7 
14 66.3 65.4 
15 60.6 65.4 
16 52.4 69.2 
17 46.6 69.2 
18 41.3 76.9 
19 36.5 84.6 
20 31.3 92.3 
21 24.5 92.3 
22 18.8 92.3 
23 16.3 92.3 
24 13.9 92.3 
25 9.1 96.2 
26 7.7 100.0 
27 5.3 100.0 
28 3.8 100.0 
29 1.9 100.0 
30 0.5 100.0 
31 0.5 100.0 
32 0.5 100.0 
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Table A8.5. The sensitivity and specificity of predicting apnoea–hypopnoea index (AHI) 
severity: condition 1 AHI ≥ 5 events per hour, condition 2 AHI ≥ 15 events per hour and 
condition 3 AHI ≥ 30 events per hour for the Epworth Sleepiness Scale at each 
threshold for total score. 
 
 
condition 1 condition 2 condition 3 
threshold sensitivity specificity sensitivity specificity sensitivity specificity 
0 100.0 0.0 100.0 0.0 100.0 0.0 
1 99.0 0.0 98.5 0.0 98.7 0.6 
2 97.5 2.9 97.7 2.9 97.4 2.5 
3 95.5 5.9 96.2 5.8 96.1 5.1 
4 92.0 5.9 92.4 7.8 90.9 7.0 
5 88.5 8.8 90.8 13.6 89.6 11.5 
6 82.0 8.8 85.5 19.4 87.0 18.5 
7 75.0 20.6 80.2 30.1 81.8 27.4 
8 71.0 23.5 74.8 32.0 77.9 31.2 
9 64.0 26.5 69.5 39.8 74.0 38.9 
10 57.0 32.4 59.5 42.7 66.2 45.2 
11 50.0 38.2 51.1 47.6 58.4 51.6 
12 47.0 50.0 49.6 55.3 57.1 57.3 
13 41.0 52.9 42.7 59.2 50.6 62.4 
14 32.0 64.7 32.8 68.0 37.7 70.1 
15 25.0 70.6 26.7 75.7 29.9 76.4 
16 20.0 85.3 22.9 85.4 26.0 84.1 
17 15.0 97.1 16.8 91.3 19.5 89.8 
18 11.5 97.1 12.2 92.2 15.6 92.4 
19 9.0 97.1 9.9 94.2 13.0 94.3 
20 6.0 100.0 6.9 97.1 10.4 97.5 
21 3.0 100.0 3.1 98.1 5.2 98.7 
22 1.0 100.0 1.5 100.0 2.6 100.0 
23 0.5 100.0 0.8 100.0 1.3 100.0 
24 0.0 100.0 0.0 100.0 0.0 100.0 
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Table A8.6. The sensitivity and specificity of predicting oxygen desaturation index 
(ODI) severity: condition 1 AHI ≥ 5 events per hour, condition 2 AHI ≥ 15 events per 
hour and condition 3 AHI ≥ 30 events per hour for the Epworth Sleepiness Scale at 
each threshold for total score. 
 
 
condition 1 condition 2 condition 3 
threshold sensitivity specificity sensitivity specificity sensitivity specificity 
0 100.0 0.0 100.0 0.0 100.0 0.0 
1 99.3 0.0 98.9 0.0 98.1 0.0 
2 98.7 2.6 98.9 2.2 98.1 1.7 
3 96.7 5.2 97.9 5.2 96.3 4.0 
4 92.1 5.2 93.6 7.5 92.6 6.9 
5 89.4 10.4 92.6 12.7 92.6 11.5 
6 83.4 15.6 87.2 18.7 92.6 19.0 
7 76.8 24.7 81.9 27.6 87.0 27.0 
8 72.8 28.6 77.7 31.3 85.2 31.6 
9 66.2 35.1 73.4 39.6 79.6 38.5 
10 57.6 39.0 66.0 46.3 72.2 45.4 
11 51.0 45.5 57.4 51.5 59.3 50.0 
12 48.3 53.2 55.3 57.5 59.3 55.7 
13 41.1 54.5 47.9 61.2 51.9 60.3 
14 31.8 64.9 37.2 70.1 35.2 67.8 
15 26.5 75.3 28.7 76.1 29.6 75.3 
16 23.2 88.3 24.5 84.3 27.8 83.3 
17 16.6 92.2 19.1 90.3 20.4 88.5 
18 12.6 93.5 13.8 91.8 16.7 91.4 
19 9.9 94.8 10.6 93.3 13.0 93.1 
20 6.6 97.4 8.5 97.0 9.3 96.0 
21 3.3 98.7 4.3 98.5 5.6 98.3 
22 1.3 100.0 2.1 100.0 1.9 99.4 
23 0.7 100.0 1.1 100.0 0.0 99.4 
24 0.0 100.0 0.0 100.0 0.0 100.0 
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Table A8.7. The sensitivity and specificity of predicting decision to treat with CPAP 
therapy (condition 1) for the Epworth Sleepiness Scale at each threshold for total score. 
 
condition 1 
threshold sensitivity specificity 
0 100.0 0.0 
1 98.3 0.0 
2 98.3 3.4 
3 97.4 6.8 
4 94.8 10.2 
5 92.2 14.4 
6 87.9 21.2 
7 82.8 31.4 
8 79.3 35.6 
9 73.3 42.4 
10 65.5 48.3 
11 62.1 58.5 
12 58.6 63.6 
13 50.9 66.9 
14 41.4 76.3 
15 32.8 81.4 
16 27.6 89.0 
17 19.8 93.2 
18 15.5 94.9 
19 12.9 96.6 
20 8.6 98.3 
21 4.3 99.2 
22 1.7 100.0 
23 0.9 100.0 
24 0.0 100.0 
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Table A8.8. The sensitivity and specificity of predicting clinician decision of obstructive 
sleep apnoea ‘yes’ , or  ‘no’ following sleep study for the Epworth Sleepiness Scale  at 
each threshold for total score. 
 
 
  
 
condition 1 
threshold sensitivity specificity 
0 100.0 0.0 
1 99.0 0.0 
2 97.5 2.9 
3 95.5 5.9 
4 92.0 5.9 
5 88.5 8.8 
6 82.0 8.8 
7 75.0 20.6 
8 71.0 23.5 
9 64.0 26.5 
10 57.0 32.4 
11 50.0 38.2 
12 47.0 50.0 
13 41.0 52.9 
14 32.0 64.7 
15 25.0 70.6 
16 20.0 85.3 
17 15.0 97.1 
18 11.5 97.1 
19 9.0 97.1 
20 6.0 100.0 
21 3.0 100.0 
22 1.0 100.0 
23 0.5 100.0 
24 0.0 100.0 
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Appendix 9 
 
Permission to use figures and graphs 
 
Table A9.1. Summary of permission from the relevant authors to reproduce their figure 
or graph in this thesis. Related proof of correspondence from the authors follows the 
table. 
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1 page 29 figure 
Lancet (2005), 
365(9646): 1046-1053 
© Lancet 2005 yes yes - - 
2 page 36 map 
http://www.rightcare.nhs.
uk/atlas/ 
© Right care 2012 yes yes - - 
3 page 44 figure 
Dr John Shneerson, 
Handbook of Sleep 
Medicine (2000), 1st Ed, 
p119 
© Blackwell 
Science Ltd 2000 
yes yes - - 
4 page 54 table 
http://www.keele.ac.uk/re
search/researchnews/201
2/title,83993,en.php 
 
 © Rowlands, G, 
Protheroe, J 2012 
yes yes - - 
5 page 57 
screening 
instrument 
Family Medicine (1993) 
25(6):391-395 
© Terry Davis yes yes - - 
6 page 183 study information 
Thorax 2012;67 
(suppl.2): 262 
© Drakatos 
Panagis 
yes yes - - 
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Proof of email correspondence from authors regarding reproduction of figures and 
graphs used in this thesis. 
 
1. 
From: Ghiassi, Ramesh 
Sent: 28 March 2013 10:35 
To: jmmarint@unizar.es 
Subject: permission to reproduce a graph 
Dear Dr Marin, 
 
 
I would like to ask your permission to reproduce one of your figures in my PhD thesis:-  
 
figure 2. 'Cumulative percentage of individuals with new-fatal and non-fatal cardiovascular events' 
from your article in the Lancet, titled:  
 
'Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or 
without treatment with continuous positive airway pressure: an observational study'  
 
This would be in my PhD thesis which is titled' developing pictorial material for obstructive sleep 
apnoea syndrome' 
 
I hope this is possible and look forward to hearing from you. 
 
kind regards, 
 
Ramesh Ghiassi 
*********************************************************************************** 
 
From: jose maria marin trigo [jmmarint@unizar.es] 
Sent: 28 March 2013 17:06 
To: Ghiassi, Ramesh 
Subject: Re: permission to reproduce a graph 
 
Dear Ramesh 
I am honoured with your wishes of using our figures. 
Good look with your thesis 
JMª 
-- 
Dr. José Mª Marin 
Professor of Medicine 
Hospital Universitario Miguel Servet 
Zaragoza, Spain 
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2. 
 
From: "Ghiassi, Ramesh" <r.ghiassi05@imperial.ac.uk> 
To: 'Erica Ison' <erica_ison@yahoo.co.uk>  
Sent: Thursday, 7 March 2013, 12:25 
Subject: RE: NHS Atlas of variation in Respiratory Healthcare 
 
Dear Erica, 
 
Matt Kearney recommended you as the right person to contact. 
 
Could I ask for permission to reproduce the map and graph on page 50 of the NHS Atlas of variation 
in Respiratory Healthcare 'rate of sleep studies per head of population per PCT' for my PhD thesis, 
which is on developing pictorial material for obstructive sleep apnoea syndrome. 
 
best wishes, 
 
Ramesh  
*********************************************************************************** 
Dear Ramesh 
 
Thank you for your email. 
 
Right Care have no objection to you using the Map on page 50 of the Respiratory Disease Atlas in 
your PhD thesis as long as due acknowledgement is given of the source. If you could insert the 
following at the end of the figure legend, we would be grateful: 
 
Reproduced with the permission of Right Care from NHS Atlas of Variation in Healthcare for People 
with Respiratory Disease: Reducing unwarranted variation to increase value and improve quality. 
September 2012. http://www.rightcare.nhs.uk/atlas/ 
 
If you would like us to supply you with an electronic version of the visualisation, please let me know. 
 
With kind regards, 
 
Erica 
 
Erica Ison 
Production Editor 
Then NHS Atlases of Variation in Healthcare 
QIPP Right Care Programme 
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3. 
 
From: Ghiassi, Ramesh 
Sent: 29 March 2013 11:24 
To: jane.warmer@papworth.nhs.uk 
Subject: permission to reproduce a figure from the Handbook of Sleep Medicine in PhD thesis 
Dear Jane, 
 
I wondered if Dr Shneerson could give me permission to use a diagram he produced in his 
handbook of Sleep Medicine (first Ed) p 119, highlighting the different causes of excessive daytime 
sleepiness. 
 
This would be for my PhD thesis on the development of pictorial material for obstructive sleep 
apnoea syndrome.  
 
I look forward to hearing from. 
 
Kind regards, 
 
Ramesh Ghiassi 
*********************************************************************************** 
From: Warmer Jane [Jane.warmer@papworth.nhs.uk] 
Sent: 03 April 2013 15:58 
To: Ghiassi, Ramesh 
Subject: PhD thesis 
Dear Ramesh 
  
Thank you very much for your e-mail about using the figure in the first edition of Sleep Medicine for 
your PhD thesis.  I am perfectly happy for you to use this figure and I hope that all goes well with 
your thesis. 
  
Yours sincerely 
  
  
Dr J M Shneerson MA DM FRCP 
Consultant Physician 
Respiratory Support and Sleep Centre 
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4. 
 
On 06/02/2013 17:14, Ghiassi, Ramesh wrote: 
 
I am a PhD student from Imperial College London. 
 
You featured an article on the University website in December 2012: 
 
http://www.keele.ac.uk/research/researchnews/2012/title,83993,en.php 
 
which I would like to replicate in my thesis. Please could you direct me to whom I need to ask 
permission to replicate this table? 
 
With Kind regards, 
 
Ramesh Ghiassi 
*********************************************************************************** 
From: Chris Stone [c.w.stone@keele.ac.uk] 
Sent: 07 February 2013 15:30 
To: Ghiassi, Ramesh 
Subject: Re: Permission to replicate a table from the University website 
Hi, 
 
Yes, it is o.k. to replicate the article but please attribute as such: 
 
"by kind permission of Rowlands,G, Protheroe,J - unpublished work in the process of 
completion for publication" 
 
Regards 
Chris 
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5. 
 
From: Ghiassi, Ramesh [mailto:r.ghiassi05@imperial.ac.uk] 
Sent: Tuesday, April 02, 2013 9:08 AM 
To: Davis, Terry 
Subject: permission to reproduce a copy of REALM in my PhD thesis 
 
Dear Professor Davis, 
 
I am a PhD student at Imperial College London. I am writing to ask for your permission in 
reproducing a copy of REALM in my PhD thesis. My PhD is titled 'developing pictorial material for 
obstructive sleep apnoea syndrome.' 
 
I look forward to hearing from you. 
 
Kind regards, 
 
Ramesh Ghiassi 
*********************************************************************************** 
Sent: 04 April 2013 22:24 
To: Ghiassi, Ramesh 
Subject: RE: permission to reproduce a copy of REALM in my PhD thesis 
 
Ramesh 
You are free to do this 
Glad to send you the REALM 
Terry 
 
Terry C. Davis, PhD 
Professor, Departments of Medicine and Pediatrics Louisiana State University Health Sciences 
Center 
1501 Kings Highway 
Shreveport, LA 71130 
Phone: 318-675-8694 
Fax: 318-675-4319 
E-mail: tdavis1@lsuhsc.edu  
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6. 
 
From: Ghiassi, Ramesh [mailto:r.ghiassi05@imperial.ac.uk]  
Sent: 23 May 2013 17:01 
To: lizzie.hill@ed.ac.uk 
Subject: RE: Thorax 2011 - pESS 
  
Dear Lizzie, 
  
I'm preparing to submit my PhD thesis and with your permission I would like to reference your work 
from the ESRS Sept 2012 and include a PDF copy of your poster in the appendix showing how the 
pESS has been used by others.  
  
I look forward to hearing from you. 
  
Best wishes, 
  
Ramesh  
*********************************************************************************** 
From: Lizzie Hill [LIzzie.Hill@ed.ac.uk] 
Sent: 28 May 2013 08:58 
To: Ghiassi, Ramesh 
Subject: RE: Thorax 2011 - pESS 
Hi Ramesh, 
  
I’d be delighted if you referenced our work in your thesis. We’ve had another poster accepted for this year’s 
ERS, using the pESS in our general sleep clinic setting. I can send you the abstract if you wish? 
  
Best of luck submitting your thesis, and thanks for considering our work for inclusion. 
  
Lizzie 
  
______________________________ 
Lizzie Hill 
Dept. of Sleep Medicine, RIE 
0131 242 3879 
www.nhsscotland.com/sleep 
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7. 
____ 
From: Ghiassi, Ramesh [mailto:r.ghiassi05@imperial.ac.uk] 
Sent: Thu 5/23/2013 4:50 PM 
To: Drakatos Panagis 
Subject: BTS poster December 2012 
 
Dear Panagis, 
 
Could I kindly request your permission to show a copy of your Winter BTS 2012 poster (BLF pictorial ESS 
data) in my thesis? 
 
Best wishes, 
 
Ramesh 
*********************************************************************************** 
 
From: Drakatos Panagis [Panagis.Drakatos@gstt.nhs.uk] 
Sent: 23 May 2013 17:34 
To: Ghiassi, Ramesh 
Subject: RE: BTS poster December 2012 
Of course you have my permission. 
 
Best Wishes, 
 
Panagis 
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Appendix 10 
 
Ethical approval information 
 
Table A10.1 
 
Ethics committee name, 
REC number and 
date of approval 
Project Title 
 
Charing Cross Research 
Ethics Committee 
 
06/Q0411/168 
 
21st December 2006 
 
 
The development of new material for the assessment 
and diagnosis of obstructive sleep apnoea syndrome. 
 
 
 
Research Governance 
Registration 
 
PARX2018 
 
9th February 2007 
 
 
The development of new material for the assessment 
and diagnosis of sleepiness and obstructive sleep 
apnoea syndrome 
 
 
Charing Cross Research 
Ethics Committee 
 
08/H0711/3 
 
21st February 2008 
 
 
The use of a pictorial screening tool to assess likelihood 
of obstructive sleep apnoea syndrome (OSAS) in a 
cardiology rehabilitation clinic. 
 
National Research Ethics 
Service West London 
REC 2 
 
08/H0711/3 
 
8th April 2010 
 
 
The use of a pictorial screening tool to assess likelihood 
of obstructive sleep apnoea syndrome (OSAS) in a 
cardiology rehabilitation clinic. 
 
Substantial Amendment to include questionnaire 
follow–up of those that declined a sleep study 
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Appendix 11 
 
Work that I have published as a result of this thesis: 
 
1. Ghiassi R, Partridge MR. Health Literacy and Sleep Apnoea. Thorax 2011 Feb; 
66(2):180. 
 
2. Ghiassi R, Cummin AR, Murphy K, Partridge MR. Developing a pictorial 
Epworth Sleepiness Scale. Thorax. 2011 Feb;66(2):97-100. 
 
3. Ghiassi R, O’Byrne, Cummin AR, Partridge MR.  What might patients mean by 
“Sleepiness”? Thorax 2010; 65:(suppl 4)209. (poster communication) 
 
4. Ghiassi R, O’Neill P,  Edwards J, Cummin AR, Connolly S, Partridge 
MR. Screening for obstructive sleep apnoea syndrome in a cardiac prevention and 
rehabilitation programme. Thorax 2009;152. (poster communication) 
 
5. Ghiassi R, Chan T, To K, Partridge MR, Hui DS. Comprehensibility of pictorial 
images of sleepiness and features of obstructive sleep apnoea syndrome in a Hong 
Kong and UK population. Journal of Sleep Research 2008;17(suppl.)142-143. (poster 
communication) 
 
 
Work that other people have published as a result of research in this thesis: 
 
1. Drakatos P, Jarrold I, Harris J, Abidi A, Douiri A, Hart N, Kosky C, Williams A, 
Steier J, Age and Gender Specific Differences in Excessive Daytime Sleepiness. 
Thorax 2012;67 (suppl.2): 262. (poster communication) 
 
2. Hill EA, Fairly D, Van Putten S, Cooper SA, Forbes JF, Williams L, Riha RL. 
Use of the pictorial Epworth Sleepiness Scale in adults with Down’s 
Syndrome.  Journal of Sleep Research 2012; 21 (suppl.1): 291. (poster communication) 
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3. Hill EA, Fairley D, Van Putten S, Cooper S, Forbes JF, Williams L, Riha 
RL. Prevalence of sleep apnoea, sleepiness and behavioural/emotional disturbances in 
adults with Down’s syndrome in Scotland. European Respiratory Journal 2012; 40 
(suppl.56): 325. (poster communication) 
 
4. Fairley DM, Vennelle M, Azuaje-Borges R, Riha R. Comparison of the pictorial 
Epworth Sleepiness Scale and the Epworth Sleepiness Scale in a sleep clinic 
population. European Respiratory Journal 2013; 41 (discussion poster communication, 
European Respiratory Society meeting, Barcelona, Spain 7-11th September 2013).  
 
 
